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1. Major depressive disorder 
 
1.1 Clinical diagnosis of major depressive disorder 
Major depressive disorder (MDD) is among the most common psychiatric disorders with a 
lifetime prevalence estimated at 16.2% in the United States1 (see 
www.hcp.med.harvard.edu/ncs/ for up to date and comprehensive statistics) and 17.5% in 
The Netherlands2, with females at higher risk than males. It is estimated that in the year 
2020 MDD will be the second leading cause of disability, only to be surpassed by ischaemic 
heart disease3. The consequences of MDD are of compound nature and characterized by 
the fact that MDD has a high tendency towards relapse, recurrence and chronicity4.  
Diagnosis of MDD is based on symptomatic criteria of the Diagnostic and Statistical 
Manual of Mental Disorders, Fourth Edition (DSM-IV). The diagnostic criteria for MDD 
require persistence of either depressed mood or loss of interest and pleasure (anhedonia), 
in association with at least four out of the following symptoms: inattention, fatigue, self-
depreciating or suicidal thoughts, and disturbances of psychomotor activity, sleep, appetite 
and weight. Symptoms need to be present consistently for at least two weeks. The variety in 
clinical symptoms of MDD underscores the complexity of the disease and, therefore, MDD is 
regarded as a heterogeneous disorder comprising of many different syndromes rather then a 
single disease. In particular, the clinical course of MDD is pleiomorphic and varies from 
subthreshold syndromes, single episodes (short or long), multiple recurrent episodes with or 
without inter-episodic recovery, residual symptoms after an episode, to chronicity5.  
 
1.2 The pathogenesis of depression 
An open question in MDD is which factors underlie a person’s vulnerability (or resilience) to 
the disease. Various putative risk factors have been suggested arising from epidemiological 
studies but difficulties in differentiating between association and causation have left many 
inconsistencies. However to date, it is generally accepted that both genetic and non-genetic 
factors, and the interaction between those, comprise disease liability6,7.  
Genetic epidemiological studies have shown depression to be a familial disorder with 
increased risk odd ratios (ratio of risks of first-degree relatives of MDD probands vs. the 
general population) of ~2.8 7. Familial studies can, however, not distinguish between genetic 
and shared environmental influences. Therefore, twin studies using mono- and dizygotic 
twins have been performed. These confirmed that genetic influences for the most part 
contribute to this familial aggregation, and heritability of liability is estimated to be ~37%7. In 
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terms of genetic contribution in psychiatric disorders this makes MDD at the lower end of the 
scale8. 
Of the environmental factors, the most consistent and dominant one is exposure to 
stressful live events. Twin studies have shown a causal relation between MDD and events 
related to ‘bad luck’ or stressful experiences related to a persons own behavior (65 – 75%), 
with odd ratios – the ratio of the risk of disease to individuals experiencing an event 
compared with persons without the stressful event – of 2.33 and 5.64, respectively6. 
Furthermore, the occurrence of stressors are 2.5 times more likely in depressed patients 
compared with controls, and in community samples, 80% of the depressed cases have 
experienced major life events prior to the onset9. In particular chronic forms of stress, often 
psychosocial in nature, may predict precipitation of depression10.  
 
1.3 Brain structures involved in MDD 
Despite the prevalence of depression and its considerable impact, knowledge about the 
pathophysiology of MDD is limited. This is caused by the fact that MDD is heterogeneous in 
terms of disease and underlying causes. Additionally, the impossibility to take a brain biopsy 
from depressed individuals hampers investigation of the affected brain tissue.  
Since currently available antidepressants adjust monoaminergic signaling (Box 1), early 
studies focused largly on monomaminergic nuclei such as the dorsal raphe nucleus and the 
locus coeruleus. From these nuclei, serotonergic and noradrenergic neurons innervate most 
other brain regions, respectively.  
However, the development of structural en functional neuroimaging technologies has 
permitted in vivo characterization of the anatomical correlates of mood disorders. Among 
these are brain regions and circuits that are known to regulate emotion, reward and 
executive function. Dysfunction of these highly interconnected ‘limbic’ regions has been 
implicated in depression and antidepressant action. In particular, these regions include the 
amygdala (anxiety and emotional memory), hippocampus (cognition), mediodorsal and 
midline thalamic nuclei (emotional expression), hypothalamus (vegetative symptoms and 
hormonal regulation), subgenual anterior cingulate cortex (negative mood states), and the 
ventral striatum (anhedonia)11. However, published findings are not consistent and are often 
complicated by comorbid diagnoses and medication history, and there has been little 
success in demonstrating any clear cause–effect relationships of pathological changes and 
MDD.  
Among the most consistent findings are a reduced grey-matter volume in the 
hippocampus12,13 and prefrontal cortex14. These pathological changes have been linked to  
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the cognitive aspects of depression, potentially underlying a ‘diminished ability to think or 
concentrate’. Cognitive difficulties in major depression fall into at least two domains. First, 
impairment of concentration and attention is likely to relate to the well-documented 
abnormalities of dorsolateral prefrontal cortex (DLPFC)-function in MDD subjects15. Second, 
MDD patients also exhibit prominent deficits in explicit memory16, a cognitive capacity well-
known to depend on the function of the hippocampus and the medial temporal lobe17. Apart 
from structural changes, hippocampal atrophy has been repeatedly documented in MDD. 
Whereas the total number of neurons and glia has not been found altered, neurons are 
reduced in size and the volume of the neuropil is reduced18. Disruption of hippocampal 
function, including the capacity for neuroplasticity, might contribute to several cognitive 
aspects of severe forms of MDD.  
In addition to its role in declarative memory, the hippocampus is a key regulator of 
prefrontal cortical function; the hippocampus and DLPFC act concertedly to regulate explicit 
memory. Disruption of hippocampal function in MDD might therefore contribute to the 
observed deficits in concentration, described above. The hippocampus is also a critical 
activity regulator of both nucleus accumbens and ventral tegmental area (VTA). It has been 
hypothesized that an indirect excitatory projection from hippocampus to VTA is important for 
coordinating the firing of VTA cells in response to novelty19. Impairment of this hippocampal 
function might lead to reduced dopaminergic tone and contribute to anhedonia20. Finally, the 
hippocampus provides an important source of negative modulation of the hypothalamus-
Box 1. Most commonly prescribed antidepressants 
Drug Brand Class Mechanism of action 
Sertraline Zoloft SSRI Inhibits serotonin transporter, and partly dopamine 
reuptake 
Escitalopram Lexapro SSRI Inhibits serotonin transporter 
Fluoxetine Prozac SSRI Inhibits serotonin transporter 
Bupropion Wellbutrin NDRI Inhibits norepinephrine and dopamine transporters 
Imipramine Tofranil TCA Inhibits serotonin, norepinephrine, and dopamine 
transporters. Is an antagonist of acetylcholine and 
histamine receptors. And is a dopamine receptor 
agonist 
Venlafaxine Efexor SNRI Inhibits serotonin and norepinephrine transporters 
Citalopram Cipramil SSRI Inhibits serotonin transporter 
Trazodone Trazolan SARI Inhibits serotonin transporter and antagonizes 
several serotonin and noradrenalin receptors 
Amitriptyline Tryptizol TCA Inhibits serotonin, and norepinephrine, transporters. 
Is an antagonist of serotonin and adrenergic 
receptors 
SSRI: specific seretonin reuptake inhibitor;  NDRI: norepinephrine-dopamine reuptake inhibitor; TCA: 
tricyclic antidepressant; SNRI: Serotonin–norepinephrine reuptake inhibitor; SARI: Serotonin 
antagonist and reuptake inhibitors.  
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pituitary–adrenal (HPA) stress hormone axis through its projections to the hypothalamus; 
hippocampal dysfunction therefore may contribute to dysregulation of the stress response21 
that is seen in major depression. 
 
1.4 Treatment of MDD 
There are several effective treatments for depression. The large majority (80%) of people 
with MDD show improvement during treatment with antidepressants or with 
electroconvulsive therapy (ECT). In particular ECT is still being considered the most 
effective22,23 treatment for patients with melancholic or psychotic depression. In addition, 
several forms of psychotherapy – in particular, cognitive and interpersonal psychotherapy – 
can be effective for patients with mild to moderate symptoms.  
The first antidepressants were discovered by chance almost 50 years ago, when 
iproniazid, a drug registered for the treatment of tuberculosis, was found to elevate mood in 
MDD patients24. Simultaneously and independently, imipramine, an experimental 
antihistamine with a tricyclic structure, was found to have antidepressant effects24. Soon 
after this, drugs with antidepressant activity were shown to increase the extracellular 
concentrations of two important monoamine neurotransmitters in the brain, serotonin (5-
hydroxytryptamine or 5-HT) and noradrenaline, by inhibiting their catabolism or reuptake into 
nerve endings. These findings were the basis for the monoamine hypothesis of depression, 
which proposes that mood disorders are caused by a deficiency in serotonin or 
noradrenaline at functionally important receptor sites in the brain24,25. Over the last few 
decades, the view that depression is produced by a chemical imbalance in the brain has 
become widely accepted among scientists, clinicians and the public, despite the lack of 
evidence for a direct role of 5-HT in this.  
It soon became evident that the monoamine hypothesis in its original form did not 
explain all of the antidepressant effects26. In particular, available antidepressants 
immediately increase monoaminergic availability, while it takes up to several weeks for the 
clinical antidepressant response to occur23. Therefore, the focus of research was re-directed 
towards the receptors and intracellular signal transduction molecules that are regulated by 
antidepressant treatment27, thereby generating new theories of the pathophysiology of MDD, 
the action of antidepressant medications, and identifying potential targets for novel 
antidepressant therapies28. A striking observation, as these downstream molecular events 
have been elucidated, is the degree of overlap between the molecular and cellular changes 
induced by antidepressant treatment and the molecular mechanisms of neuroplasticity, 
especially synaptic plasticity29.  
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In line with this, accumulating evidence suggests that the glutamatergic system and its 
plasticity play an important role in the neurobiology and treatment of depression. For 
example, the N-methyl-D-aspartate receptor (NMDAR) antagonist ketamine has consistently 
shown antidepressant effects within a few hours of its administration30,31. Also, it is 
hypothesized that increased alpha-amino-3-hydroxy-5-methyl-4 isoxazolepropionic acid 
receptor (AMPAR) throughput may represent a convergent mechanism for the rapid 
antidepressant actions of ketamine30,32. This raises the possibility that AMPA receptor 
potentiators might be useful in the treatment of MDD30. 
  
 
2. Stress, depression and neuroplasticity 
 
As discussed above, there is a clear relationship between psychosocial stressors and MDD. 
Also, in animal models of depression, stress induces depressive symptom-like behaviors33,34, 
and can lead to atrophy of the hippocampus similar to that seen in depression35. Increasing 
evidence shows that exogenously applied chronic stress has detrimental effects on 
neuroplasticity18,36,37. 
As outlined below, in these animal models an overlap between antidepressant-induced 
changes and mechanisms of neuroplasticity is observed. For example, antidepressant action 
in the hippocampus is found to be dependent on cAMP response element-binding (CREB) 
protein38 that has a well-established role in synaptic plasticity and learning and memory.  
These findings have resulted in the hypothesis that chronic stress, which can precipitate 
or exacerbate depression, disrupts neuroplasticity, whereas antidepressant treatment 
produces opposing effects and can enhance neuroplasticity (Fig 1). Experimental evidence 
for this hypothesis is discussed below, and originated for a large part from animal models on 
stress-related research (Box 2).  
 
2.1 Stress and neuroplasticity  
 
Memory, plasticity and cell survival 
In animal models, transient mild stress has been shown to increase hippocampus-
dependent memory performance39. However, more severe or chronic stressors induce 
hippocampus-dependent spatial memory impairments40,41. Similar results were obtained by 
treatment with glucocorticoid stress hormones40. Specific impairments of hippocampus-
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dependent explicit memory were also observed after treatment of human subjects with 
glucocorticoids42.  
Hippocampus-dependent memory formation is known to be dependent on long-term 
potentiation (LTP) and long-term depression (LTD), the basic cellular mechanisms of 
synaptic plasticity within the hippocampus29. Interestingly, both stress and increased 
glucocorticoid levels inhibit LTP in the rodent hippocampus43. Conversely, paradigms 
inducing stress in rodents enhance hippocampal LTD43.  
Sustained levels of stress or glucocorticoids could damage hippocampal cells. Stress 
leads to atrophy and retraction of the apical dendrites of hippocampal pyramidal cells44. In 
addition, different forms of acute and chronic stress have been shown to reduce adult 
hippocampal neurogenesis in rodents18. It has been established that new neurons are 
generated in the dentate gyrus region of the hippocampal formation of the adult mammalian 
brain45. Neurogenesis appears to be required for the behavioral response to antidepressants 
in rodents46 and impaired neurogenesis has been hypothesized to represent a core 
pathophysiological feature of MDD18,47. Thus, neurogenesis might mediate the effects of 
stress on mechanisms of neuroplasticity and may contribute to the development of MDD. 
Similar effects of stress have been obtained in the PFC, such as reduced synaptic 
plasticity in projections coming from the amygdala48, regression of the apical dendrites of 
pyramidal cells49, and a reduction in the number of glial cells50. In contrast, in the amygdala, 
stress enhanced synaptic plasticity and the function of amygdala neurons51. Stress could 
also enhance amygdala-dependent learning52, and the size and activity of the amygdala 
were increased in depressed patients53. This contrast in stress-related response of different 
brain areas makes clear that the well-documented effects of stress on hippocampal 
morphology and function are not the mere manifestations of a universal effect of stress 
hormones, or other aspects of stress, on neuronal integrity. Rather, the effects of stress on 
brain morphology and function are region- and circuit-dependent. 
 
Stress and molecular plasticity 
Accumulating evidence suggests a role for glutamate in response to stress that might 
subsequently yield depression54. Glucocorticoid excess increases glutamate release in the 
CA1 region of the hippocampus55 and chronic behavioral stress increases extracellular 
levels of glutamate in the CA3 region56. This excess glutamate likely contributes to cell 
damage in these regions and possibly even cell death35,57. Chronic stress increases 
glutamate levels, which activates extrasynaptic NMDA receptors58. Extrasynaptic NMDA 
receptors have been found to inhibit LTP58.  
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Figure 1. The neuroplasticity hypothesis for depression. In healthy humans or animals (left), stress 
can disrupt neuroplasticity in specific neuronal networks, i.e. the hippocampus or PFC (right). 
Antidepressant drugs, electroconvulsive treatment, of behavioral therapy can all enhance 
neuroplasticity, thereby bringing plastic processes back to normal levels and relieving (cognitive) 
depressive symptoms.  
Stress can also alter downstream molecular signaling at the synapse in several ways. 
For example, both acute and chronic stress alter the activity of mitogen-activated protein 
kinase (MAPK)59 and calcium-calmodulin-dependent kinase II (CaMKII)60, two proteins that 
become activated by sufficient synaptic activity and therefore are involved in both early and 
late phase LTP. In addition, stress leads to reductions in hippocampal brain-derived 
neurotrophic factor (BDNF) mRNA levels, suggesting an impairment of some of the 
mechanisms of neuroplasticity. BDNF is known to be induced in activity-dependent LTP and 
it has a critical role in stabilizing synaptic change61.  
 
2.2 Antidepressants and neuroplasticity 
 
Memory, plasticity and cell survival 
As stress reduces neuroplasticity, and MDD is associated with a depressed synaptic state, it 
is likely that antidepressant treatment has the opposite effect. Indeed, accumulating 
evidence shows that antidepressants influence plasticity in a contrasting, but not exactly 
opposite way. In this respect, studies in healthy individuals / non-stressed animals are 
sparse and sometimes conflicting, but antidepressants consistently restore decreased 
plasticity.  
Some lines of research show that, in healthy humans, antidepressant treatment 
increases memory and acts on other cognitive domains62,63, although evidence is sparse. 
GENERAL INTRODUCTION 
17	  
Also in naïve animals, there is not a lot known of the effects of antidepressants. Some, 
although not all, antidepressants increase performance in the Morris water maze, a spatial 
learning and memory model64.  
At the synaptic level, antidepressant treatment predominantly increases plasticity. In 
naïve animals, several studies show increased LTP in dentate gyrus and CA1 synapses, 
although results have not been consistent and were dependent on the type of 
antidepressant65. More importantly, antidepressant treatment has consistently been found to 
rescue stress-induced reductions in LTP and increases in LTD66,67. Furthermore, chronic 
antidepressant treatment blocks the stress-induced changes in dendritic morphology and 
neurogenesis68, and some classes of antidepressants also increase neurogenesis in naïve 
animals68.  
 
Molecular changes induced by antidepressants 
Several lines of evidence suggest that antidepressants can directly modulate glutamate 
neurotransmission. For example, both riluzole and lamotrigine, which have antidepressant 
properties, increase the surface expression of alpha-amino-3-hydroxy-5-methyl-4 
isoxazolepropionic acid receptor (AMPAR) subunits GluR1 and GluR2, and riluzole 
reversibly attenuates AMPAR-mediated synaptic currents in cultured cells69. More typical 
antidepressants, such as fluoxetine, can regulate the phosphorylation state and thereby the 
function of AMPARs70 in frontal brain areas. These effects of antidepressants, targeting 
other molecules and pathways, have led to the proposal that direct modulators of AMPAR 
function, such as AMPAkines, can act as antidepressants.  
Furthermore, in rodents, chronic antidepressant administration increases cAMP levels71, 
and activates cAMP-dependent protein kinase (PKA)72 and CREB73. Since this cAMP-PKA-
CREB pathway is important in the maintenance of LTP, it is hypothesized that activation of 
this pathway accounts for the antidepressant induced increase in LTP. However, this 
suggested direct link needs validation in future studies. Another line of evidence supporting 
the hypothesis that antidepressant treatment leads to altered neuroplasticity, is the 
regulation of neurotrophic factors by antidepressants. Chronic antidepressant administration 
increases the expression of BDNF in the hippocampus and PFC74. Roles for BDNF in 
depression and its antidepressant action are supported by studies showing that levels of 
BDNF were decreased in the brains of MDD patients75 and were increased in patients 
receiving antidepressant treatment at the time of death76. Also, BDNF infusions produced an 
antidepressant response in animal models77.  
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Non-pharmacological treatment 
Apart from pharmacological treatment, also ECT and behavioral therapy have profound 
effects on neuroplasticity. Both these forms of treatment have been found to increase 
plasticity in frontal brain areas, i.e., reverse the stress-induced decrease in neuroplasticity in 
animal models of depression. Both treatments increase hippocampal LTP78 and prevent 
stress-induced alterations in cellular morphology and neurogenesis20.  
 
2.3 Neuroplastcity and the relevance for depression 
The effects of stress and antidepressants suggest that decreased neuroplasticity is a core 
pathophysiological feature of MDD. However, these data are best applicable to the 
hippocampus and PFC, whereas in other brain areas, such as the amygdala and the 
nucleus accumbens, increased plasticity after stress is related to depressive-like phenotypes 
in animal models34,51. For example, expression of CREB in the nucleus accumbens 
increased behavioral despair and helplessness in the forced swim and learned helplessness 
paradigms, and CREB inhibition has an antidepressant effect79. Therefore it is likely that 
decreased plasticity contributes to the installment of a depressive state only in certain brain 
areas.  
Most of the behaviors used to assay antidepressant effects in rodents, e.g., learned 
helplessness, the forced swim test, and the tail suspension test (see below and Box 2), are 
models of behavioral despair and coping. Animals are placed in an adverse environment 
from which it is difficult or impossible to escape, and, after a period of struggle, they enter a 
behavioral state of passivity. It might be that enhancement of neuroplasticity, and the 
concomitant increased capacity to adapt and learn, lead to an enhanced potential repertoire 
of behaviors or capacities to explore new escape options in adverse circumstances, and 
thus reduces the tendency to enter a state of behavioral despair. This interpretation predicts 
that enhanced neuroplasticity is indeed of causal importance for reduced depression-like 
behaviors after antidepressant treatment. Additionally, considering the undisputed relation 
between neuroplasticity and learning and memory, it is tempting to speculate that cognitive 
impairments seen in depressed patients are associated to these neuroplastic changes. 
Future studies using animal models of depression should provide evidence for a causal 
relationship between depression-related cognitive impairments and reduced neuroplasticity, 
and in particular, what molecular changes might account for these impairments.  
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Box 2. Animal models used in depression research 
Model Main features of symptoms and antidepressant effects 
Forced swim 
test 
Lack of struggling when placed in a chamber of water, thought to represent a state 
of despair. Antidepressants acutely increase the time an animal struggles. 
Tail suspension 
test 
Lack of struggling when suspended by its tail, thought to represent a state of 
despair. Antidepressants acutely increase the time an animal struggles. 
Learned 
helplessness 
Animals exposed to inescapable foot shock take a longer time to escape, or fail to 
escape entirely, when subsequently exposed to escapable foot shock. 
Antidepressants acutely decrease escape latency and failures. 
Chronic mild 
stress 
Animals exposed repeatedly to several unpredictable stresses (cold, disruption of 
light-dark cycle, foot shock, restraint, etc.) show reduced sucrose preference and 
sexual behavior. Chronic antidepressant treatment reverses these symptoms.  
Social stress Animals exposed to various types of social stress (proximity to dominant males, 
odors of natural predators, defeat by a dominant conspecific) show behavioral 
abnormalities. Chronic antidepressant treatment reverses these symptoms. 
Early life stress Animals separated from their mothers at a young age show some persisting 
behavioral and HPA axis abnormalities as adults, some of which can be reversed 
by antidepressant treatments. 
Olfacotry 
bulbectomy 
Chemical or surgical lesions of the olfactory bulb cause behavioral abnormalities, 
some of which can be reversed by antidepressant treatments. 
Anxiety-based 
tests 
The degree to which animals explore a particular environment (open space, brightly 
lit area, elevated area) is increased by anxiolytic drugs (e.g., benzodiazepines). 
Reward-based 
tests 
Animals show highly reproducible responses to drugs of abuse (or to natural 
rewards such as food or sex) in classical conditioning and operant conditioning 
assays. 
Cognition-based 
tests 
The ability of animals to attend, learn, and recall is measured in a variety of 
circumstances. This possibly models cognitive impairments. 
 
3. Rodent models of depression 
 
Animal models of depression are evaluated for their validity based on four criteria: (1) 
similarity in the symptom profile presented, such as decreased interest in pleasure (face 
validity), (2) amelioration or attenuation by treatments effective in treating the human 
condition i.e. antidepressants and behavioral therapy (predictive validity), (3) provocation by 
events thought to be important in eliciting the human disorder, such as stressful life events 
(etiological validity), and (4) involvement of similar neurochemical processes, like decrease 
hippocampal BDNF expression (construct validity). This is a challenge. Many of the core 
symptoms of depression (e.g., depressed mood, feelings of worthlessness and suicide) 
cannot be easily measured in laboratory animals. As a result, most available animal models 
of depression rely on one of two principles: 1) effects of known antidepressants and 2) 
responses to stress, thereby modeling depressive symptoms (Box 2).  
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3.1 The forced swim test 
Some of these tests, in particular the forced swim test, have been very effective at predicting 
the antidepressant efficacy of pharmacons (predictive validity)80. In this test, rodents 
immersed in a vessel of water develop an immobile posture after initial struggling. This 
immobility is considered as behavioral despair. Most antidepressants, administered acutely 
before the test, reverse immobility and promote struggling80. Obviously, models that use an 
acute stressor (for example, forced swimming) are better thought of as read-out of coping 
style, and cannot recapitulate a long-lived multidimensional syndrome such as depression. 
Therefore, this test should be considered as a fast and cost-efficient screening paradigm for 
potential antidepressants, rather than an animal model reflecting multiple aspects of the 
disorder. In this thesis this test was used to screen for the possible long-lasting 
antidepressant effect of the novel antidepressant ketamine.  
 
3.2 The social defeat paradigm 
Animal models that try to incorporate the multidimensional aspects of depression in order to 
study its neurobiological underpinnings are limited to stress models such as social defeat or 
chronic mild stress. These are more technically challenging paradigms, however, they show 
unique sensitivity to chronic and not acute antidepressant administration, which is 
comparable to the therapeutic delay of 3–6 weeks that is required for all available 
antidepressant drugs to adequately treat depression in humans26. In the social defeat model 
the experimental male rodent is placed in the territory of a large dominant male, after which 
a fight takes place and the intruder gets (socially) defeated. Apart from having etiological 
validity, because of the social stressor used as trigger, this model also has face validity, in 
which certain behavioral changes brought about by stress superficially resemble depressive 
symptoms. For instance, the defeated animal shows decreased sucrose intake or a reduced 
anticipation towards sucrose after chronic stress, which is thought to model anhedonia33,81. 
However, most studies of these models mimic the effects of acute stress, i.e. effects are 
studied acutely after the last stress-encounter, whereas we know from human studies that 
depressive symptoms are still apparent long after cessation of the stressor82. Moreover, 
these paradigms do not model the effects of more passive forms of stress, such as social 
isolation83. This is unfortunate since the lack of social support is known to be important 
especially for maintenance of depressive symptoms33. Therefore, to be able to study the 
long-term consequences of social defeat stress on depressive-like behavior, I adopted a 
social defeat paradigm33 in which experimental rats get socially defeated after which they 
are kept in social isolation for an additional 10-12 weeks. This paradigm might match human 
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depression in which active stress is often involved in the onset of depression, while passive 
stress, e.g., in the form of impaired social interaction, has strong precipitating effects on the 
development of the disease84.  
 
 
4. Aim and outline of the thesis 
 
MDD is a devastating brain disease that negatively impacts on the lives of many people 
worldwide. The aim of this thesis is to identify novel molecular targets that can be used to 
address the cognitive dysfunction that comes with MDD. For this I made use of two animal 
models, 1) temporal effects of ketamine in the mouse forced swim test, 2) social defeat (SD) 
stress in rats, which has best validity in terms of modeling aspects of MDD. In particular, I 
investigated the molecular and cellular neurogenic and plasticity changes that might affect 
hippocampal function, short and long-term after SD stress. I investigated whether typical 
antidepressants have a positive effect on the changes that are brought about by SD stress. 
Also I investigated the effect of behavioral therapy in this model. In this thesis there are 
several specific questions concerning stress-induced hippocampal plasticity that are 
addressed in the four experimental chapters.  
First of all the antidepressant action of ketamine was investigated. This NMDA receptor 
antagonist produces rapid (1 hour), robust and sustained (up to two weeks) antidepressant 
actions in treatment-resistant MDD patients31 and in preclinical models of depression 
following a single systemic infusion32. The rapid antidepressant effect of ketamine is of great 
interest since all other available antidepressants take weeks to exert their antidepressant 
effects. However, the mechanism through which ketamine exerts its effects is largely 
unknown. In chapter 2 I investigated the synaptic mechanism through which ketamine 
produces its antidepressant effect.  
Then I went on to get better insight into the neurobiology of MDD by using an animal 
model with profound validity for the human disorder. First, I investigated cognitive functioning 
and molecular changes at the level of the synapse that might occur directly after severe SD 
stress exposure when compared to the long-term effect of SD. These molecular alterations 
are involved at the onset of neuroplastic changes and the installment of a depressive-like 
phenotype, and are addressed in chapter 3 of this thesis.  
A second issue concerns the longitudinal effects of stress on neuroplasticity. As we 
know from human studies (see82 for review), depressive symptoms are often still apparent 
long after the end of a stressful life event and MDD is considered a chronic disease. 
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Therefore, it is of interest to determine whether the long-term effects of SD stress on 
depressive-like (cognitive) symptoms are related to altered hippocampal plasticity. In 
chapter 4 I questioned whether the depressive symptoms that are seen long after the 
cessation of social defeat stress exposure and are maintained by social isolation, are 
associated with reduced hippocampal memory performance. Ongoing, I investigated which 
type of cellular and molecular plasticity occurred at hippocampal synapses that could be 
involved in hippocampus-dependent memory impairment long after SD stress, and whether 
a form of behavioral therapy or chronic antidepressant treatment could restore these 
changes. In addition, I investigated whether long-term effects of SD stress were also 
associated with changes in the neurogenic process in the hippocampal dentate gyrus, which 
is discussed in chapter 5. Here, I also investigated the antidepressant action on SD-affected 
neurogenesis.  
Finally, chapter 6 of this thesis brings together my data, and here the most important 
conclusions are discussed in the context of MDD. 
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Abstract  
The NMDA receptor antagonist ketamine produces rapid, robust and prolonged 
antidepressant actions in treatment-resistant patients and preclinical models of depression 
following a single systemic infusion. Elucidating the neural sites and mechanisms underlying 
its effects are crucial for further development of novel treatments. Here, we examined the 
contribution of synaptic hippocampal glutamate receptors in depressive-like behavior as 
measured using an optimized set-up and automated protocol for the forced swim test (FST) 
in mice, a test of behavioral despair. Increased behavioral despair correlated with higher 
synaptic membrane expression of hippocampal NMDA receptor (NMDAR) subunit GluN2A. 
Subsequently, we analyzed the short- and long-term behavioral effects, and long-term 
molecular effects of a single dorso-hippocampal infusion of ketamine. Ketamine caused both 
rapid and enduring antidepressant effects without impairing memory retention. These long-
term antidepressant effects were paralleled by increased turnover of AMPA receptors 
(AMPARs) as shown by increased Ser-845 phosphorylation of GluA1. The relative 
contribution of hippocampal AMPAR over NMDAR appeared to be crucial for the 
antidepressant-like effect, as molecular blockade of regulated AMPAR endocytosis by a 
TAT-Glu23Y peptide in the CA1 region of the dorsal hippocampus partially mimicked the 
effects of ketamine. The well-known long-term antidepressant effect of a single treatment 
with ketamine is potentially mediated by increased hippocampal AMPAR function. 
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Introduction 
Major depressive disorder (MDD), also referred to as major depression, is a common, 
chronic, recurrent mental illness that affects millions of individuals worldwide. Since current 
available antidepressants target the monoaminergic systems (serotonin, norepinephrine, 
and dopamine), these transmitter systems have received most attention in depression-
related research. However, these antidepressants take weeks to achieve their therapeutic 
effect and leave patients particularly vulnerable to the devastating symptoms and the risk of 
self-harm. Therefore, treatment strategies that exert a rapid and prolonged antidepressant 
effect within days or even hours could substantially benefit public health. Previously, clinical 
trials have shown the immediate improvement of depressive symptoms in treatment-
resistant patients by the use of a sub-anesthetic single dose of ketamine31,85. This 
antidepressant effect is characterized by a very rapid onset of action (within hours) and a 
robust and prolonged effect, lasting one to two weeks. Recently, the rapid activation of the 
mTOR pathway, leading to increased synaptic signaling proteins and increased number and 
function of new spines, was shown as mechanism for the acute antidepressant effects of 
ketamine86. As yet, molecular insight into the more lasting effects of ketamine, as well as the 
main anatomical site of action in the brain is not available. 
Ketamine is a non-competitive N-methyl-D-aspartic acid (NMDA) receptor antagonist87 
and has been used clinically as a dissociative anesthetic in both pediatric and adult 
patients88. Its primary mechanism of action is blocking the NMDA receptor (NMDAR) at the 
phencyclidine site in the ion channel. In addition, ketamine induces rapid increases in 
presynaptic release of glutamate, a process hypothesized to be mediated by NMDA 
autoreceptors, and/or by activated GABAergic neurons89. Apart from ketamine, other 
NMDAR antagonists, such as MK-801 and CGP 37849, have antidepressant-like effects in 
several preclinical paradigms90,91. A better understanding of the antidepressant effect of 
ketamine might aid future development of rapidly acting and effective pharmacological 
therapies.  
Apart from the antidepressant effect of ketamine, other clinical and preclinical lines of 
research points to the involvement of the glutamatergic system in the pathophysiology of 
depression. Several reports showed increased glutamate levels in blood and cerebrospinal 
fluid in patients with MDD92. In rodent models of depression, synaptic plasticity was affected 
in glutamatergic neurons in both the CA1 and the dentate gyrus of the hippocampus93. 
Growing evidence supports the idea that antidepressants, via a cascade of time-dependent 
signaling, ultimately converge to regulate α-amino-3-hydroxy-5-methyl-4-isoxazole propionic 
acid (AMPA) and NMDA receptor-mediated synaptic plasticity (reviewed in94). Consequently, 
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several studies showed that positive allosteric modulators of AMPA receptors (AMPARs), 
referred to as AMPA potentiators, display antidepressant effects in both clinical31 and 
preclinical95 studies.  
Recently, a large body of evidence from preclinical studies indicates that the acute 
effect of ketamine is mediated through a functional interplay between AMPARs and 
NMDARs32,96. The increased presynaptic release of glutamate preferentially acts on 
AMPARs, due to the ketamine inhibition of NMDARs. This direct effect of ketamine on 
glutamatergic signaling explains the rapid onset of action when compared to other 
antidepressants. Given these acute effects, the prolonged antidepressant action of up to at 
least a week31,86,97 remains unexplained.  
Here, we investigated how ketamine prolongs its antidepressant effects much beyond 
its short half-life (~13 min in serum of mice;98) and duration of NMDAR blockade. Secondly, 
we investigated through which neuronal circuits ketamine exerts its antidepressant effects. 
We show, by using an automated forced swim test (FST) analysis of depressive-like 
behavior in mice, that the long-term effects of ketamine are likely to be regulated by 
persistently increased AMPAR function in the dorsal part of the CA1 region in the 
hippocampus. 
 
 
Methods & Materials 
Animals 
All experiments were carried out in accordance to the Animal User Care Committee (VU 
University). Adult male (>8 weeks) C57BL/6J and DBA/2J mice (20-25 g, Charles River) 
were singly housed on a 12/12 h light/dark cycle with ad libitum access to food and water, 
light on at 7 AM. All mice were habituated to the facility for at least 1 week prior to testing, 
and were allowed to recover for at least 1 week after surgery. 
 
Pharmacalogical Interventions 
Acute systemic injection – Imipramine (Sigma Aldrich, Germany; 8 or 16 mg/kg) was injected 
intraperitoneally 30 min before testing. 
Chronic treatment – An osmotic minipump (Model 1004; Alzet, Cupertino, CA) containing 60 
mg/ml imipramine was placed subcutaneously during isoflurane anesthesia, resulting in 6-8 
mg/kg/day (for mice weighing 26-20 gram, respectively) administration of imipramine (28 
days).  
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Hippocampal injection – Mice were implanted with double guide cannulae (Plastics One, 
Roanoke, VA) targeting the CA1 region of the dorsal hippocampus as described 
previously99,100, using mouse brain atlas coordinates101. Ketamine hydrochloride (Alfasan, 
Woerden, The Netherlands) at a dose of 0.25 µg (0.125 µg/side) and 2.5 µg (1.25 µg/side) 
was infused in a volume of 0.25 µl/hemisphere during 2 min. To block regulated endocytosis 
of AMPARs in the CA1 region of the dorsal hippocampus, a synthetic peptide derived from 
the GluA2 carboxyl terminal fused to the cell membrane transduction domain of the HIV-TAT 
protein (GluA23Y: 869YKEGYNVYG877102) or control peptide (GluA23A: AKEGANVAG) were 
injected at (15 pmol/side; 60 µM) similar to ketamine delivery. Injection sites were verified 
(0.25 µl methylene blue), and mice that did not receive symmetrical and bilateral injections in 
Figure 1. Automated analysis of FST performance detects low-dose imipramine effects. 
Imipramine (Imi; 30 min prior to testing, i.p., 8 and 16 mg/kg) had no significant effect on immobility, as 
often measured during the last 4 min of the FST (A, left). However, measuring immobility during the 
total 6-min test time (A, right), as well as novel parameters resulting from our automated analysis like 
strategy (i.e. activity over time; B), total activity C), latency to first float (D) and time to change swim 
strategy (E) showed robust effects due to imipramine. Data derived from digital images are explained in 
detail in Fig. S1. For detailed ANOVA results, see Table S1. *** P<0.001, ** P<0.01, * P<0.05 vs. 
saline. 
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the CA1 region of the dorsal hippocampus were excluded. Days of testing after insertion of 
the pump or hippocampal injection are indicated  (Tables S1 and S3). 
 
Tissue Preparation and Immunoblotting.  
The hippocampus (strain differences) or its dorsomedial part (ketamine effect) were 
dissected from fresh brains and immediately frozen (–80 °C). Synaptic membranes were 
isolated (pool of 2 or 3 mice per sample) on a discontinuous sucrose gradient, as described 
previously103. SDS-PAGE (8%) was run using 5 µg/sample (Laemli lysis buffer). Proteins 
were blotted onto a PVDF membrane (Bio-Rad Laboratories, Hercules, CA). After blocking 
and incubation of the first antibody, against GluA1 (1:1,000; Genscript, Piscataway, NJ), 
GluA1-Ser845 (1:1,000; Phosphosolutions, Aurora, CO) GluA2 (1:1,000; Neuromab, Davis, 
CA), GluN1 (1:1,000; Millipore, Billerica, MA), GluN2A (1:1,500; Abcam, Cambridge, UK) 
and GluN2B (1:1,000; Neuromab, Davis, CA) the blot was washed and incubated for 1 h at 
RT with AP-conjugated secondary antibody (1:10,000; GE Healthcare, Diegem, Belgium) 
allowing detection using the ECF immunoblotting detection system (GE Healthcare, Diegem, 
Belgium). The lower half of the same gel was cut and stained for coomassie, as shown 
previously to be a good control for general input103. Quantification of immunoblots was 
performed using Quantity One® 1-D analysis software (Bio-Rad, Veenendaal, The 
Netherlands). 
 
Forced Swim Test 
Mice were placed in a rectangular transparent Perspex tank (22 x 14 x 35.5 cm, length x 
width x height), filled up to a height of 30 cm with water (25 °C)(Fig. S1). Traditionally, a 
round tank is used in many FST setups. However, round tanks distort the image of the 
mouse in the tank particularly on the sides thereby confounding the precision of quantitative 
motion-detection analysis. A single swim session of 6 min was conducted, as the swim 
strategy is modified in a second swim session (Fig. S1D). After the session, mice were 
placed on a clean dry tissue under a warm light bulb (max. 5 min) in their home cage. A 
high-resolution digital camera (Sunkwang B140XP/SO; RF Concepts, Dundonald, UK), in 
combination with Virtualdub software (v1.9; www.virtualdub.org) was used to record the 
swim session (AVI files) at a rate of 25 frames per sec. 
The digital movie was used offline for automatic analysis, using custom-developed software 
for motion detection (R.F. Jansen and O. Stiedl; see http://www.falw.vu/~ngc/FST.html) (Fig. 
S1A). This program yields the activity diagram (Fig. S1B). As the cumulative plot of activity, 
i.e., the strategy plot, yields non-stationary data due to changes in swim strategy of the 
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animal over time, cumulative movement data were fitted using a Douglas-Peucker polyline 
algorithm104 with an 8-pixel tolerance (Fig. S1C). The program for automatic analysis, using 
a custom-developed motion detection algorithm, is made available upon contact (R.F. 
Jansen and O. Stiedl, oliver.stiedl@cncr.vu.nl). 
Immobility – Time (%) spent inactive with very low activity (change between frames < X 
pixels) below the threshold set per time bin (0.6 s per bin). 
Latency to immobility – Time (s) before the first bout of inactivity lasting > 1 s. 
Strategy plot – The coordinates of the average cumulative activity (y) by time (x) of each 
fitted line segment was calculated and plotted. This parameter gives detailed information 
about the average swim strategy over time. Because the swim strategies were mostly 
Figure 2. Mouse strain differences in expression of synaptic hippocampal glutamate receptors 
and behavioral despair. Hippocampal synaptic membrane fractions from C57BL/6J (C57) and 
DBA/2J (DBA) mice (n=4 samples) were used for immunoblotting with glutamate receptor subunit 
antibodies; GluN1 (A), GluN2A (B), GluN2B (C), GluA1 (D), GluA2 (E). Bar graphs (left) show 
quantification of samples. (Right) A typical example of the immuno-detected protein is shown for each 
strain, together with the coomassie-stained lower part of the gel. * P=0.013. (F,G) A strain-specific 
effect (C57BL/6J mice (n=11), DBA/2J mice (n=10)) was apparent for immobility (F) and latency to 
first float (G), as well as other parameters (see Fig. S4), ** P<0.01 and * P<0.05 vs. C57BL/6J. 
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captured by at least 3 line segments for every mouse, only those segments were used for 
analysis.  
Total activity – The sum of the activity during the 6-min swim session calculated by the 
motion-detection analysis. 
Time to change strategy – Total time before activity was less than before. The latency to 
reach the fitted line segment of which the slope was lower than before, i.e. when the second 
derivative was at a minimum, was taken. 
 
Statistical Analyses 
Behavioral data was subjected to univariate ANOVA/Kruskal-Wallis with dose or strain as 
between-subject variables. For statistically significant main effects, post-hoc comparisons 
were conducted using Student-Newman-Keuls/Mann-Whitney-U tests. Immunoblot and 
behavioral results using single drug injections were analyzed using student’s t-test with 
either strain or treatment as factors. The level of probability for statistically significant effects 
was set at P<0.05. All data are displayed as mean values ± SEM (except for EPM 
parameters that are displayed as box plots with mean ± maximum values). 
 
Results 
Novel FST parameters for detection of antidepressant action 
Predictive validity of the behavioral despair test is important in preclinical settings to assess 
effectiveness of novel pharmacological agents with antidepressant effects. Here, we first 
investigated whether the two most commonly used parameters, namely immobility105, and 
latency to first float106, are optimal to segregate between different classes of antidepressants 
used at clinically relevant doses.  
Traditionally, the last 4 min of a 6-min FST are used to measure immobility80,105. 
Relative low doses of imipramine (8 and 16 mg/kg) that were previously reported to be 
ineffective in C57BL/6J mice106,107 did indeed only reveal a trend (P=0.064) for immobility 
when the last 4 min were used for analysis (Fig. 1A). However, based on total test-time, a 
highly significant effect on immobility was obtained (P=0.001, Fig. 1A, Table S1). In addition, 
our optimized FST set-up and its analysis procedure increased sensitivity of detection as 
these relative low doses had a significant effect on latency to first float (P<0.001), that went 
previously undetected106. 
Movement detection of digital images allows more relevant information to be extracted, 
such as total amount of activity displayed, as well as changes in patterns of activity on a 
high-resolution time scale (Fig. 1B, Fig. S1). Mice have a tendency to start swimming 
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actively and vigorously for a certain period before they change strategy resulting in a 
combination of swimming and floating (Fig. S1). Here we show for the first time that 
specifically total activity, strategy and hence latency to change swim strategy are very 
sensitive to antidepressant treatment (Fig. 1B,C,E; Table S1). In addition, chronic 
imipramine treatment at a relative low dose (6-8 mg/kg/day, s.c.) for 3 weeks revealed a 
significant effect (P<0.05) on these novel parameters (Fig. S2B,C,E; Tables S1, S2), and no 
significant persistent effect was measured using the classical parameter of immobility (Fig. 
S2A). Notably, at this low dose, the previously reported effects of imipramine on locomotion 
are not detectable (Fig. S3; Table S3). Thus, we provide evidence that our improved 
protocol and automated analysis is very sensitive in measuring antidepressant-like effects, 
and could thereby improve the predictive validity of the FST.  
Figure 3. Acute and long-term effect of hippocampal ketamine on behavioral despair in 
C57BL/6J mice. Bilateral dorso-hippocampal injection of saline (n=6) or ketamine (0.25 µg, n=6-8; 2.5 
µg, n=8), were given 1 h or 9 days before the test. Ketamine treatment caused differences from saline 
controls with respect to immobility (A), strategy (see Fig. S5), and time to change swim strategy (D). 
Total activity (B) and latency to first float (C) were specifically affected on the short-term and the long-
term, respectively. For detailed ANOVA results see Table S1. ** P<0.01, * P<0.05, # P<0.2 vs. saline.  
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Strain differences in behavioral despair and hippocampal NMDA receptor subunit expression 
Depressive-like behavior in the FST is likely influenced by glutamatergic transmission90. 
Therefore we tested whether two inbred strains of mice (C57BL/6J and DBA/2J) that show 
well-known differences in behavioral despair108,109 also show differences in synaptic 
hippocampal glutamate receptor expression. We performed immunoblotting for NMDAR and 
AMPAR subunits on hippocampal synaptic membranes (Fig. 2). A significantly reduced 
expression level of GluN2A was found in DBA/2J mice (79.3%±0.3, P=0.013), with no 
change in levels of AMPAR or other NMDAR subunits (Table S4). 
Figure 4. Synaptic hippocampal glutamate receptors are involved in the long-lasting 
antidepressant effect of ketamine. (A) Dorso-medial hippocampal synaptosome fractions of mice with 
dorso-hippocampal injections of saline or ketamine (0.25 µg, n=6) were used for immunoblotting with 
glutamate receptor subunit antibodies; P-GluA1 and total GluA1 (See Fig. S8). Typical examples of the 
immuno-detected protein levels are shown for each treatment (saline, S and ketamine, K) mice, 
together with the coomassie-stained lower part of the gel to the right of each bar graph. ** P=0.007. (B-
E) Bilateral dorso-hippocampal injections of the GluA23Y blocking peptide (60 µM, n=13) or GluA23A 
control peptide (n=12) were given 1 h before the test. Treatment with this blocking peptide showed 
differences from control with respect to immobility (B), as well as novel parameters resulting from our 
automated analysis like latency to first float (D), but not total activity (C), and time to change swim 
strategy (E). *** P<0.001, * P<0.05 vs. control peptide. 
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We replicated the previously reported increased immobility108 in C57BL/6J compared 
with DBA/2J mice (P<0.005; Fig. 2F,G; Table S2). In addition, C57BL/6J mice showed lower 
values for strategy (P<0.05), decreased total activity (P=0.007) and latency to the first float 
(P=0.021)(Fig. S4B-D). Thus, increased GluN2A levels correlated with a higher level of 
behavioral despair.  
 
Rescue of depressive-like phenotype by inhibiting hippocampal NMDA receptors 
According to current views32,96, changing the balance between AMPAR and NMDAR 
involvement might contribute to antidepressant efficacy. Accordingly, AMPAR potentiators110 
and NMDAR antagonist have antidepressant effects91,111,112. Since C57BL/6J mice show 
increased behavioral despair and increased hippocampal synaptic NMDAR subunit 
expression, we tested the hypothesis that inhibiting hippocampal NMDARs in mice with 
endogenously elevated NMDAR subunits levels has antidepressant-like effects. 
First, we showed that dorso-hippocampal injection of ketamine, a non-specific NMDAR 
antagonist, indeed had a clear acute antidepressant-like effect (immobility_last minutes: 
F(2,17)=4.041, P=0.037; immobility_total time: F(2,17)=5.542, P=0.014) (Fig. 3A, Table S1). In 
addition, the novel parameters of strategy (P<0.05; Fig. S5), total activity (F(2,17)=5.897, 
P=0.011), and time to change strategy (F(2,17)=4.957, P=0.020) showed that hippocampal 
ketamine had a significant antidepressant effect, with the highest effect at 0.25 µg (Fig. 3). 
Second, when behavioral despair was measured 9 days after local injection of ketamine 
(Fig. 3), an antidepressant-like effect was still observed for immobility, but only using total 
test-time (F(2,21)=3.523, P=0.048; Table S1). In addition, parameters time to change swim 
strategy (F(2,21)=3.977, P=0.034; Table S1) and latency to first float (F(2,21)=4.633, P=0.022) 
showed prolonged effects from ketamine that were more pronounced than the acute effects. 
In all parameters, the 0.25 µg dose was more effective than the 2.5 µg dose.  
In an independent group of mice we observed that a hippocampal ketamine injection 
(0.25 µg) reduced anxiety in the novel exploration test (P=0.025) and elevated plus maze 
(P=0.044; Fig. S6, Table S3), with no effect on locomotion and anxiety in the open field 
test113, nor in contextual fear learning (Fig. S7). 
 
Antidepressant effects by increased AMPA functionality 
As the long-term behavioral effect cannot be attributed to the antagonistic properties of 
ketamine on NMDARs, but rather reflects a down-stream molecular consequence of 
ketamine action reaching further than the recently described activation of the mTOR 
pathway86, we determined the effect of ketamine on synaptic hippocampal glutamate 
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receptor expression nine days after injection in a separate group of mice not used in the FST 
experiment. A single ketamine injection increased the levels of P-Ser-845-GluA1 in the 
hippocampus (P=0.007; Fig. 4A), with no difference in expression of GluA and GluN 
subunits (Fig. S8, Table S4). Phosphorylation at this site increases the number of 
membrane-localized AMPARs96,114. Because we did not observe an increase in total level of 
GluA1, the long-term effect of ketamine might be attributable to stimulated receptor turnover 
in hippocampal synapses. This increased cycling could serve to increase functional non-
desensitized AMPARs in the synaptic membrane.  
If increased AMPAR functionality would play a role in the lasting antidepressant effect of 
ketamine, then increasing the total number of AMPARs might mimic the antidepressant 
effects. Therefore, we blocked the regulated endocytosis of AMPARs in order to create a 
phenocopy of the lasting antidepressant-like effect. For this, we used a molecular tool to 
impair retrieval of AMPARs from hippocampal synaptic membranes. We injected the GluA2 
regulated endocytosis blocking peptide102,103 into the dorsal hippocampus and tested the 
effect on behavioral despair. This peptide had no acute effects on basal locomotion (Fig. 
S9), and therefore appears to be a highly specific tool for behavioral intervention. Both 
immobility (P=0.021; total test time) and latency to the first float (P=0.0004) were decreased 
significantly (Fig. 4B,D). No effect was observed on total activity and time to change strategy 
(Fig. 4C,E; Table S5), thus creating a partial phenocopy of the enduring effects of ketamine.  
 
 
Discussion 
Here, we first implemented a new approach using automated FST analysis to objectively 
quantify subtle effects of antidepressant-like actions on both classical and novel FST 
parameters with high sensitivity. Our data indicate a role for hippocampal glutamate 
receptors as targets for the antidepressant action of ketamine both acutely and on the long-
term. Finally, we provide evidence that prolonged effects of ketamine are mediated through 
an increased functionality of AMPARs that could result in neuronal and behavioral plasticity. 
 
Novel forced swim test parameters:  
The improved protocol and the automated analysis for the FST employed have the 
advantage that it combines the measurement of classical FST parameters, such as 
immobility, and novel FST parameters related to the intensity of activity and swim strategy. 
With low-dose imipramine using both an acute and chronic treatment, we showed that this 
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protocol has an improved sensitivity to detect changes in immobility and latency to first float, 
resulting in antidepressant-like effects that remained unnoticed previously106,107.  
Furthermore, by introducing the novel parameters of total activity, strategy and time to 
change strategy, we show that we can distinguish different types of effects that characterize 
both chronic and acute treatment. Specifically, the effect of chronic imipramine treatment at 
low doses could be measured using these parameters without having an effect on classical 
parameters like immobility. In addition, prolonged effects of ketamine affected strategy and 
time to change strategy but not activity. Acute ketamine also affected the latter parameter. 
Finally, automated analysis of digital images increases replicability and favors reduction of 
potential observer bias, and thus a more objective analysis of the data. Taken together, this 
protocol increases sensitivity and predictive value of the FST as a measure of 
antidepressant action.  
 
NMDA/AMPA receptors 
Impaired neural and structural plasticity is assumed to play a causal role in the development 
of mood disorders94,115. Furthermore, there is growing evidence from preclinical and clinical 
studies for altered NMDAR activity and a role for glutamatergic transmission in the pathology 
of depression, making glutamate receptors a promising potential therapeutic target. Clinical 
evidence comes from antidepressant effects of ketamine and the GluN2B subunit-selective 
antagonist CP-101,606, in a group of treatment-resistant patients116. Interestingly, NMDARs 
containing the GluN2B subunit are localized primarily in the forebrain, including the 
hippocampus, which is implicated in the pathology of mood disorders like MDD. The 
hippocampus is a crucial site for pathological alterations in neuronal plasticity resulting from 
various stressors35,117.  
Recently, the role of the GluN2A receptor subtype in the etiology of depression has 
been under investigation, with GluN2A knockout mice exhibiting a robust depression-
resistant phenotype118. In line with this, we found that a higher abundance of NMDARs, 
specifically the GluN2A-containing receptor in the hippocampus of C57BL/6J mice, appears 
to be important for the depressive-like phenotype of this strain in the forced swim test.  
In line with this, we show that ketamine injected into the CA1 region of the dorsal 
hippocampus alleviates the depressive symptoms in C57BL/6J mice not only acutely but 
also 9 days after infusion. The behavioral patterns differ slightly, and this is possibly related 
to the differences in molecular mechanisms taking place (see below, Fig. 5). Acutely, this 
antidepressant effect of ketamine is likely to be mediated by the well-described inhibitory 
effect of this drug on the ion-channel of the NMDARs, and concurrently its ability to increase 
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pre-synaptic glutamate release at low non-anesthetic doses32,89,112,119. Both actions favor 
AMPAR over NMDAR transmission (Fig. 5). The acute antidepressant effect of ketamine 
was completely abolished when NBQX, an AMPAR antagonist, was given prior to ketamine 
infusion32. Similarly, NBQX blocked the ketamine-related induction of synaptic proteins in the 
PFC that are causal to the immediate antidepressant effects86. Classic antidepressants with 
a long therapeutic lag after treatment onset, like imipramine, do not share this mechanism of 
action as the acute antidepressant effect of imipramine was unaffected by NBQX. Increasing 
glutamate signaling via AMPARs relative to NMDARs is therefore the likely mechanism by 
which ketamine exerts its rapid effect86. 
Here, we show that the long-term effects of ketamine are also modulated by AMPAR-
related mechanisms. Nine days after ketamine administration, there was an increase in 
levels of Ser845 phosphorylated GluA1, with no effect on total amounts of surface 
expressed AMPAR and NMDAR subunits. This is surprising, since acutely after 
administration, ketamine has been shown to decrease phosphorylation of GluA1 at 
Ser84590. However, this might be due to the fact that in this study the animals were tested 
directly after the forced swim test. Ser845 phosphorylation is known to prime GluA1 for 
membrane insertion and increases its open probability96,114. This finding of increased AMPA 
receptor functionality has important implication for the antidepressant effects of ketamine. 
Figure 5. Model of hippocampal synaptic plasticity mechanism induced by ketamine. In 
individuals with a depression-like phenotype there is an imbalance in AMPARs and NMDARs, favoring 
the contribution of NMDARs (increased green arrow). Acutely, ketamine blocks NMDARs, and 
concurrently it increases pre-synaptic glutamate release thereby favoring AMPAR over NMDAR 
signaling. On the long-term, increased trafficking of AMPARs into the membrane might yield a higher 
proportion of functional AMPARs, thereby recovering the imbalance between AMPARs and NMDARs 
and decreasing the depression-like phenotype. 
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Depressive-like behavior induced by long-lasting stress is mediated by an impairment of 
AMPA-dependent hippocampal LTP43. The ketamine-induced increase in AMPA receptor 
functionality could therefore counteract these stress-induced deficits. 
Even in the absence of increased levels of GluA1 on the membrane, it is likely that an 
increased turnover of AMPARs leads to increased functionality due to less desensitized 
receptors at the membrane (Fig. 5). Interestingly, increased phosphorylation of GluA1 at 
Ser845 has been found to underlie chronic treatment with classic and novel antidepressants, 
such as fluoxetine and tianeptine70,120, and was linked to the antidepressant action of several 
AMPAR potentiators that improve glutamatergic transmission121. In addition, chronic 
treatment with riluzole, and lamotrigine increases the amount of P-Ser845, but also 
enhances AMPAR surface levels70,122. Thus, the molecular changes of a single ketamine 
infusion are shared with those observed after chronic treatment with several (classical) 
antidepressants.  
In order to substantiate our hypothesis that increased hippocampal AMPAR functionality 
is key to the lasting effects of a single ketamine injection, we kept AMPARs at the synaptic 
membrane by blocking stimulated-endocytosis using a mimetic peptide. This intervention 
prevents induction of LTD102, and likewise it mimics the enduring antidepressant-like effects 
of ketamine on immobility and latency to immobility (Fig. 4). Increased phosphorylation of 
GluA1 at Ser845 increases its availability at the active zone of glutamatergic synapses123. 
Since GluA2-regulated endocytosis is know to induce GluA1-containing heterodimeric AMPA 
receptor endocytosis124, the GluA2-regulated endocytosis blocking peptide will most likely 
also increase GluA1 availability at the active zone of the synapse. Therefore, it will mimic the 
ketamine-induced effect of increasing AMPAR synaptic availability. Thus, we postulate that 
the described long-term effect of a single injection of ketamine on AMPARs causes a critical 
increase in synaptic strength by restoring the balance between AMPAR and NMDARs 
functionality, thereby generating a non-depressed state (Fig. 5). It is important to note that a 
single infusion of ketamine into the hippocampus has long lasting anxiolytic effects but has 
no deleterious side-effects on baseline locomotion and fear memory. 
In conclusion, we have identified a molecular process in which AMPARs are involved in 
the long-term antidepressant effects of a single ketamine treatment. This mechanism might 
be common to classical antidepressants when given chronically. Importantly, we 
demonstrate that this effect takes place in the dorsal hippocampus. Our findings are of 
interest for development of antidepressants that have rapid and enduring effects, bypassing 
negative side effects and delayed onset of prototypical antidepressants.  
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Supplemental Material 
 
Materials and Methods 
Mice & intracranial delivery 
Mice were housed individually in standard Macrolon cages (type II) on sawdust bedding, and for the 
purpose of animal welfare, the cages were enriched with cardboard nesting material and a curved 
PVC tube. Food (Teklad, Harlan, The Netherlands) and water was provided ad libitum. Housing 
rooms were controlled for temperature, humidity and light-dark cycle (7 AM lights on, 7 PM lights off). 
Experiments were performed during the light phase. All experimental procedures were approved by 
the local animal research committee and complied with the European Council Directive (86/609/EEC). 
For intra-hippocampal injections, mice were chronically implanted with double guide cannulae (C235, 
Plastics One, Roanoke, VA) in a customized high precision stereotaxic system (10 µm resolution). 
Outer diameter of both guide cannulae is 0.46 mm (26 gauge), whereas the double injectors and the 
dummy cannulae that are normally placed in the guide cannula have an outer diameter of 0.20 mm 
(33 gauge). The double injectors and dummy cannulae protruded 1 mm beyond the tip of the guide 
cannulae. The surgical procedures were performed under aseptic conditions. Mice were anesthetized 
by intraperitoneal injection of avertin (1.2%, 0.02 ml/g) as described previously125. Each double guide 
cannula (with inserted dummy cannula and dust cap) was fixed to the skull by dental cement. The 
guides were directed towards both dorsal hippocampi targeting the area ventral of CA1. The 
coordinates were based on the stereotaxic plates of the mouse brain atlas126 with anterior–posterior 
(AP) coordinates referred to bregma, lateral (L) coordinates to the midsagittal suture line, and ventral 
coordinates (V) to the surface of the skull: AP, –1.6 mm; L, +/- 1.03mm and V, –2.3 mm (injection 
site). The depth of injections was chosen to avoid micro-lesions of both dentate gyri by the cannula 
tips. Buprenorphine was injected subcutaneously at a dose of 0.1 mg/kg as analgesic. The mice were 
allowed a minimal of 7 days of recovery before the initiation of subsequent experiments. During this 
postsurgical period, mice were checked for signs of distress such as apparent behavioral 
abnormalities and profound loss of body weight. 
A microinjection pump (CMA/100, CMA/Microdialysis, Solna, Sweden) was used for bilateral 
injections into the dorsal hippocampus (0.25 µl/hemisphere) at a rate of 0.33 µl/min as described 
before99,125. Two 25 µl gas-tight syringes were mounted onto the pump and connected by 
polyethylene tubing to the double injection cannula (Plastics One, Roanoke, VA). The injection 
cannula delivered the injection solution 1 mm below the tip of the guide cannula at the depth of 2.3 
mm. Before injection, both dust cap and dummy cannula were removed. Injections into the dorsal 
hippocampus were applied during a 90 s isoflurane (Forene, Abbott, Wiesbaden, Germany) inhalation 
anesthesia. After the end of the injection, the injector remained in place for 15 s in order to prevent 
backflow into the cannula guides. Thereafter, the injector was replaced by the dummy cannula before 
the dust cap was screwed back onto the guide cannula. Injections were applied minimally 1 h before 
testing. 
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Tissue Preparation and Immunoblotting.  
The hippocampus (strain differences) or the dorso-medial part of the (ketamine effect) hippocampus 
was dissected from fresh brains and immediately frozen (< –60 °C). Synaptic membranes were 
isolated (pool of 3 or 2 mice per sample) on a discontinuous sucrose gradient, as described 
previously103. Protein concentration was measured by a Bradford assay. For all groups 5 µg/sample 
was dissolved in Laemli lysis buffer and loaded on an 8% SDS-PAGE gel. Proteins were blotted onto 
a PVDF membrane (Bio-Rad Laboratories, Hercules, CA). After blocking and incubation of the first 
antibody, against GluA1 (1:1,000; Genscript, Piscataway, NJ), GluA1-Ser845 (1:1,000; 
Phosphosolutions, Aurora, CO) GluA2 (1:1,000; Neuromab, Davis, CA), GluN1 (1:1,000; Millipore, 
Billerica, MA), GluN2A (1:1,500; Abcam, Cambridge, UK) and GluN2B (1:1,000; Neuromab, Davis, 
CA) the blot was washed and incubated for 1 h at RT with AP-conjugated secondary antibody 
(1:10,000; GE Healthcare, Diegem, Belgium). Before being used for immunoblotting, all antibodies 
were checked for specificity, i.e., whether they showed a band at the designated apparent molecular 
weight on Western blot. Immunodetection was performed using the ECF western blotting detection 
system (GE Healthcare, Diegem, Belgium) and blots were scanned with the FLA-5000 (Fuji Photo 
Film, Rotterdam, The Netherlands). Relative amounts of immunoreactivity were quantified using 
ImageJ (NIH, Bethesda, MD). For standardization of immunoblots, the lower half of the same gel was 
cut and stained for coomassie as shown previously to be a good control for general input. 
Quantification of immunoblots was performed using the program Quantity One® 1-D analysis 
software (Bio-Rad, Veenendaal, The Netherlands).  
 
Open field (OF)  
Open field box 1 – Mice were introduced into a corner of the white square open field (50 x 50 cm, 
walls 35 cm high) illuminated with a single white fluorescent light bulb from above (130 lx), and 
exploration was tracked for 10 min (12.5 frames/s; EthoVision 3.0, Noldus Information Technology, 
Wageningen, The Netherlands). Time spent in, and number of entries into the center square area (20 
x 20 cm) was measured using EthoVision.  
Open field box 2 – Mice were introduced into a Plexiglas chamber with a stainless steel grid floor with 
constant illumination (100-500 lx) and background sound (white noise, 68 dB SPL (sound pressure 
level)). The box contained 12 infrared beams on each side, allowing measurement of both activity and 
exploration (area covered within x time). Measurements (3 min) took place after a single habituation 
trial (3 min). 
 
Elevated plus maze (EPM)  
Mice were introduced into the same closed arm of an EPM (arms 30 x 6 cm, walls 35 cm high, 
elevated 50 cm above the ground), facing the closed end of the arm. The EPM was illuminated with a 
single white fluorescent light bulb from above (130 lx) and exploratory behavior was video tracked for 
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5 min (12.5 frames/s, EthoVision 3.0, Noldus Information Technology, Wageningen, The 
Netherlands). The border between center and arm entries was defined at 2 cm into each arm, 
producing the number of entries into the open arms, into the closed arms, onto the center platform, 
and time spent on the open arms. In addition, latency to explore was defined by the time between 
introduction into the maze and the first appearance in the maze center.  
 
Contextual Fear Conditioning 
Contextual fear conditioning - All experiments were carried out in a fear conditioning system (TSE-
Systems, Bad Homburg, Germany), as described previously127. Briefly, training and testing was 
performed in a Plexiglas chamber with a stainless steel grid floor with constant illumination (100-500 
lx) and background sound (white noise, 68 dB SPL). The chamber was cleaned with 70% ethanol 
prior to each session. Training consisted of placing mice in the chamber for a period of 180 s after 
which a 2 s foot shock (0.7 mA) was delivered through the grid floor. Mice were returned to their home 
cage 30 s after shock termination.  
Contextual fear retrieval - Retrieval test consisted of placing the animals in the conditioning context for 
180 s. The automatically measured percentage of inactivity99 served as measure of learning-induced 
fear response.  
 
Forced swim test 
We used a rectangular tank since a round tank gives image distortions when recording movements by 
camera recording using a lateral view (Supplemental Fig. 1A). As mice have the tendency to swim in 
circles in a round tank by simply following the curvature of the tank, the image of the animal is 
distorted. The distortion depends on the position and will affect the magnitude of detected 
movements. The more lateral the position of the object, the larger the distortion and the lower the size 
of detected movements. In a rectangular tank the visible surface of the animal remains almost 
constant irrespective of its position especially since we slightly reduced the depth of the tank. Thus, a 
rectangular tank causes substantially fewer image artifacts. The side-view and top-view give highly 
correlated results. Tail movements are more prominent in the top-view setup, and leg movements 
more prominent in the side-view setup. However, the side view offered a slightly higher sensitivity and 
was therefore selected for our analysis. 
The digital movie was used for automatic analysis, using a motion detection algorithm to determine 
whether a mouse is moving or not. The motion detection is based on the differences between two 
successive video frames. First, each frame is divided into small rectangles (grid; see Supplemental 
Figure 1B). The size of the rectangles determines the sensitivity to motion with smaller rectangles 
giving higher sensitivity. The program counts the number of rectangles where motion was detected 
given a specific detection threshold (noise filter). This measure yields the activity diagram 
(Supplemental Figure 1C). A threshold for mobility can be set manually for all digital movies to be 
analyzed batch-wise. Analysis was performed with 15 frames/bin, each bin representing 0.6 sec. As 
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the cumulative plot of activity yields non-stationary data due to changes in swim strategy, the 
separate stationary segments were fitted to line curves using Douglas-Peucker polyline fit104 with an 8 
pixel tolerance (Supplemental Figure 1D). Parameters as measured from digital images were: 
Immobility – Time (%) spent inactive with activity detected below the threshold of 7 transitions per 
time bin. 
Latency to immobility – Time (s) spent before a first bout of inactivity, lasting > 1 s. 
Strategy plot – The coordinates of the average cumulative activity (y) and time (x) of each fitted line 
segment (each set of stationary data) was calculated and plotted. This parameter gives detailed 
information about the swim strategy over time. Because the swim strategies were mostly captured by 
at least 3 line segments for every mouse, only those segments were used for analysis.  
Total activity – The sum of the activity during the 6 min swim session calculated by the quantitative 
motion-detection analysis. 
Time to change strategy – Total time before activity was less than before. The latency to reach the 
fitted line segment of which the slope was lower than before, i.e. when the second derivative was at a 
minimum, was taken. 
The program for automatic analysis, using a custom-developed motion detection algorithm, is made 
available upon contact (R.F. Jansen and O. Stiedl (oliver.stiedl@cncr.vu.nl). For more information, 
see http://www.falw.vu/~ngc/FST.html. 
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Figure S1. Analysis of classical and novel parameters for behavioral despair in the FST. (A) From 
digitized images (zoom in), using a grid structure to monitor activity, classical and novel parameters of the 
FST are captured. (B) Examples are given from the analysis window for 2 individual mice that received 
either saline or imipramine (8 mg/kg, i.p.) 30 min before the test. The most widely used classical parameter 
mobility/immobility (green/red) was extracted from the activity plot. The lower panel (red lines) displays the 
binned time of mobility and immobility, with imipramine-treated mice (i.p. injection 30 min before the test) 
showing more mobility both during the total period as well as during the last 4 min. In addition, the latency to 
float for ≥ 1 sec is indicated (>2 bins; 0.6 sec/bin). Naive and saline-treated C57BL/6J mice show a low 
latency to the first float (~10 sec), while imipramine-treated mice have a prolonged latency (~50-60 sec). (C) 
Novel parameters, such as strategy, total activity and time to change swim strategy can be extracted from 
the individual swim strategy plots, which shows the cumulative activity (number of rectangles in the 
detection grid with activity above the set threshold (horizontal black line) vs. time (seconds). Strategy plots 
are shown for the same two mice as in B. The blue lines indicate separate line fits to the non-stationary 
data, and the red line indicates a cumulative distribution with no change in activity (stationary data). Note 
that the latency to the first change in swim strategy, denoted by the first change towards less activity (purple 
vertical line), is longer in imipramine-treated mice. In addition, the total activity of imipramine-treated mice is 
higher than that of saline-treated mice. (D) A second swim session changes the swim strategy of mice 
(lower panel), and hence parameters typical for a first swim session (upper panel) cannot be used. Note the 
regular swimming bouts in the second session, lacking the vast amount of activity displayed during the 
beginning of the first session. 
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Figure S2. Effects of low chronic imipramine on FST performance of C57BL/6J mice. An osmotic 
minipump was placed subcutaneously 26 days before the test and delivered imipramine at a dose of 6-8 
mg/kg/day for 28 days. Imipramine-treated mice (n=13) differed from control mice (saline; n=11) only in the 
novel FST parameters strategy (B), total activity (C), and time to change swim strategy (E), but not in 
classical parameters of behavioral despair, such as immobility (A), nor in the latency to first float (D). # 
P<0.1, * P<0.05. 
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Figure S3. Effect of low chronic imipramine on locomotor and anxiety parameters of C57BL/6J 
mice. An osmotic minipump was placed subcutaneously 26 days before the test and delivered imipramine 
at a dose of 6-8 mg/kg/day for 28 days. Imipramine-treated mice (n=13) did not differ statistically (P<0.05) 
from control mice (saline; n=11) in open field behavior determined by the time spent in the center (A), 
frequency in the center (B), total distance moved (C), nor in elevated plus maze behavior such as 
frequency of the open arm visits (D) and duration on open arms (E). For the latter, only a trend was visible 
(P=0.176) towards reduced anxiety-like behavior. 
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Figure S4. Mouse strain differences in FST performance. A strain-specific effect (C57BL/6J mice 
(n=11), DBA/2J mice (n=10)) was apparent for immobility as measured traditionally during the last 4 min (A, 
left), as well as measured during the total 6-min test time (A, right). Novel parameters resulting from our 
automated analysis like strategy (i.e. activity over time displayed for fitted line segments shared by all mice 
within a group (i.c. up to ~ 200 sec), see Methods; B), total activity (C) and latency to first float (D) showed 
strain-specific differences, but not time to change swim strategy (E). *** P<0.001, ** P<0.01 and * P<0.05 
vs. C57BL/6J. 
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Figure S6. Long-term effects of 
hippocampal ketamine on 
exploration and anxiety-like 
behavior of C57BL/6J mice. 
Novelty exploration in the home 
cage was measured 6 h after 
dorsohippocampal injection of 
ketamine (0.25 µg; n=8) or saline 
(n=8) for log-normalized (ln) 
latency of exploration (A; P=0.443) 
and duration of exploration (B; * 
P=0.025). Two days after 
hippocampal injection of ketamine 
(0.25 µg; n=22) or saline (n=20), 
anxiety parameters as frequency 
open arms (C; P=0.116) and 
duration on the open arms (D; * 
P=0.044) were measured on the 
elevated plus maze. 
 
Figure S5. Acute and long-term effect of hippocampal ketamine on strategy of swim 
behavior. Bilateral dorsohippocampal injection of saline (n=6) or ketamine (0.25 µg, n=6-
8; 2.5 µg, n=8) were given 1 h (A) or 9 days (B) before the test. Ketamine treatment 
caused differences from saline controls with respect to swim strategy only in the 0.25 µg 
dose. The effect was highest acutely after ketamine injection (A). * P<0.05, # P<0.2 vs. 
saline. 
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Figure S7. Long-term effects of hippocampal ketamine injection on locomotion and contextual fear 
conditioning in C57BL/6J mice. Open field behavior was measured 1 day after hippocampal injection of 
ketamine (0.25 µg; n=22) or saline (n=20) for time spent in the center (A), frequency in the center (B), total 
distance moved (C), with no significant differences in either of the parameters measured. Contextual fear 
conditioning took place 5 days after hippocampal injection of ketamine (0.25 µg; n=8) or saline (n=8), and 
48 h later animals were tested for expression of fear memory. No significant differences were observed in 
inactivity (D) or exploration (E). Note that both groups expressed high levels of conditioned fear based on a 
substantially increased inactivity and reduced exploration.  
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Figure S8. Long-term effects of hippocampal ketamine on synaptic hippocampal glutamate 
receptors. Dorso-medial hippocampal synaptosome fractions of mice with dorsohippocampal injections of 
saline or ketamine (0.25 µg, n=6) were used for immunoblotting with glutamate receptor subunit antibodies; 
GluN1 (A), GluN2A (B), GluN2B (C), P-GluA1 (D), GluA1 (E), GluA2 (F). Typical examples of the immuno-
detected protein levels are shown for each treatment (saline, S and ketamine, K) mice, together with the 
coomassie-stained lower part of the gel to the right of each bar graph. ** P=0.007. 
 
 
 
Figure S9. Effect of TAT-GluA23Y 
peptide on locomotor activity. 
The GluA2 blocking peptide (3Y; 
n=9) and control peptide (3A; n=9) 
were injected 1 h before an open 
field test. The peptide had no 
effect on exploration (A) and 
activity (B).  
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Table S1. Statistical results of the FST performance of C57BL/6J mice with pharmacological 
interventions. ANOVA results (F- and P-value) and subsequent t-tests (P-value) for the acute effect of 
imipramine (8 and 16 mg/kg, i.p.), and the acute and long-term effect of local hippocampal infusion of 
ketamine (0.25 and 2.5 mg). Parameters measured (cf. Supplemental Figure 1) and P-values (<0.05, bold; 
<0.2, italics) are indicated. *Non-parametric test results (Kruskall-Wallis and Mann-Whitney U-test) are 
indicated. ‡Albeit significant or a trend towards significance, Kruskall-Wallis/ANOVA did not allow to 
perform post-hoc analysis. 
 
Forced Swim Test ANOVA  t-test  
30 min after Imipramine (i.p.) F-value 
(2,24) 
P-value P-value  
(8 mg/kg) 
P-value  
(16 mg/kg) 
Immobility_last minutes * 0.064 0.022‡ 0.606 
Immobility_total * 0.001 <0.001 0.001 
Total_activity 13.023 <0.001 0.00018 0.00026 
Latency_first_float 11.058 <0.001 0.00003 0.00284 
Time_strategy_change 5.850 <0.001 0.00795 0.00537 
 
1 h after local ketamine F-value 
(2,17) 
P-value P-value  
(0.25 µg) 
P-value  
(2.5 µg) 
Immobility_last minutes 4.041 0.037 0.0433 0.7025 
Immobility_total 5.542 0.014 0.0074 0.7182 
Total_activity 5.897 0.011 0.0123 0.4892 
Latency_first_float 1.138 0.344 0.2402 0.2574 
Time_strategy_change 4.957 0.020 0.0166 0.0434 
 
9 days after local ketamine F-value 
(2,21) 
P-value P-value  
(0.25 µg) 
P-value  
(2.5 µg) 
Immobility_last minutes 3.433 0.051 0.0370‡ 0.0528‡ 
Immobility_total 3.523 0.048 0.0123 0.1104 
Total_activity 0.672 0.521 0.2761 0.7887 
Latency_first_float 4.633 0.022 0.0364 0.0324 
Time_strategy_change 3.977 0.034 0.0020 0.2088 
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Table S2. Statistical results of the FST performance by imipramine and strain difference. Values of t-
tests (P-value) for the long-term effect of imipramine (6-8 mg/kg/day, s.c. in C57BL/6J mice) and the strain 
difference between C57BL/6J and DBA/2J mice. Parameters measured (cf. Supplemental Figure 1) and P-
values (<0.05, bold; <0.2, italics) are indicated. 
 
Forced Swim Test Imipramine (minipump) Strain difference 
 P-value P-value 
Immobility_last minutes 0.9876 0.0001 
Immobility_total 0.1984 0.0034 
Total_activity 0.0170 0.0074 
Latency_first_float 0.2546 0.0207 
Time_strategy_change 0.0280 0.9999 
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Table S3. Statistical results of anxiety tests and contextual fear conditioning performances after 
pharmacological intervention in C57BL/6J mice. T-test or Mann-Whitney U test (P-value) for the long-
term effect of imipramine (6-8 mg/kg/day, s.c. by minipump) and long-term effect of local hippocampal 
infusion of ketamine (0.25 mg). Parameters measured, time after insertion of a minipump or local injection, 
and P-values (<0.05, bold; <0.2, italics) are indicated. 
 
Anxiety & learning   t-test / MWU test 
Imipramine minipump days post 
minipump 
test parameter P-value 
Novelty exploration 13 Latency exploration 0.8308 
  Duration exploration 0.4012 
Open field 15 Duration center 0.9979 
  Frequency center 0.9321 
  Duration center 0.6753 
Elevated plus maze 16 Duration open arms 0.1755 
  Frequency open arms 0.4321 
Fear conditioning 19 Inactivity pre-shock 0.2312 
 19 Exploration pre-shock 0.3147 
 21 Inactivity 48 h post-shock 0.6858 
 
Local Ketamine days post 
Ketamine 
test parameter P-value (0.25 µg) 
Novelty exploration 0.25 Latency exploration 0.4427 
  Duration exploration 0.0250 
Open field 1 Duration center 0.2547 
  Frequency center 0.2232 
  Duration center 0.8578 
Elevated plus maze 2 Duration open arms 0.0440 
  Frequency open arms 0.1160 
Fear conditioning 5 Inactivity pre-shock 0.8749 
 5 Exploration pre-shock 0.4299 
 7 Inactivity 48 h post-shock 0.9056 
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Table S5. Statistical analyses of FST performance test after molecular intervention in C57BL/6J 
mice. T-tests (P-value) for the acute effect of local GluA2 endocytosis block using the GluA23Y peptide and 
GluA23A control peptide (15 pmol per side, 30 pmol total). Parameters measured (cf. Supplemental Figure 
1) and P-values (<0.05, bold) are indicated. 
 
Behavioral despair t-test 
1 h after local GluA2 endocytosis block P-value (30 pmol) 
Immobility_last minutes 0.0331 
Immobility_total 0.0210 
Total_activity 0.3508 
Latency_first_float 0.0004 
Time_strategy_change 0.9732 
 
Immunoblot analysis t-test 
Strain difference P-value 
GluA1 0.295 
GluA2 0.125 
GluN1 0.924 
GluN2A 0.013 
GluN2B 0.727 
 
9 days post local Ketamine P-value 
GluA1 0.675 
P-GluA1 0.007 
GluA2 0.928 
GluN1 0.398 
GluN2A 0.522 
GluN2B 0.585 
Table S4. Immunoblot analysis for 
hippocampal synaptic membrane 
glutamate receptor subunits. Statistical 
analyses for strain difference between 
C57BL/6J and DBA/2J mice (cf. Figure 3), 
and the long-term effects of local ketamine 
injection (0.25 µg). P-values (<0.05, bold) 
are indicated.  
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Abstract 
Cognitive functions, such as learning and memory are greatly affected by stress, but the 
synaptic changes causing these deficiencies are largely unknown. Therefore, we 
investigated hippocampus-dependent memory function and concomitant expression of 
synaptic glutamate receptors over time after social defeat stress in rats. Acutely, 24 hours 
after cessation of social defeat exposure (5 daily social defeat encounters), plasma 
corticosterone levels were increased 2.5 fold, and performance in a hippocampus-
dependent object place recognition task was significantly reduced. Moreover, this impaired 
spatial memory was associated with decreased synaptic expression of glutamate receptor 
subunits GluN1, GluN2B and GluA2 in the dorsal hippocampus. In addition, we found that 
glutamate receptor levels were unaltered 3 months after social defeat, whereas spatial 
memory performance remained impaired. Therefore, we conclude that different synaptic 
molecular mechanisms underlie memory impairment at the short and long term after social 
defeat stress. 
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Introduction 
Cognitive functions such as learning and memory are greatly affected by stress128. In 
humans, acute stress disrupts declarative memory retrieval for previously learned 
information42,129. Also, in stress-related psychiatric disorders, such as depression, decreased 
attention and spatial memory have been found130. In rodents, acute and chronic stress also 
disrupts spatial memory formation and retrieval40,41,131.  
The hippocampus is a medial temporal lobe structure implicated in the consolidation of 
declarative memory in humans and spatial memory in rodents132. Increased corticosterone 
after stress has been shown to alter hippocampal synaptic plasticity, and to affect spatial 
memory performance133. Stress and glucocorticoids have a profound influence on the two 
most well characterized forms of synaptic plasticity of the hippocampal CA1 region, i.e., 
long-term potentiation (LTP) and long-term depression (LTD), the proposed cellular 
substrates for learning and memory134.  
Stress hormones have been extensively studied and were shown to have facilitating or 
impairing effects on hippocampal physiology and memory37. Recent evidence shows that, on 
the short term, rapid, non-genomic effects of corticosterone are mediated via high-affinity 
mineralocorticoid receptors (MRs), which act to enhance alpha-amino-3-hydroxy-5-methyl-4 
isoxazolepropionic acid receptor (AMPAR) mobility135 and miniature evoked post-synaptic 
current (mEPSC) frequency136, and facilitate synaptic potentiation137. However, long-lasting 
effects (>1 hour) are mediated via genomic glucocorticoid receptors (GRs), which impair N-
methyl-D-aspartate receptor (NMDAR)-mediated LTP43 and facilitate LTD43,133. This 
hippocampal LTD has been shown to be necessary and sufficient to cause acute stress-
induced impairment of spatial memory retrieval and is dependent on GluN2B-containing 
NMDARs133. Similarly, acutely (~24 h) after chronic stress (>20 days exposure) spatial 
recognition memory has been repeatedly demonstrated to be impaired128.  
Thus, the degree through which stress alters spatial memory is dependent on many 
factors among which the severity and duration of the stressor, and the time between stress 
experience and behavioral assessment128,138. A persistent finding is that the time frame for 
chronic stress to influence performance is critical; for instance, a wire mesh restraint over a 
relatively long period (21 days) impaired spatial recognition on the Y-maze, but this restraint 
over a shorter time frame (5 – 10 days) was ineffective139.  
Here, we used a social defeat paradigm to assess short- and long term effects of a 
natural type of stressor. Social defeat stress was inflicted over a short 5-day period, and 
tested for its effects immediately thereafter or after a period of 3 months; socially defeated 
rats were individually housed from the first day of defeat onward. The repeated social defeat 
CAHPTER 3 
60	  
stress as used here has previously been shown to reduce hippocampal LTP, and to increase 
LTD on the long-term (up to 9 months)140. In this study, we investigated both the direct and 
long-term effect of social defeat on glutamate receptor synaptic membrane expression in 
conjunction with the associated spatial memory deficits.  
 
Materials and methods 
Animals 
Male Wistar rats (Harlan, Horst, The Netherlands) 8 weeks of age and weighing 180–200 g 
at the time of arrival were initially socially housed (2 per cage) in Makrolon type IV cages 
(Tecniplast, Milan, Italy). Long-Evans male rats (Harlan, UK), weighing 300–350 g were 
used as residents for social defeat141. These animals were pair-housed with age-matched 
sterilized females in plastic cages (63 x 25 x 33 cm) located in a separate room. All animals 
were housed in a temperature-controlled room (21±1 °C) under regulated lighting conditions 
(lights on at 7:00 p.m. and off at 7:00 a.m.). Food and water were available ad libitum. All 
experimental manipulations were conducted during the dark phase (activity period) under a 
dim red light. All experiments were approved by the Animal Users Care Committee of the VU 
University Amsterdam.  
 
Experimental design and social defeat procedure 
Wistar rats (age ≥ 11 weeks) of the social defeat group were subjected to 5 days of social 
defeat stress and were then housed individually in macrolon class III cages from the first 
defeat onwards, as described before140,142. Control rats were housed in pairs. The social 
defeat procedure consisted of daily resident-intruder interaction sessions using dominant 
male Long-Evans rats. Control animals were daily handled. All behavioral, 
electrophysiological and molecular analyses were performed either 24 h (acute) or 3 months 
(long-term) after the last social defeat session. 
 
Corticosterone assay 
Corticosterone levels were measured as described previously142. In short, trunk blood 
samples were collected via decapitation between 9:00 am and 11:00 am. Samples were 
collected into a 7-mL heparin-coated tube (Greiner Bio-One, Monroe, North Carolina) and 
kept on ice. The samples were spun at 1000x g for 10 min. Plasma was decanted and 
stored at −80 °C until the assay was used. Levels of plasma corticosterone were assessed 
using a rat Glucocorticoid (GC) ELISA kit (Cusabio Biotech Co., LTD), according to the 
manufacturers instructions. 
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Recognition tests 
Recognition memory testing was conducted based on two previously reported tasks relying 
on spontaneous exploration of objects in an open field143,144. All testing was carried out in a 
rectangular arena, 79 x 57 surface area with 42 cm tall black walls. The box was surrounded 
by visual cues: computer light coming from the west side; a white wall (north); a metal rack 
(east side); and an open space where the experimenter was sitting (south). The arena was 
always placed inside the room at the same location and in the same orientation. All rats 
were habituated to the empty arena twice for 30 minutes on the two days preceding 
behavioral testing, as well as on the test day for 10 min and 1 min prior to the sample phase.  
Object-recognition task – Round or square aluminum bars were used as novel or 
familiar objects and were chosen using a pseudorandom protocol, balanced across 
treatment groups. In the 4-minute sample phase, rats were exposed to two identical objects 
(round or square metal bars) followed by a 15 min inter-trial interval (Supplemental Fig. 1). In 
the test trial, one object (chosen using a pseudorandom protocol, balanced across treatment 
groups) was replaced with a novel object and rats were allowed to explore both objects for 4 
minutes (Supplemental Fig. 1). The familiar object was a third copy of the two objects seen 
in the sample phase, to prevent possible carry-over of olfactory cues. Each session was 
recorded by a video camera suspended above the field and interfaced with a computerized 
tracking system using the ‘Viewer’ software package (BIOBSERVE, GmbH, Bonn, 
Germany). The nose of the rats was tracked by the ‘Viewer’ software and during both trials, 
the object exploration (defined as the time of the nose spent within 2 cm from the object) 
was measured for each object. Only rats that had accumulated at least 15 s of exploration at 
each object within the sample phase were included in the analysis (all but one tested met 
criteria). To further analyze object discrimination during the test trial, the discrimination index 
((novel-familiar)/(novel + familiar)) was calculated for each rat using the individual object-
exploration times recorded. 
Object-place task – For the 4-minute sample phase, rats always entered the testing box 
from the south, and were placed facing the south wall. Rats were exposed to two identical 
objects (round aluminum bars) followed by a 15 min inter-trial interval. During test trials, rats 
entered the box from the east or west side and were placed facing the east or west wall, 
respectively. Thus, for each trial, the entry point on the sample and test phases were 
different. In the test phase a third and fourth copy of the same object were placed back in 
the arena, one in a familiar corner and one in a novel corner. The location of the novel 
object-place configuration was counterbalanced such that on each trial different corners 
were used as familiar and novel locations. Rats were now only able to discriminate between 
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objects based on their location with respect to its surrounding. Further analysis of 
discrimination was the same as for the object recognition task.  
 
Tissue preparation  
Following decapitation, brains were removed and rapidly frozen in ice-cold isopentane and 
stored at –80 °C until further use. The dorsal hippocampus (Bregma: –2.56 till –5.0) was 
removed freehand at –20 °C from 1-mm-thick slices. Synaptic membrane fractions were 
isolated for every hippocampus (left and right pooled). Samples were homogenized in ice-
cold 0.32 M sucrose (5% of homogenate was collected as total cell lysate) and then 
centrifuged at 1000 g for 10 min. The supernatant was loaded on top of a sucrose gradient 
consisting of 0.8 and 1.2 M sucrose. After centrifugation at 100,000 g for 2 h, the 
synaptosome fraction at the interface of 0.85/1.2 M sucrose was collected and then lysed in 
hypotonic solution. The resulting synaptic membrane fraction was recovered by 
centrifugation using the sucrose step gradient as stated above. The synaptic membrane 
fraction was collected from the 0.85/1.2 M interface and protein concentrations were 
determined using a Bradford assay (Bio-Rad, Hercules, CA, USA).  
 
Immunoblotting 
Synaptic membranes of the dorsal hippocampus were isolated from two independent groups 
of animals (n=6 each) per time point. Samples (3 – 5 µg) were lysed in Laemli lysis buffer, 
separated by electophoresis on a Criterion 10.5 – 14% Tris-HCl sodium dodecyl sulfate-
polyacrylamide precast gel and blotted onto a polyvinylidene difluoride membrane (Bio-Rad 
Laboratories) as described before145. All antibodies were checked for specificity, i.e. whether 
they showed a band at the designated height on Western blot. The following antibodies were 
used:  mouse anti- PSD95, (NeuromAB; 1:5000), mouse anti-GluN1 (BD Biosciences; 
1:1000), rabbit anti-GluN2A (Abcam, 1:1000), mouse anti-GluN2B (NeuroMab, 1:1000), 
rabbit anti-GluA1 (GenScript, 1:1000), mouse anti-GluA2 (NeuroMab, 1:500).  
  
Statistics 
Determination of corticosterone levels (n=8 acute; n=6 long-term), behavioral assessments 
(n=12), and molecular analysis (n=6 in both experiments) were performed in independent 
groups of animals for each of the time points addressed. Physiological parameters were 
assessed in all experimental animals (n=32 acute, n=24 long-term). Significant differences 
between stress and control groups was determined by unpaired, two-tailed, Student’s T-
tests. 
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Results 
 
Effect of repeated social defeat on physiological parameters 
Social defeat stress resulted in a 2.5 fold increase in plasma corticosterone levels 24 hours 
after the last social defeat exposure (Fig. 1A, P=0.0023). These levels were back to normal 
at 3 months after social defeat, and there was no difference between treatment groups. The 
acute effect of social defeat was also evident by a decrease in body weight (Fig. 1B, 
P<0.001), and a decrease in food- (Fig. 1C, P<0.001) and water consumption (Fig. 1D, 
Figure 1. Social defeat stress affects physiological parameters. Either acute (24 h) or long-term (3 
months) after the last social defeat encounter various physiological parameters were measured. 
Acutely after social defeat stress, plasma corticosterone levels (n=8) were increased (A), and body 
weight (B), food intake (C), and daily water intake (n=32) (D) were decreased. All these parameters 
were normalized at 3 months after social defeat (n=24). Data presented are mean+SEM. Unpaired, 
two-tailed, Student’s t-test: **P<0.01, ***P<0.001. 
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P<0.001). All of these physiological parameters were back to normal at 3 months after social 
defeat. Previously described age-related differences in corticosterone-levels were observed 
(P<0.001)146, as well as age-related increases in body weight (Fig. 1A,B). 
 
Object-place memory is reduced short and long-term after social defeat stress 
To test whether repeated social defeat stress affected hippocampus-dependent and/or 
hippocampus-independent memory, object place recognition and novel object recognition 
tests were performed, respectively (Langston and Wood 2009). For both tests, during the 
sample trials, two similar objects were explored equally for the different treatment groups. In 
the object-place recognition test, control rats showed place recognition by having a 
preference for the object placed in the novel location. This spatial memory was significantly 
reduced acutely after social defeat stress (Fig. 2A, P=0.038). Interestingly, this 
hippocampus-dependent cognitive deficit was still present 3 months after social defeat 
(P=0.0034). At this stage, depressive-like phenotypes in the affective domain were also 
present in this paradigm33, indicative of a multi-layered phenotype. In contrast, in the object 
recognition test, both the acute and the long-term social defeat groups did not differ from 
their controls in the test-phase (Fig. 2B), suggesting that this form of hippocampus-
independent memory was still intact. Interestingly, hippocampus-dependent processing in 
the object-place task seemed prone to ageing, although this effect was not significant 
(P=0.11). 
 
Changes in synaptic expression of glutamate receptor subunits in the dorsal hippocampus 
short after social defeat stress 
Reduced spatial memory performance is caused by altered synaptic plasticity at excitatory 
neurons of the dorsal hippocampus43. Therefore, it is of interest to investigate whether 
glutamate receptors, mediating hippocampal synaptic plasticity, are involved in the observed 
social defeat stress-induced impairment in spatial memory performance. We compared the 
expression of ionotropic glutamate receptors in dorsal hippocampal synaptic membrane 
fractions using quantitative immunoblot analysis (Supplemental Fig. 1). This revealed 
significantly lower levels of two NMDAR subunits, namely GluN1 (P<0.001) and GluN2B 
(P=0.048), acutely after social defeat stress (Fig. 3A). Synaptic expression of GluN2A was 
unaffected. Also, synaptic expression of the AMPAR receptor subunit GluA2 was lower (Fig. 
3B, P=0.035), while GluA1 was unaffected. The change in expression of these subunits in 
synaptic membrane fractions was validated in an independent set of rats. The expression of 
the synaptic scaffold protein PSD-95 did not change after social defeat (Fig. 3B).  
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 We then measured the expression of synaptic glutamate receptor subunits 3 months 
after social defeat stress. Despite the reported change in LTP at this moment140, we did not 
find any change in levels of the glutamate receptor subunits, nor in the level of PSD-95 (Fig. 
3). 
 
Discussion 
Here, we show that repeated social defeat stress for 5 consecutive days resulted in a 
hypothalamic-pituitary-adrenal (HPA) axis response, expressed by an increase in plasma 
levels of the stress hormone corticosterone 24 hours after cessation of the stressor. This 5-
day social defeat exposure also reduced performance in a hippocampus dependent spatial 
memory task, and this was associated with reduced synaptic expression of the glutamatergic 
receptor subunits GluN1, GluN2B and GluA2. However, long-term after social defeat the 
Figure 2. Repeated social defeat impairs 
spatial memory performance. Either acute 
(24 h) or long-term (3 months) after the last 
social defeat encounter object place recognition 
(A) and objects recognition (B) were assessed 
during the test phase. (A) Social defeat stress 
significantly suppressed object place 
recognition both acutely as well as long after 
social defeat. Note the difference in task 
performance between 3-month vs. 6-month old 
rats. (B) Social defeat stress did not affect 
performance on object recognition in either 
group. Data presented are mean+SEM of the 
discrimination index; n=12 for all groups. 
Unpaired, two-tailed, Student’s t-test: *P<0.05.  
 
CAHPTER 3 
66	  
spatial memory deficit remained in the absence of elevated corticosterone levels and 
changed glutamate receptor expression. 
Synaptic expression of GluN1, GluN2B and GluA2 is reduced acutely after social defeat 
stress, and associated with the deficit in spatial memory performance. Since GluA2 
endocytosis underlies NMDAR-induced LTD124,147, it is likely that the reduction in synaptic 
GluA2 expression acutely after repeated social defeat stress induces hippocampal CA1 
LTD. This in turn might contribute to the observed memory impairments. The regulation of 
GluN1 and GluN2B levels acutely after social defeat stress is less straightforward to explain, 
especially since the number and subunit composition of synaptic NMDARs have long been 
considered to be quite static148. However, recent evidence shows that neuronal activity 
drives NMDAR synaptic targeting and incorporation, receptor retrieval, and lateral diffusion 
between synaptic and extrasynaptic sites149. An emerging concept is that activity-dependent, 
bidirectional regulation of NMDAR trafficking provides a dynamic and potentially powerful 
mechanism for the regulation of synaptic efficacy and remodeling. Indeed, it has been 
shown that alterations in NMDAR number and/or subunit composition contribute to the 
expression mechanisms of LTP (NMDAR-LTP)150 and LTD (NMDAR-LTD)151. Low frequency 
stimulation and mGluR group I agonists induce NMDAR-LTD at CA1 synapses in 
hippocampal slices and the internalization of NMDARs in hippocampal neurons152. This 
might explain the reduced synaptic expression of GluN1 and GluN2B directly after social 
defeat stress. Alternatively, synaptic over-activation, accelerating the turnover rate of a 
subset of receptor subunits, such as GluN1 and GluN2B, may change the relative 
abundance of these subunits and decrease their levels in highly active synapses153.  
Stress-induced alterations in NMDAR-mediated synaptic strength are of great interest in 
that they involve potentiation of the plasticity trigger itself and, as such, would be expected to 
critically influence metaplasticity. This supports the current view37 of stress-induced plasticity 
in which on the short term stress-induced hormones facilitate strengthening of contacts 
involved in the formation of memories directly associated to the stressor. As such a mild 
stressor enables avoidance learning of stressful associations. However, high levels of 
corticosterone and severe chronic stress suppress hippocampal LTP and promote LTD, with 
a delay of at least an hour. This would lead to an increased threshold for synaptic 
strengthening of input from other sources, thereby dampening the aversive learning process. 
Here, we show that repeated social defeat stress decreased expression of specific NMDA 
and AMPA receptor subunits. This might potentially underlie the process of metaplasticity 
and affect hippocampus-dependent learning.  
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We found that differences in levels of glutamate receptors were absent months after 
social defeat. However, at this time point hippocampus-dependent spatial memory function 
was still impaired. Also, previously it was shown that at this time point hippocampal LTP was 
affected140. Thus, despite the changes in hippocampal physiology and hippocampus-
dependent task performance, the plasticity of ionotropic glutamate receptors expression at 
the synaptic membrane is not affected. There are several possible explanations for this 
outcome. For example, glutamate receptors, or their interacting proteins, may have 
undergone persistent posttranslational modifications that were not studied here. In particular, 
more in depth molecular analysis of the hippocampal synaptic proteome of rats 3 months 
Figure 3. Repeated social defeat stress alters synaptic expression of Glutamate receptor 
subunits in the dorsal hippocampus. Either acute (24 h) or long-term (3 months) after the last social 
defeat encounter the dorsal hippocampus was dissected for synaptic membrane proteome analysis. (A 
– F) Quantitative Western blot analysis of glutamate receptor subunits revealed a downregulation of 
NMDA receptor subunits GluN1 (A) and GluN2B (C), while GluN2A was unaffected (B) acutely after 
social defeat stress, with no differences long-term after social defeat. In addition, GluA2 was 
downregulated (E), while GluA1 was unaffected (D) acutely after social defeat stress, with no 
differences long-term after social defeat. The marker of the postsynaptic density PSD-95 was 
unaffected at any time point after social defeat stress (F). Data presented are mean+SEM; n=6 for all 
groups. Unpaired, two-tailed, Student’s t-test: *P<0.05, ***P<0.001.  
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after social defeat may shed light on this. Alternatively, these effects could be caused by 
changes in hippocampal circuitry, such as altered neuronal morphology or reduced 
neurogenesis18,36,142). Taken together, these results show that different synaptic mechanisms 
are involved in deficits in hippocampal plasticity and spatial memory performance long and 
short after social defeat stress. 
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Abstract 
Depressed patients often persistently suffer from comorbid cognitive impairments, such as 
deficits in explicit memory. Here, we modeled persistent affective depression symptoms and 
memory deficits in a social defeat paradigm in rats. We found that hippocampus-dependent 
cognitive impairments were still apparent three months after social defeat stress. This 
maintenance phase of depression was characterized by increased levels of the Na,K 
ATPase subunit AT1B2 in hippocampal synapses and by a reduced potential to evoke 
hippocampal CA1 long-term potentiation (LTP). The antidepressant imipramine normalized 
the level of AT1B2 and rescued the hippocampal LTP deficit and cognitive decline. Most 
importantly, we found that behavioral therapy, consisting of daily housing in an enriched 
environment for one hour, thereby modeling positive activities and exercise, was just as 
effective as imipramine treatment in relieving all molecular, cellular and behavioral aspects 
of the depression-like state. 
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Introduction 
Major depressive disorder (MDD) is a complex neuropsychiatric syndrome. Although MDD is 
most markedly typified as a mood disorder, with strong affective symptoms, most MDD 
patients suffer from associated cognitive impairments, such as disturbances in explicit and 
spatial memory16,130. Thus, MDD has debilitating properties both in the affective and 
cognitive domains, eliciting questions concerning underlying mechanisms and adequate 
therapies.  
Stress is a potent causal factor in eliciting MDD. Over the years, compelling evidence 
has linked cognitive deficits in MDD to reduced hippocampal volume12,154, and impaired 
hippocampal function155. In line with this, rodent models of depression involving acute stress 
showed morphological changes in the hippocampus, e.g., neuronal atrophy and reduced 
neurogenesis, plasticity changes, e.g., reduced long-term potentiation (LTP), and stress-
induced reduction of dorsal hippocampus-dependent spatial learning (reviewed in35,156. 
However, paradigms with clinical validity, modeling and examining the maintenance phase 
of depression weeks to months after initial stress exposure, are scarce. To assess the long-
term effects of stress exposure on cognitive function, to reveal its underlying synaptic 
mechanisms, and to investigate treatment options, we adopted a social defeat paradigm in 
rats, in which five daily encounters of social defeat were followed by individual housing for a 
period of 12 weeks33. This particularly enabled us to model long-term stress effects, as 
social isolation would appear to be particularly relevant to certain subtypes of human 
depression157, and moreover, a combination of active and passive stress has strong 
precipitating effects on the development of the disease84. Importantly, the majority of stress 
stimuli that lead to MDD are of psychosocial nature82, 
This stress paradigm has been shown to cause insensitivity to rewards33, resulting in 
impaired reward anticipation behavior indicative of an anhedonic state, a core symptom of 
depression, that can be counteracted by chronic antidepressant therapy141. In the present 
study, the long-term effects of social defeat stress on dorsal hippocampus-dependent 
cognitive performance were addressed. We examined the cellular plasticity mechanisms 
contributing to these impairments, and we investigated the changes in the synaptic 
proteome long after social defeat stress exposure. Since in humans, physical exercise and 
positive psychosocial activities can improve cognitive function, reduce depressive symptoms 
and increase stress resiliency158, we questioned whether, next to pharmacotherapy, 
behavioral therapy would alleviate impairments in the social defeat paradigm at the 
molecular, cellular and behavioral level.  
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Materials and methods 
 
Animals 
Male Wistar rats (Harlan, Horst, The Netherlands) 8 weeks of age, weighing 180–200 g at 
the time of arrival were initially socially housed (2 per cage) in Makrolon type IV cages 
(Tecniplast, Milan, Italy) in a temperature-controlled room (21±1 °C) under regulated lighting 
conditions (lights on at 7:00 p.m. and off at 7:00 a.m.). Food and water were available ad 
libitum. Long-Evans male rats (Harlan, UK), weighing 300–350 g were used as residents for 
social defeat141. These animals were pair-housed with age-matched sterilized females in 
plastic cages (63 x 25 x 33 cm) located in a separate room. Housing conditions were the 
same as for Wistar rats. All experimental manipulations were conducted during the dark 
phase (activity period) under a dim red light. All experiments were approved by the Animal 
Users Care Committee of the VU University Amsterdam.  
 
Experimental design and treatment 
Wistar rats (age ≥ 11 weeks) of the social defeat group were subjected to 5 days of social 
defeat stress and were then housed individually for three months in macrolon class III cages 
from the first defeat onwards, as described before140 (Supplemental Fig. 1). Control rats 
were housed in pairs. The social defeat procedure consisted of daily resident–intruder 
interaction sessions using dominant male Long-Evans rats for five consecutive days. Control 
animals were handled daily. 
During the last three weeks of this social isolation, rats were treated by gavage 
administration of the antidepressant imipramine (20 mg/kg per 0.5 ml water; Sigma- Aldrich, 
Germany), behavioral therapy (BT), consisting of housing in an enriched environment for 
one hour every day, or water as control. This 2 x 3 design resulted in six experimental 
groups: (1) control rats with water (Control+H20), (2) control animals with chronic imipramine 
treatment (Control+IMI), (3) control animals with BT (Control+BT), (4) socially defeated 
animals with water (Defeat+H20), (5) socially defeated animals with chronic imipramine 
treatment (Defeat+IMI), and (6) socially defeated animals with BT (Defeat+BT). All 
behavioral, electrophysiological and molecular analyses were performed at the end of 
treatment, unless stated otherwise.  
 
Reward anticipatory behavior 
A classical Pavlovian conditioning setup was used to investigate anticipatory behavior, as 
described earlier140. To investigate the behavioral response to the conditioning stimulus 
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(repetitive sound (keyboard) and light flashes (three times)), animals were observed before 
training (trial 0) to determine baseline activity, and again after 35 training trials of pairing with 
a 5% sucrose-reward, using the computer program ‘The Observer’ (Noldus Information 
Technology, Wageningen, The Netherlands). The researcher who analyzed the behavioral 
data had no knowledge of the experimental groups. Differences in activity (reflected by 
frequency or transitions of behavioral elements) displayed before training compared with 
those after training were used as parameter for reward anticipation. 
 
Sucrose preference 
The preference for sucrose (5%) was measured in a two-bottle (sucrose and water) 
consumption test. Consumption was assessed after 24 h by reweighing the pre-weighted 
bottles. After 2 days, the consumption test was repeated. In case of social housing, 
consumption for each subject was set to half of the total consumption. Sucrose preference 
was expressed as the increase in consumption (gram) relative to water (gram), and this 
difference was represented as percentage of the total consumption (gram) [100% x (Δ 
sucrose–water)/total volume sucrose and water consumed]. 
 
Recognition tests 
Recognition memory testing was conducted based on two previously reported tasks relying 
on spontaneous exploration of objects in an open field143,144. All testing was carried out in a 
rectangular arena, 79 x 57 in surface with 42 cm tall black walls. The box was surrounded by 
visual cues: computer light coming from the west side; a white wall (north); a metal rack 
(east side); and an open space where the experimenter was sitting (south). The arena was 
always placed inside the room at the same location and in the same orientation. All rats 
were habituated to the empty arena twice for 30 minutes on the two days preceding 
behavioral testing, as well as on the test day for 10 min and 1 min prior to the sample phase.  
Object-recognition task – Round or square aluminum bars were used as novel or 
familiar objects and were chosen using a pseudorandom protocol, balanced across 
treatment groups. In the 4-minute sample phase, rats were exposed to two identical objects 
(round or square metal bars) followed by a 15 min inter-trial interval (Supplemental Fig. 2). In 
the test trial, one object (chosen using a pseudorandom protocol, balanced across treatment 
groups) was replaced with a novel object and rats were allowed to explore both objects for 4 
minutes (Supplemental Fig. 2). The familiar object was a third copy of the two objects seen 
in the sample phase, to prevent possible carry-over of olfactory cues. Each session was 
recorded by a video camera suspended above the field and interfaced with a computerized 
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tracking system using the ‘Viewer’ software package (BIOBSERVE, GmbH, Bonn, 
Germany). The nose of the rats was tracked by the ‘Viewer’ software and during both trials, 
the object exploration (defined as the time of the nose spent within 2 cm from the object) 
was measured for each object. Only rats that had accumulated at least 15 s of exploration at 
each object within the sample phase were included in the analysis (all but one tested met 
criteria). To further analyze object discrimination during the test trial, the discrimination index 
((novel-familiar)/(novel + familiar)) was calculated for each rat using the individual object-
exploration times recorded. 
‘Allocentric’ object-place task – For the 4-minute sample phase, rats always entered the 
testing box from the south, and were placed facing the south wall. Rats were exposed to two 
identical objects (round aluminum bars) followed by a 15 min inter-trial interval. During test 
trials, rats entered the box from the east or west side and were placed facing the east or 
west wall, respectively. Thus, for each trial, the entry point on the sample and test phases 
were different. In the test phase a third and fourth copy of the same object were placed back 
in the arena: one in a familiar corner and one in a novel corner (Supplemental Fig. 2). The 
location of the novel object-place configuration was counterbalanced such that on each trial 
different corners were used as familiar and novel locations. Rats were now only able to 
discriminate between objects based on their location with respect to its surrounding. Further 
analysis of discrimination was the same as for the object recognition task.   
 
Long-term potentiation (LTP) measurements 
Rats were sacrificed by decapitation. Subsequently, brains were rapidly removed, and 
placed in ice-cold artificial cerebrospinal fluid (ACSF; in mM: NaCl 124, KCl 3.3, KH2PO4 1.2, 
MgSO4 1.3, CaCl2 2.5, NaHCO3 20 and Glucose 10.0, constantly gassed with 95% O2/5% 
CO2). Horizontal hippocampal slices were cut on a vibrating microtome at 400 µm thickness 
and then placed in a submerged-style holding chamber in ACSF, bubbled with carbogen 
(95% O2, 5% CO2). Slices were allowed to recover for 1 hour following slicing. A planar 
multi-electrode recording setup  (MED64 system, Alpha Med Sciences Co., Ltd, Tokyo, 
Japan) was employed to record the field excitatory post-synaptic potential (fEPSP), and to 
study LTP as described in159(see supplemental materials and methods). 
 
iTRAQ-based Proteomics 
To analyze differential expression of hippocampal synaptic membrane proteins between 
experimental groups, quantitative iTRAQ proteomics was performed. To this end, tissue 
preparation, iTRAQ labeling, two-dimensional liquid chromatography, MS⁄MS and protein 
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identification and quantification were performed as described previously145,160 (see 
supplemental materials and methods). 
  
Immunoblotting 
The total homogenate and synaptic membranes of the dorsal hippocampus was isolated 
from an independent group of animals (n=6) as compared to those used in iTRAQ. Samples 
(3 – 5 µg) were lysed in Laemli lysis buffer, separated by electophoresis on a Criterion 10.5–
14% Tris-HCl sodium dodecyl sulfate-polyacrylamide precast gel (Bio Rad Laboratories), 
and blotted as described before145. The following antibodies were used: mouse anti-β-CaM 
Kinase II (ZYMED Laboratories; 1:1000), mouse anti-Sodium/potassium-transporting 
ATPase subunit beta-2 (Santa Cruz, 1:5000), mouse anti-Caseine Kinase IIβ (Santa Cruz, 
Figure 1. Social defeat impacts on cognitive and affective behavioral tasks. (A) Discrimination 
index during the test phase of an allocentric object place task. The social defeat paradigm (social 
defeat) significantly suppressed spatial memory performance, whereas behavioral therapy (BT) and 
imipramine treatment (IMI) reversed this long-term stress-induced effect (treatment F(1,47)=5.30, 
P=0.008;. n=12 for al experimental groups). (B) Discrimination index during the test phase of a novel 
object recognition task. Social defeat does not affect performance on this task. (C) Anticipation towards 
5% sucrose expressed as the difference in activity in the CS-US interval post-training compared with 
pre-training. Social defeat significantly suppressed reward anticipation, whereas behavioral therapy and 
imipramine treatment reversed this effect (defeat x treatment interaction F(1,33)=5.48, P=0.0093). (D) 
Sucrose preference. Social defeat does not affect sucrose preference (sucrose intake – water 
intake)/total fluid intake (%). Data is presented as mean ± SEM. LSD Post hoc: *P<0.05, **P<0.001. 
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1:1000), mouse anti-cAMP-dependent protein kinase catalytic subunit alpha (PKA) (Santa 
Cruz 1:1000).  
 
Statistical analysis 
The iTRAQ-based proteomics was performed in six biological independent experiments. 
Proper correction for multiple measurements was carried out in the R computing 
environment (1.81, Raqua) using the Linear models for Microarray data package161 (Limma, 
1.3.13), which is part of the Bioconductor project162 (http://www.Bioconductor.org) with 
adjusted P-values163. For all other data, statistical analysis was performed using SPSS18.0. 
All results are expressed as group means ± SEM. Treatment effects were assessed with 
two-way analysis of variance (ANOVA), followed by Least-square difference (LSD) post-hoc 
analyses. 
 
 
Results 
 
Social defeat results in hippocampus-dependent cognitive impairments 
Using a model of the maintenance phase of depression, in which 5 daily social defeat 
sessions were followed by individual housing for 12 weeks (Supplemental Fig. 1), we tested 
recognition memory based on spatial position and novelty of the object144 (Supplemental Fig. 
2). Social defeat decreased performance in the hippocampus-dependent object-place 
memory task (P=0.0034; Fig. 1A). Pharmacotherapy, in the form of imipramine treatment 
only during the last three weeks of the paradigm (Supplemental Fig. 1) was able to reverse 
this deficit, illustrating the predictive value of this model as antidepressants can also restore 
cognitive deficits in depressed patients63. Similarly, behavioral therapy (1 h daily enriched 
housing) was able to completely reverse these cognitive deficits (Fig. 1A), showing the 
potential of this type of treatment. Pharmacological and behavioral therapies had no effect in 
control animals. Socially stressed rats showed no difference in object-recognition, a task that 
is hippocampus-independent. Also there was no effect of treatment in control groups in this 
task (Fig. 1B). Thus novelty preference and discriminative ability were similar among all 
groups. 
We confirmed that socially defeated rats display a deficit in the affective domain, i.e. an 
anhedonic phenotype33,140,141, as shown by a reduced anticipation towards a 5 % sucrose 
solution compared with control rats (P=0.0034). This increase in anhedonia was reversed to 
control levels by behavioral therapy (Fig. 1C). In addition, a similar reversal was observed 
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for the chronic administration of imipramine141. Neither treatment in control animals had an 
effect on anticipation towards 5 % sucrose. As reported previously, this long-term social 
defeat paradigm had no significant effect on sucrose preference164, and no side effects were 
observed by behavioral therapy or imipramine (all F(1,30)<0.2, P>0.80, Fig. 1B). Also, no 
difference in plasma corticosterone levels was observed between any of the groups (all F(1, 
30)<0.2, P>0.90, Supplemental Fig. 3), indicative of the absence of an acute stressor.  
 
Reduction in LTP by long-term social stress is reversed by imipramine and behavioral 
therapy 
As imipramine treatment and behavioral therapy were both capable of rescuing cognitive 
performance on a hippocampal-dependent memory task, we questioned whether behavioral 
therapy was able to recover reduced LTP in this long-term social defeat paradigm140. Using 
Figure 2. Effect of long-term 
social stress on LTP in the CA1 
of the dorsal hippocampus. (A) 
Coronal section of the dorsal 
hippocampus on a MED64 
electrode array. An electrode in 
the Schaffer collateral pathway 
(white) was used as stimulating 
electrode. Field potentials were 
recorded and averaged for the 
electrodes in the dendritic field of 
CA1 (marked x). (B) 
Representative traces from one 
experiment recorded before (gray) 
and after (black) LTP induction. 
(C) Time course of percentage 
change in fEPSP measured before 
and after HFS (arrow). (D) Change 
in fEPSP 50 min after LTP 
induction (gray indicated in C). 
Social defeat significantly 
suppressed CA1 LTP, whereas 
behavioral therapy (BT) and 
imipramine treatment (IMI) 
reversed this effect (defeat: 
F(1,45)=4.08, P=0.049; treatment: 
F(1,45)=3.96, P=0.026; n=6 for al 
experimental groups). Data is 
presented as mean ± SEM. LSD 
Post hoc *P<0.05, **P<0.001. 
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a microelectrode array in the Schafer collateral pathway going from CA3 to CA1 subfields of 
the dorsal hippocampus (Fig. 2A) we applied a tetanus of field potentials. In control rats, 
average spike amplitude was increased to a response of 113% in CA1 at 50 min after LTP 
induction (Fig. 2C). LTP was significantly reduced after social defeat (P=0.019). This 
reduced potential to elicit full LTP in socially defeated rats was reversed to control levels by 
both imipramine and behavioral therapy. Imipramine treatment in controls slightly enhanced 
LTP, whereas behavioral therapy alone had no side effect on LTP maintenance. 
LTP is well-known to be dependent on a the subunit-specific regulation of the AMPARs, 
during initiation and maintenance phases. In various paradigms, stress has been shown to 
impact directly on the basal levels of AMPAR subunits, thereby modulating LTP induction 
and maintenance43,165,166. Also, we find that immediately after social defeat AMPAR subunits 
are regulated (See Chapter 3, Fig. 3). Thus a straightforward explanation of the fact that, 
long after social defeat stress, LTP induction is impaired is that synaptic AMPAR levels are 
not at baseline. However, in contrast we find that synaptic expression of the glutamate 
receptor subunits is normal at this time point (See Chapter 3, Fig. 3). These results 
prompted us to further investigate the synaptic proteome long after social defeat stress and 
investigate alternative modes of synaptic modulation. 
 
Reduced spatial performance and CA1 LTP are associated with an increased synaptic 
expression of AT1B2 
To reveal the molecular basis of synaptic plasticity dysfunction that underlies decreased 
spatial memory after social defeat stress, we compared the proteomes of hippocampal 
synaptic membrane fractions of socially stressed and control rats. We used iTRAQ labeling 
of tryptic digests of synaptic proteins, separated these with 2D LC, and identified and 
quantified peptides using MS/MS (Supplemental Fig. 4). Previously, we used this method to 
detect subtle changes in synaptic membrane protein abundances in other animal models of 
disease145,167. In total, 382 proteins were identified with at least 3 distinct peptides with a 
confidence of ≥ 95% present among experimental groups (data not shown). To correct for 
multiple measurements P-values were adjusted to control for the false discovery rate163. Five 
proteins were significantly regulated (adjusted P-value <0.05) after social defeat stress 
(Supplemental Table 1). Differential expression of three of these proteins was confirmed by 
quantitative immunoblotting in the same sample set (Supplemental Fig. 5, middle panel); 
Sodium/potassium-transporting ATPase subunit beta-2 (AT1B2), cAMP-dependent protein 
kinase catalytic subunit alpha (PKAα), and Casein kinase II subunit beta (CSK2B). Of these 
three proteins AT1B2 was confirmed as upregulated (51%) by social defeat in a biologically 
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Figure 3. Long-term social stress increases 
synaptic expression of AT1B2 in the dorsal 
hippocampus. At the end of treatment, the dorsal 
hippocampus was dissected for synaptic membrane 
proteomics analysis. (A) Quantification of iTRAQ 
reagents revealed a significant higher levels of 
AT1B2 after long-term social stress (social defeat). 
Behavioral therapy (BT), and imipramine treatment 
(IMI) reversed the stress-induced increase in 
synaptic expression of AT1B2 (stress F(1,33)=8.05, 
P=0.009; treatment F(1,45)=8.58, P=0.002;, stress 
x treatment interaction F(1,33)=8.97, P=0.001; see 
Supplemental Table 1 for adjusted p-values; n=6 for 
al experimental groups.) (B) Regulated synaptic 
expression of AT1B2 was validated in an 
independent set of rats by quantitative immunoblot 
analysis (stress x treatment interaction: 
F(1,45)=4.08, P=0.049; n=8 for al experimental 
groups). Insets: representative example of 
immunoblots showing the regulated synaptic 
expression of AT1B2 (45 kDa). Data is presented 
as mean ± SEM. LSD Post hoc: *P< 0.05, **P< 
0.01, ***P< 0.001.  
 
independent set of animals (P=0.007; Fig. 3B, Supplemental Fig. 5, lower panel). At the level 
of gene expression there was a trend for downregulation of this transcript (P=0.133; 16%). 
To substantiate that dysregulation of AT1B2 is associated with the animal’s depressed 
state, we measured the effects of both imipramine treatment and behavioral therapy on 
AT1B2 levels. Indeed, we found that both treatments normalized the increased synaptic 
expression of AT1B2 after social stress, bringing it back to basal levels (Fig. 3A,B), with no 
additional effect of treatment alone. 
 
Discussion 
Cognitive deficits associated with human depression have been well-characterized168, with 
reductions in hippocampus-dependent declarative and spatial memory16,130. Recently a link 
between these reported cognitive impairments and hippocampal function was shown155, 
giving way to a hippocampus-dependent symptomatology of depression. In the present 
study, we showed that in a preclinical model of the maintenance phase of depression, 
impairments in the affective and cognitive domains are persisting over a long period of time. 
Because depressed patients still experience symptoms long after the cessation of stress 
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exposure82, the long-term social defeat model has a high level of both etiological- and face-
validity. Behavioral therapy was able to restore the social defeat-induced deficits from the 
molecular level all the way up to behavior, similar as achieved by pharmacotherapy using 
the tricyclic agent imipramine. This indicates that apart from having predictive validity, the 
present model might also have construct validity, i.e., at the level of the mechanism 
underlying cognitive core symptoms of MDD.  
The reduction in hippocampus dependent memory long after social defeat was found 
associated with a reduction in the capacity to elicit hippocampal CA1 LTP. This form of 
synaptic plasticity is known to involve plasticity of glutamate receptors. On the short term, 
stress-induced effects on LTP are dependent on NMDA receptors133 and insertion of AMPA 
receptors165,169. Also, stress hormones have been shown to regulate the mobility and 
postsynaptic membrane levels of AMPA receptors135. Accordingly, immediately after social 
defeat stress glutamate receptor levels are altered. However, here we show that the social 
defeat-induced impairment of LTP on the long term is not caused by pre-altered synaptic 
expression of glutamate receptor subunits, as their levels are not affected long after social 
defeat. Instead, our proteomics analysis showed the increased synaptic expression of a 
Na,K-ATPase subunit AT1B2 that might well influence the induction of LTP. Importantly, the 
reversal of AT1B2 to normal levels due to imipramine or behavioral therapy indicates that 
dysregulation of AT1B2 is indeed related to the disease phenotype. Taken together, our data 
suggests that on the long-term, different synaptic mechanisms are involved in causing LTP 
impairments when compared to acute stress.  
One might wonder whether the observed changes in the cognitive domain are a 
consequence of individual housing per se, because social isolation is considered a social 
stressor by itself83. However, at the end of the social defeat paradigm, stress hormone levels 
have normalized, indicative of the absence of acute stressors. Also, the social defeat-
induced changes in basal physiology, i.e. body weight and food/water intake, have already 
returned to basal levels during the isolation period (Supplemental Fig. 6). Moreover, we 
showed that hippocampal CA1 LTP is not affected by individual housing without previous 
social defeat (Supplemental Fig. 7). Thus individual housing after social defeat apparently 
does not result in a severe stress experience that affects basal physiology and neuronal 
plasticity.  
The observation that reduced CA1 LTP is associated with increased synaptic 
expression of AT1B2 has interesting implications for the molecular mechanism underling the 
cognitive deficits observed after social defeat. AT1B2 is a β subunit of the P-type Na,K 
ATPase family. The protein complex is a heterodimer composed of two subunits: the 
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catalytic α subunit that contains ATPase activity and the β subunit that regulates, through 
assembly of alpha/beta heterodimers, the number of sodium pumps transported to the 
plasma membrane170,171. Na,K ATPases are expressed throughout neurons, i.e., at neuronal 
cell bodies and dendrites, and are found enriched in synaptosomes172. They are membrane 
localized transporters responsible for active transport of Na+ and K+ ions across the plasma 
membrane, thereby generating a gradient responsible for the neuronal rest membrane 
potential, but also its repolarization after eliciting action potentials173. Increased levels of the 
regulatory subunit AT1B2 after social defeat on the presynaptic site, and hence increased 
numbers of Na+/K+ transporters, will lead to a faster clearance of Na+ ions from the synaptic 
spine and influx of K+ ions from the synaptic cleft (Fig. 4). Consequently, after generation of 
an action potential, increased pump activity will induce a faster repolarization, resulting in 
less glutamate release from the presynaptic site and longer after-hyperpolarization174. As a 
result, there will be less activation of postsynaptic glutamate receptors and thus less 
Figure 4. Model of the hippocampal synaptic adaptation after long-term social defeat stress 
associated with reduced LTP and impaired spatial memory. After social defeat stress and 
subsequent individual housing, the synaptic levels of subunit AT1B2 of the Na+/K+ transporter is 
increased by ~50%. This increased expression likely causes an increased transporter activity (shown 
by an increased number of ion pumps), thereby faster clearance of potassium from the synaptic cleft 
([Na+]i), and of sodium from the synaptic compartments ([K+]i). This causes faster membrane re-
polarization after firing of an action potential, and therefore less glutamate release and calcium influx. 
Together, increased levels of Na+/K+ transporter causes less plasticity in hippocampal synapses that 
might underlie impaired LTP. 
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induction of plasticity postsynaptically, reflected by reduced LTP. In line with presynaptic 
effects, increased numbers of Na+/K+ transporter post-synaptically will reduce building up a 
membrane depolarization, counteracting postsynaptic plasticity. The involvement of the 
Na+/K+ transporter in synaptic plasticity has been demonstrated in Leech and 
Drosophila170,174,175 
Other subunits of the Na,K ATPase complex, e.g., AT1A1 subunits, have been 
implicated in antidepressant response, i.e., the effect of lithium176 and in stress-induced 
animal models of depression177. In this perspective it is noteworthy that a trend of higher 
synaptic expression has been found for other subunits of this complex, e.g., AT1A2 
(P=0.095), AT1b1 (P=0.170; Supplemental Table 2). Also, most of these subunits show 
decreased levels of expression due to behavioral therapy, and to a lesser extent due to 
imipramine, in socially defeated animals. 
AT1B2 has been found regulated at the level of gene expression both in clinical and 
preclinical studies. Lower levels of AT1B2 transcript were observed in the hippocampus of 
depressed individuals178, as well as in the hippocampus of a genetic model of endogenous 
depression, i.e., the Wistar-Kyoto strains179), similar to the lower transcript levels observed in 
this study. However, we find the AT1B2 protein at higher levels in the synaptic membrane 
fraction, indicating that caution should be taken when translating gene expression data into 
synaptic protein levels and further into a clinical perspective. 
Our finding that the beneficial effects on cognitive domains of both chronic imipramine 
treatment and behavioral therapy are associated with a recovery to normal levels of synaptic 
AT1B2 holds important promises for intervention at Na,K ATPase-related mechanisms in the 
maintenance of depressive symptoms and their treatment. Obviously, application by 
pharmacological intervention at Na,K ATPases is complicated considering that after social 
defeat its expression was found only increased at synaptic sites and not in total cell lysates. 
Moreover, its ubiquitous expression throughout the body further precludes direct 
pharmacological interference. Fine-tuning the level of these transporters might be crucial, as 
too low levels could induce anxiety symptoms and increases stress-induced memory 
impairments in mice177.  
Behavioral therapy, consisting of housing in an enriched environment for one hour daily, 
thereby modeling positive activities and exercise, was effective in restoring stress-induced 
long-lasting cognitive impairments and its underlying cellular and molecular deficiencies. 
Also, in the affective domain, behavioral therapy restored the social defeat-induced 
reduction in reward anticipation (anhedonia). These findings, when translated to the human 
condition have important implications for treatment strategies in the clinic. Several forms of 
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psychotherapy –in particular, cognitive and behavioral therapies– were shown effective for 
patients with mild to moderate MDD180, and the combination of medication and 
psychotherapy can exert a synergistic effect. Our study implies that, in addition to 
pharmacological treatment, with often bearing negative side effects, another form of 
behavioral therapy, i.e. physical exercise, should be explored further as treatment option for 
depressed patients with cognitive impairments and anhedonia.  
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Supplemental material 
 
Material and methods 
 
Social isolation 
Wistar rats (age ≥ 11 weeks) of the social Isolation group were housed individually for three months in 
macrolon class III cages. Control rats were housed in pairs.  
 
Corticosterone assay 
Trunk blood samples were collected via decapitation between 9:00 am and 11:00 am. Samples were 
collected into a 7-mL heparin-coated tube (Greiner Bio-One, Monroe, North Carolina) and kept on ice. 
The samples were spun at 1000 x g for 10 min. Plasma was decanted and stored at −80 °C until the 
assay was used. Levels of serum corticosterone were assessed using a rat Glucocorticoid (GC) 
ELISA kit (Cusabio Biotech Co., LTD), according to the manufacturers instructions. 
 
LTP recording 
A planar multi-electrode recording setup (MED64 system, Alpha Med Sciences Co., Ltd, Tokyo, 
Japan) was employed to record the field excitatory post-synaptic potential (fEPSP), and to study LTP. 
The methodology has been described in detail elsewhere 159. Briefly, hippocampal slices were placed 
on special probes that were fabricated with 8 x 8 electrode arrays and pre-coated with 
polyethylenimine (PEI, Sigma). P210A probes (Alpha Med Sciences) with an inter-electrode distance 
of 100 µm were used. Correct placement of the electrodes at the CA3–CA1 region was done 
manually, monitored by a microscope (MIC-D, Olympus Ltd., Japan) (fig. 2A). Four slices per rat were 
studied simultaneously. Each slice was superfused by 100 ml oxygenated ACSF, which was 
recirculated at a flow rate of 2 ml/min. fEPSPs were recorded from multiple electrodes in the dendritic 
layer of CA1 neurons by choosing an electrode in the Schaffer collateral pathway as the stimulating 
electrode. Based on the stimulus–response curve, we chose a stimulation intensity that evoked the 
fEPSP with a magnitude of 50% of the maximum response (around 1 mV in most cases). We found 
that this setting was suitable for the induction of LTP in healthy slices in the setup. After allowing a 
stable baseline of 20 min, an induction protocol that evoked LTP was applied, which consisted of 2 
trains of 100 Hz stimulus that lasted for 1 s, separated by 10 seconds. The field potential response 
was recorded for 1 h after the tetanus. LTP was quantified as % change in the average amplitude of 
the fEPSP taken from 50 to 60 min interval after LTP induction. LTP in al electrodes within the CA1 
region was averaged, and average LTP of all 4 slices was defined as final LTP per individual rat.  
 
iTRAQ-based Proteomics 
Tissue preparation – Following decapitation, brains were removed and rapidly frozen in ice-cold 
isopentane and stored at –80 °C until further use. The dorsal hippocampus (Bregma –2.56 till –5.30) 
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was removed freehand at –20 °C from 1-mm-thick slices. Synaptic membrane fractions were isolated 
for every hippocampus (left and right pooled). Samples were homogenized in ice-cold 0.32 M sucrose 
(5% of homogenate was collected as total cell lysate) and then centrifuged at 1000 g for 10 min. The 
supernatant was loaded on top of a sucrose gradient consisting of 0.8 and 1.2 M sucrose. After 
centrifugation at 100,000x g for 2 h, the synaptosome fraction at the interface of 0.85⁄1.2 M sucrose 
was collected and then lysed in hypotonic solution. The resulting synaptic membrane fraction was 
recovered by centrifugation using the sucrose step gradient as stated above. The synaptic membrane 
fraction was collected from the 0.85⁄1.2 M interface and protein concentrations were determined using 
a Bradford assay (Bio-Rad, Hercules, CA, USA). For each sample, 75 µg of protein was used for 
iTRAQ labeling (see below), and synaptic membrane fractions were dried in a SpeedVac overnight. 
iTRAQ labeling – Synaptic membranes were resuspended in 28 µL of dissolution buffer and 2 
µL of cleavage reagent [iTRAQ reagent kit, with 0.85% RapiGest (Waters Associates, Milford, MA, 
USA)] to solubilize synaptic membranes. After incubation for 1 h, 1 µL of cys blocking buffer (Applied 
Biosystems, Carlsbad, CA, USA) was added and vortexed for 20 min. Next, 10 µL of trypsin 
(Promega) dissolved in water was added and incubated overnight at 37 °C. Trypsinized peptides from 
each experimental group were then tagged with iTRAQ reagents (113, CON+H2O; 114, CON+IMI; 
115, CON+BT; 116, Stress+H2O; 117, Stress+IMI; 118, Stress+BT) dissolved in 80 µL ethanol. After 
incubation for 3 h, the six samples were pooled and acidified with 10% trifluoroacetic acid (TFA) to pH 
2.5 – 3.0. After 1 h, the final sample was centrifuged and the supernatant dried overnight in a 
SpeedVac.  
Two-dimensional liquid chromatography – The dried iTRAQ sample was dissolved in 300 µL of 
loading buffer (20% acetonitrile, 10 mM KH2PO4, pH 2.9) and loaded onto a polysulfoethyl A column 
(PolyLC, Columbia, MD, USA). Peptides were eluted with a linear gradient of 0–500 mM KCl in 20% 
acetonitrile, 10 mM KH2PO4, pH 2.9, over 25 min at a flow rate of 50 µL⁄min. Fractions were collected 
at 1-min intervals. In the second-dimensional liquid chromatography separation, peptides were 
delivered with a Famos autosampler (Dionex Corp., Sunnyvale, CA) at 30 µL⁄min to a C18 trap 
column (1 mm x 300 µm i.d. column) and separated on an analytical capillary C18 column (150 mm x 
100 µm i.d. column) at 400 nL⁄min using the LC-Packing Ultimate system. Peptides were separated 
using a linearly increasing concentration of acetonitrile from 5 to 50% in 45 min, and to 90% in 5 min. 
The eluent was mixed with matrix (7 mg a-cyano-hydroxycinnaminic acid in 1 mL of 50% acetonitrile, 
0.1% TFA, 10 mM dicitrate ammonium) delivered at a flow rate of 1.5 µL⁄min and deposited off-line to 
the Applied Biosystems metal target every 15 s for a total of 192 spots using a robot (Dionex, 
Sunnyvale, CA, USA). 
Mass spectrometry – The Matrix-assisted laser desorption/ionization (MALDI) plates were 
analyzed on a 4800 proteomics analyzer (Applied Biosystems) and peptide collision induced 
dissociation (CID) was performed at 2 kV with nitrogen collision gas. MS⁄MS spectra were collected 
from 2500 laser shots. Peptides with a signal-to-noise ratio above 50 at the MS mode were selected 
CHAPTER 4 
88	  
for MS⁄MS, at a maximum of 25 MS⁄MS per spot. The precursor mass window was set at 200 relative 
resolution full width at half maximum (FWHM). 
Protein identification – The MS⁄MS spectra were searched against the rat database [Swissprot 
and National Center for Biotechnology Information (NCBI)] using GPS Explorer (Applied Biosystems) 
and Mascot (MatrixScience, Boston, MA, USA). A library was then generated containing all annotated 
peptides with a confidence interval score higher than 20%. Database redundancy and sequence 
redundancy were removed. Hence, quantification was performed only on those peptides that were 
annotated to a single protein, and are referred to as ‘unique peptides’. Only proteins identified with ≥ 2 
unique peptides, and of which at least one peptide had a confidence interval ≥ 95%, were selected for 
quantification and statistical analysis. All regulated proteins were analyzed with a large number of 
peptides, of which the majority was analyzed with high confidence.  
Protein quantification – The iTRAQ experiment was repeated six times with independent samples. 
The iTRAQ areas (m⁄z 113–118) were extracted from raw spectra and corrected for isotopic overlap 
using GPS Explorer. To compensate for the possible variations in the starting amounts of the 
samples, the individual peak areas of each iTRAQ signature peak were log2-transformed to obtain a 
normal distribution, normalized to the mean peak area for each sample, and finally standardized to 
the normalized peak average per peptide. The protein abundances in every experimental group were 
determined by taking the average normalized standardized iTRAQ peak area of all unique peptides 
annotated to a protein. In total, the iTRAQ-proteomics experiment was repeated six times with 
independent biological samples. Only proteins that were identified in five out of six replicates were 
included for further statistical analyses. For presentation of differential expression of synaptic proteins 
between groups, regulation was calculated by subtracting the average log2-transformed protein 
abundance of groups of interest. For presentation of absolute expression differences, exponents of 
these values were calculated.   
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Supplemental figure 2. 
Experimental design for object-
place and object-recognition tests. 
Schematic representation of the 
recognition tasks (Place, A; 
Recognition, B) and geometric 
arrangement of objects. The ‘x’ and 
‘y’ indicate start locations of the rat in 
the tasks. In the object place test the 
start locations are counterbalanced 
between ‘x’ and ‘y’ over treatment 
groups. The circle and square 
represent the different objects.  
 
 
 
 
 
Supplemental figure 1. Experimental design and treatment groups. The social defeat 
paradigm (social defeat) in combination with behavioral therapy (BT) or imipramine treatment (IMI) 
was applied in 11-week old rats. After habituation to the new housing conditions, rats of the social 
defeat group received daily bouts (5 min) of social defeat during 5 days and subsequent individual 
housing (3 months). Control animals were handled daily for 5 days and were housed in pairs. 
Behavioral or pharmacotherapy was applied only during the last three weeks (or no treatment, 
H2O) of the individual housing period. The length of each period is indicated. All behavioral and 
electrophysiological and biochemical analysis were performed at the end of the paradigm, at the 
end of treatment (arrow). Independent cohorts of animals were used for behavioral physiological 
and biochemical analyses. 
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Supplemental figure 3. Mean 
levels of plasma corticosterone (± 
SEM), measured at the end of 
water (H2O), imipramine (IMI) or 
behavioral therapy (BT) treatment. 
No difference between any of the 
groups was observed. 
 
Supplemental figure 4. Set up of 
the iTRAQ experiments. Synaptic 
membrane fractions were isolated 
from one dorsal hippocampus (left 
and right) from one rat per 
experimental group. Tryptic 
digests of synaptic membranes 
from these samples were tagged 
with 6-plex iTRAQ reagents (one 
per experimental group). Peptides 
from each set of iTRAQ 
experiment were pooled together, 
fractionated by two-dimensional 
liquid chromatography and 
subjected to tandem mass 
spectrometric analysis. Protein 
identification and quantification 
were performed as detailed in the 
main text. The experiment was 
performed six times, each time 
with a biological independent set 
of samples.  
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Supplemental figure 5. Synaptic expression of CSK2b, AT1b2 and KAPCA determined by iTraq and 
Western blot. Protein expression in synaptic membrane samples was determined both by iTRAQ 
quantitative proteomics (upper panels), and by immunoblot (middle panels) on the same set of samples. 
Expression differences of these three proteins was tested in an independent set (indep.) by immunoblot 
(lower panels). Bar graphs show standardized average relative expression levels (vs. Control+H2O) 
(±SEM) for CSK2b, AT1b2, and KAPCA (cf. Supplemental table 1). *P<0.05 vs. Control+H2O. Regulated 
expression of only AT1b2 could be validated in the independent set of samples. Insets show representative 
examples of the immuno-detected band, as well as the coomassie-stained gel, used for correction of input 
material. 
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Supplemental figure 6. Basal physiological parameters tested acutely after social defeat and their 
normalization over time. Parameters were acquired in the first five weeks after the start of social defeat, 
before behavioral therapy and imipramine treatment had started. At this time point only two groups were 
present: social defeat, and controls. (A) Social defeat reduced body weight (A), food intake (B), and water 
intake (C). These parameters were normalized after 4, 3, and 2 weeks, respectively. Data is presented as 
mean ± SEM. *P<0.05, **P<0.01, ***P<0.001. 
 
 
 
 
Supplemental figure 7. Effect of individual housing on LTP in the CA1 of the dorsal hippocampus. 
Average change (±SEM) in fEPSP 50 min after LTP induction. Individual housing had no effect on LTP.  
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Supplemental table 1. Synaptic protein changes after long-term social stress. Five proteins were 
significantly regulated (adjusted p-value < 0.05) after long-term social stress after adjustment for multiple 
hypothesis-testing using the Benjamini and Hochberg method. Expression of two of these proteins (AT1B2 
and ANXA6) were rescued to control levels by imipramine treatment and three (AT1B2, KAPCA, and 
ANXA6) were rescued to control levels by behavioral therapy. Regulated expression of three of these 
proteins (CSK2B, AT1B2 and KAPCA; bold) could be confirmed by quantitative immunoblot analysis on the 
same samples as used for iTRAQ analysis. Regulated expression of AT1B2 (bold) could be confirmed by 
immunoblot in an independent set of biological samples. Indicated are protein accession number, protein 
name, average number of peptides (over six replicate experiments) used for quantification and 
identification, expression ratios (log2) of Stress+H2O vs CON+H2O and their adjusted-p-value for the iTraq 
data, of Stress+IMI vs CON+H2O and Stress+BT vs CON+H2O as a measure of rescue to control levels, of 
Stress+H2O vs CON+H2O and their p-values (t-test) of the immunoblots on the samples used for iTRAQ 
quantification and on an independent set of biological replicates. NA: not available; no antibody suitable for 
quantification was available.  
 
 
 
 
 
 
iTRAQ Western blot 
SwissProt 
Accession 
number 
Protein 
name 
Nr 
unique 
peptides 
Regulation 
SDH vs. 
CONH 
Adjusted 
P-value 
Regulat
ion SDI 
vs. 
CONH 
Regulat
ion 
SDB vs. 
CONH 
Regulat
ion 
SDH vs. 
CONH 
P-
value 
Regulation 
SDH vs. 
CONH 
independent 
P-value 
indep. 
CSK2B_ 
RAT 
Casein 
kinase II 
subunit 
beta 4 -0.29 0.008 -0.19 -0.17 -0.47 0.047 0.21 0.557 
AQP4_ 
RAT 
Aquaporin
-4 6 0.30 0.008 0.23 0.17 NA NA NA NA 
AT1B2_ 
RAT 
Sodium/ 
potassium
-
transporti
ng 
ATPase 
subunit 
beta-2 8 0.21 0.008 0.09 0.01 0.38 0.045 0.68 0.040 
KAPCA_ 
RAT 
cAMP-
dependen
t protein 
kinase 
catalytic 
subunit 
alpha 7 0.12 0.049 0.11 0.01 0.24 0.009 0.00 1.00 
ANXA6_ 
RAT 
Annexin 
A6 43 0.23 0.014 -0.08 -0.05 NA NA NA NA 
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Supplemental Table 2. Several Na,K ATPase subunits are rescued by behavioral and pharmacological 
therapy in social defeated (SD) rats. Proteins as identified by iTRAQ proteomics are indicated by the 
protein accession number (SwissProt). Comparisons (regulation (log2), P-value) are made for the effect of 
water-treated social defeat (SD_H) vs control (Con_H) animals (upregulation), and the effect of behavioral 
therapy (BT) or imipramine (Imi) in defeated animals vs. defeated water-treated (SD_H) animals (down-
regulation). Orange: P<0.05; yellow: P<0.1. Note that most of the ATPAse type 1 subunits are affected 
similarly. 
 
  SD_H vs. Con_H SD_BT vs. SD_H SD_Imi vs. Sd_H 
Protein 
accession Regulation p-value Regulation p-value Regulation p-value 
AT1A1_RAT 0.01 0.769 -0.09 0.127 -0.03 0.473 
AT1A2_RAT 0.51 0.095 -0.60 0.015 -0.53 0.072 
AT1A3_RAT -0.16 0.498 -0.14 0.024 -0.13 0.056 
AT1B1_RAT 0.09 0.170 -0.19 0.016 -0.11 0.120 
AT1B3_RAT 0.08 0.372 -0.16 0.014 0.10 0.093 
AT2A2_RAT 0.05 0.293 -0.10 0.045 -0.04 0.343 
AT2B1_RAT -0.23 0.790 -0.07 0.321 -0.04 0.573 
AT2B2_RAT 0.04 0.460 -0.08 0.127 -0.03 0.376 
AT2B3_RAT 0.01 0.825 -0.11 0.106 -0.04 0.410 
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Abstract 
Major depressive disorder is a chronic disabling disease, often triggered and exacerbated by 
stressors of a social nature. Hippocampal volume reductions have been reported in 
depressed patients. In support of the neurogenesis theory of depression, in several stress-
based animal models of depression, adult hippocampal neurogenesis was reduced and 
subsequently rescued by parallel antidepressant treatment. Here, we investigated whether 
repeated social defeat and subsequent individual housing for three months induces long-
lasting changes in adult hippocampal neurogenesis in rats, and whether these can be 
normalized by late antidepressant treatment, as would match human depression. 
Neurogenesis was analyzed by stereological quantification of the number of immature 
Doublecortin (DCX) immunopositive cells, in particular young (class-I) and more mature 
(class-II) DCX+ cells, to distinguish differential effects of stress or drug treatment on these 
subpopulations. Using this social defeat paradigm, the total DCX+ cell number was 
significantly reduced. This was most profound for older (class-II) DCX+ cells with long apical 
dendrites, whereas younger, class-I cells remained unaffected. Treatment with the broad-
acting tricyclic antidepressant imipramine, only during the last 3 weeks of the 3-month period 
after social defeat, completely restored the reduction in neurogenesis by increasing both 
class-I and-II DCX+ cell populations. We conclude that despite the lack of elevated 
corticosterone plasma levels, neurogenesis is affected in a lasting manner by a decline in a 
distinct neuronal population of more mature newborn cells. Thus, the neurogenic deficit 
induced by this social defeat paradigm is long-lasting but can still be normalized by late 
imipramine treatment.  
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Introduction 
Exposure to stress forms an important risk factor for development of human 
psychopathologies such as major depressive disorder181. In particular chronic forms of 
stress, often psychosocial in nature, may predict precipitation of depression10. As patients 
who underwent a first episode, are at increased risk to develop recurrent or chronic 
depression, interest has been raised into the underlying mechanisms that determine 
particularly longitudinal aspects of the disorder and its maintenance182.  
Of the many brain regions affected in depression, the hippocampus is well known for its 
role in cognition and stress sensitivity. Volumetric studies have repeatedly found reductions 
in hippocampal volume in patients suffering from major depression, paralleled by alterations 
in various neuropsychological and cognitive measures12,154. In preclinical models, stress 
exposure in rodents causes mild volume reductions of the hippocampus as a whole, reduces 
dendritic complexity of neurons in the CA3 subregion, and impairs neurogenesis in the 
dentate gyrus (DG)183. Despite the absence of causal evidence that changes in adult DG 
neurogenesis are critical to the etiology of major depression, impaired hippocampal plasticity 
likely contributes to the cognitive symptoms of depression, as well as clinically effective 
antidepressant treatment47,68,184. Indeed, neurogenesis is affected by many factors, among 
which treatment with antidepressant drugs – an effect that is age-dependent185 and is found 
both in stressed and naive animals186-190.  
Most studies examining the effect of stress as model for depression have measured 
neurogenesis shortly after exposure to either acute or chronic stressors that notably were 
often of a physical nature, like restraint47,68. Most stressors relevant for depression however, 
are chronic and psychosocial in nature10, and depression may develop long after the initial 
stress exposure. Also, the effects of antidepressant drugs have been evaluated, but when 
used in conjunction with a stress model, they have been administered during or parallel to, 
and not after an extended period after stress exposure68,186,191. Therefore, we questioned (i) 
whether stress induced by social defeat has long-term effects on neurogenesis or 
corticosterone levels, and (ii) whether neurogenesis can still be normalized by 
antidepressant treatment starting at a late stage, when depressive-like symptoms are 
already manifest. 
To address this, adult rats were subjected to a long-term social defeat paradigm, 
consisting of exposure to repeated severe social defeat stress followed by subsequent 
individual housing for three months. This type of paradigm models mainly the maintenance 
phase of depression as it results in increases in stress responsivity as well as decreases in 
social interaction and sensitivity to reward anticipation over time33,141,192. Social defeat stress 
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followed by subsequent individual housing for three months leads to impaired hippocampal 
long-term potentiation and this could be restored by late antidepressant treatment140. In view 
of the persistent changes in behavior and hippocampal function in this model, we 
investigated whether neurogenesis in the DG was affected on the long-term. As read-out we 
quantified the number of Doublecortin (DCX) immunopositive (DCX+) cells. Doublecortin is a 
microtubule-associated protein selectively expressed in young, immature neurons from 
approximately 4 to 14 days after birth of a newborn cell193,194. During this period, the 
temporal course of dendrite maturation can be used to morphologically distinguish younger 
(class I) and older (class II) DCX-positive cells195,196. We used this classification to 
distinguish between differential effects of our social defeat paradigm or drug treatment on 
these DCX+ subpopulations. 
 
 
Materials and methods 
 
Animals 
Male Wistar rats (Harlan, Horst, The Netherlands) 8-9 weeks of age, weighing 180–200 g at 
the time of arrival, were initially socially housed (2 per cage) in Makrolon class IV cages 
(Tecniplast, Milan, Italy). Long-Evans male rats (Harlan, UK), weighing 300–350 g were 
used as residents for social defeat141. These animals were pair-housed with age-matched 
sterilized females in plastic cages (63 x 25 x 33 cm) located in a separate room. All animals 
were housed in a temperature-controlled room (21±1 °C) under regulated lighting conditions 
(lights on at 7:00 p.m. and off at 7:00 a.m.). Food and water were available ad libitum. All 
experimental manipulations were conducted during the dark phase (activity period) under a 
dim red light. The Animal Users Care Committee of the VU University Amsterdam approved 
all experiments.  
 
Experimental design and treatment 
Wistar rats (age ≥ 11 weeks) of the social defeat group were subjected to 5 days of social 
defeat stress and were then housed individually for three months in macrolon class III cages 
from the first defeat onwards, as described before140 (Fig. 1). Control rats were housed in 
pairs. The social defeat procedure consisted of daily resident–intruder interaction sessions 
using dominant male Long-Evans rats for five consecutive days. Control animals were 
handled daily. 
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During the last three weeks of this three-month period, rats were treated by gavage 
administration of the antidepressant imipramine (20 mg/kg per 0.5 ml water; Sigma- Aldrich, 
Germany) or water as control (Fig. 1). Subsequently, four experimental groups were 
generated: 1) control rats with water (Control+H20), 2) control animals with chronic 
imipramine treatment (Control+IMI), 3) social defeated animals with water (Social 
defeat+H20), and 4) social defeated animals with chronic imipramine treatment (Social 
defeat+IMI). All behavioral and immunohistological analyses where performed at the end of 
the treatment period. Independent cohorts of animals were used for behavioral and 
immunohistochemical analyses. 
 
Reward anticipatory behavior 
A classical Pavlovian conditioning setup was used to investigate anticipatory behavior, as 
described earlier140. To investigate the behavioral response to the conditioning stimulus 
(repetitive sound (keyboard) and light flashes (three times)), animals were observed before 
training (trial 0) to determine baseline activity, and again after 35 training trials of pairing with 
a 5% sucrose-reward, using the computer program ‘The Observer’ (Noldus Information 
Technology, Wageningen, The Netherlands). The researcher who analyzed the behavioral 
data had no knowledge of the experimental groups. Differences in activity (reflected by 
frequency or transitions of behavioral elements) displayed before training compared with 
those after training were used as parameter for reward anticipation.  
 
Sucrose preference 
Figure 1. Experimental design and treatment groups. The social defeat paradigm (social defeat) in 
combination with antidepressant treatment was applied in 11-week old rats. After habituation to the new 
housing conditions, rats of the social defeat group received daily bouts (5 min) of social defeat during 5 
days and subsequent individual housing (3 months). Control animals were handled daily for 5 days and 
were housed in pairs. Treatment with the tricyclic antidepressant imipramine was applied only during 
the last three weeks (IMI; or no treatment, H2O) of the individual housing period. The length of each 
period is indicated. All behavioral and immunohistological tests were performed at the end of the 
paradigm, at the end of treatment (arrow). Independent cohorts of animals were used for behavioral 
and immunohistochemical analyses. 
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The preference for sucrose (5%) was measured in a two-bottle (sucrose and water) 
consumption test. Consumption was assessed after 24 h by reweighing the pre-weighted 
bottles. After 2 days, the consumption test was repeated. In case of social housing, 
consumption for each subject was set to half of the total consumption. Sucrose preference 
was expressed as the increase in consumption (gram) relative to water (gram), and this 
difference was represented as percentage of the total consumption (gram) [100% x (Δ 
sucrose–water)/total volume sucrose and water consumed]. 
 
Corticosterone assay 
Trunk blood samples were collected at the end of the experiment via decapitation (between 
9 – 11 AM) into a 7-mL heparin-coated tube (Greiner Bio-One, Monroe, North Carolina) and 
kept on ice before centrifugation at 1000 x g for 10 min. Plasma was decanted and stored at 
−80 °C until analysis. Levels of plasma corticosterone were assessed using a rat 
Glucocorticoid (GC) ELISA kit (Cusabio Biotech Co., LTD), according to the manufacturers 
instructions. 
 
Tissue preparation and immunohistochemistry 
Animals were anesthetized (between 9 – 11 AM) by injection of pentobarbital sodium salt 
(Nembutal; 1 mg/kg bodyweight; A.U.V. Cuijk) and perfused transcardially with saline 
followed by 4% paraformaldehyde in phosphate buffer (PB; 0.1 M, pH 7.4). Brains were 
post-fixed overnight in the skull at 4 °C, after which they were carefully removed, washed, 
and cryoprotected in 20% sucrose in PBS. Frozen sections (35 µm thick) were cut using a 
sliding microtome and collected in PB/azide.  
The number of young, differentiating neurons was identified with an antibody against 
doublecortin (DCX; 1:800; polyclonal goat anti-DCX; Santa Cruz Biotechnology) as 
described before187. Amplification was performed with a biotinylated secondary antibody, 
donkey anti-goat (1:500; Jackson ImmunoResearch Laboratories)] and avidin-biotin complex 
(1:1000; Elite Vectastain ABC kit, Brunschwig Chemie) in combination with tyramide (1:500; 
0.01% H2O2; kindly provided by Dr. I. Huitinga, Netherlands Institute for Neuroscience, 
Amsterdam, The Netherlands). Subsequent chromogen development was performed with 
diaminobenzidine (20 mg per 100 ml of Tris buffer, 0.01% H2O2).  
 
Stereological quantification and phenotypic analysis  
Quantification of cell numbers was performed in every 10th coronal section along the entire 
rostrocaudal axis of the brain, in a total of 9 sections per animal as described before196. Total 
REDUCED HIPPOCAMPAL NEUROGENESIS LONG AFTER SOCIAL DEFEAT 
103	  
numbers of DCX+ cells per DG were quantified by systematic random sampling performed 
using the Stereo Investigator System (MicroBrightField) with optical fractionator settings of 
180 x 150 grid size and 180 x 150 counting frame, resulting in 200 – 450 markers per 
animal. A single examiner unaware of the group codes performed the data collection.  
We further distinguished morphologically different subclasses of DCX+ cells, based on an 
adaptation of the stages of neuronal differentiation described before195; the most mature 
DCX+ cells were named class-II; these were characterized by a primary dendrite that was 
orientated perpendicular to the subgranular zone and radially projecting up into the 
molecular layer. The younger cells were named class-I and were located in the SGZ, without 
a dendrite, or only a short dendrite reaching no further than the granule cell layer196 (See 
Fig. 3).  
 
Statistical analysis 
Statistical analysis was performed using SPSS 18.0. Results are expressed as group means 
± SEM. Treatment effects were assessed with two-way analysis of variance (ANOVA), 
followed by Student Newman’s Keuls post-hoc analyses for further examination of group 
differences. 
 
 
Results 
 
Behavioral and physiological consequences of social defeat 
In the present model, we studied consequences of repeated social defeat and subsequent 
individual housing for three months (Fig. 1), and assessed several pathological dimensions 
of depression141,192. We confirmed that socially defeated rats in this paradigm display a 
depressive-like phenotype33,141, as shown by a reduced anticipation towards a 5 % sucrose 
solution compared with control rats (Fig. 2A). This was reversed to control levels by chronic 
administration of imipramine (IMI). Two-way ANOVA (stress x treatment) revealed a 
significant effect of SD stress ((F(1,20)=4.77, P=0.041), and an interaction of stress and 
treatment (F(1,20)=5.55, P=0.029). Post hoc comparisons showed a significant decrease 
after social defeat without treatment compared to controls (P=0.012), and for social defeat 
without treatment when compared with the imipramine-treated socially defeated group 
(P<0.029). In contrast, no difference was found for the social defeat group that was treated 
by imipramine when compared with either of the control groups. Imipramine treatment alone 
in control animals had no significant effect on anticipation towards 5 % sucrose. In contrast 
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to sucrose anticipation, neither stress nor imipramine treatment had a significant effect on 
sucrose preference (Fig. 2B), which is an indicator of more acute stress. 
Also, no difference was observed in plasma corticosterone levels between any of the 
groups (Fig. 2C), indicating that no lasting changes in stress hormone levels had been 
induced, nor that antidepressant treatment had been stressful.  
 
Figure 2. Behavioral and physiological 
consequences of long-term social stress. (A) 
Anticipation towards 5 % sucrose expressed as the 
mean difference in activity (# behavioral transitions) 
in the CS-US interval post-training compared with 
that during pre-training. The social defeat paradigm 
(social defeat) significantly suppressed reward 
anticipation, whereas imipramine treatment (IMI) 
reversed this stress-induced effect. *P=0.0034 vs. 
Control+H2O. (B,C) Sucrose preference (sucrose 
intake-water intake)/total fluid intake (B) and plasma 
corticosterone level (C) were not affected. All data 
show mean ± SEM. n=6 for al experimental groups. 
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Long-term social stress affects neurogenesis by reducing differentiation and survival 
of DCX-positive cells  
Immunohistological staining of the adult hippocampus revealed numerous DCX+ cell bodies 
located in the SGZ and only few DCX+ cells within the granule cell layer itself. DCX-
expressing cells were classified195,197,198 into class-I (Fig. 3A), or class-II cells  (Fig. 3B). 
About 70 % of all DCX+ cells belonged to class-II (Fig. 3C). Hence, at any given time point, 
DCX identifies a majority of cells with a relatively mature phenotype. 
To examine whether adult hippocampal neurogenesis was affected by the social defeat 
paradigm and/or antidepressant treatment, we first quantified the total population of DCX+ 
neurons. Two-way ANOVA revealed a significant effect of defeat (F(1,30)=6.17, P=0.019) on 
total number of DCX+ neurons (Fig. 4A). Social defeat significantly reduced the total number 
of DCX+ cells (P=0.004). This effect was not present anymore after three weeks of 
imipramine treatment, as the social defeat group treated with imipramine differed 
significantly from the social defeat group (P=0.048) and was not different from both control 
groups (CON+H2O, CON+IMI).  
To further address which subset of the DCX cells was affected, i.e., the relatively younger 
or older cells, we quantified class-I and -II DCX+ cells. No effect of defeat or treatment was 
Figure 3. Class-I and class-II DCX-expressing cells in the DG subgranular zone. (A, B) High-power 
images of clusters of DCX+ cells with different morphology. The granule cell layer (GCL) is seen as a 
purple cell layer. The hillus (H), subgranular zone (SGZ), and molecular layer (MOL) are indicated. 
Scale bar, 30 µm. (A) Class-I cells (arrow) with no or short processes reaching no further than the 
granule cell layer. Note how the initial segment of the dendrite grows parallel to the SGZ (arrow heads). 
(B) Class-II cells (arrow) with at least one dendrite reaching into the molecular layer (arrow heads) and 
occasionally showing delicate branching with few major branches. (C) Percentage of total amounts of 
class-I and –II cells in control animals (mean ± SEM). 
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found on the number of cells belonging to class-I cells (F(1,30) < 1) (Fig. 4B). However, a 
significant effect of both defeat (F(1,30)=10.41, P=0.003) and treatment (F(1,30)=4.96, 
P=0.034) with no interaction was found on class-II DCX+ cells. Social defeat significantly 
reduced the number of class-II cells (P=0.002), and three weeks of imipramine treatment 
reversed this effect (P=0.026; Fig. 4C). Imipramine treatment alone had no effect in control 
rats (P=0.369).  
To confirm whether long-term social stress indeed enforced its strongest effect on class-II 
cells, the ratio of class-II cells over class-I cells was calculated. This ratio was significantly 
affected by social defeat (F(1,30)=7.58, P=0.010). Post hoc comparisons showed that social 
defeat significantly reduced the ratio of class-II/class-I cells (P=0.004). However, imipramine 
was not able to restore this ratio to basal levels. Together these data demonstrate that (1) 
social stress on the long term reduces neurogenesis by specifically reducing class-II DCX+ 
cells, whereas class-I cells were unaffected, and (2) imipramine restored this reduction in 
neurogenesis by increasing both class-I and –II DCX+ cells, thereby leaving their ratio 
unaffected.  
 
Discussion 
Here, we showed for the first time that adult hippocampal neurogenesis is still reduced at the 
end of a three-3 month individual housing period that followed a short period of severe social 
defeat stress. The reduction in neurogenesis was observed, despite that corticosterone 
levels were normal at the end of this paradigm, and was most profound for the class-II DCX+ 
cells with long apical dendrites, arguing that neuronal differentiation and/or survival of 
newborn neurons is affected. Treatment with imipramine for the last 3 weeks completely 
restored this reduction by stimulating both class-I and -II DCX+ cells. 
 
Validity of the social stress model 
The present social defeat model recapitulates several behavioral dimensions of 
depression33,141. We showed that the depressive-like phenotype of reduced anticipation 
towards sucrose is associated with a decrease in hippocampal neurogenesis, although 
sucrose consumption was not changed. This reward-related consummatory response is 
different from appetitive behaviors measured by anticipation199. Although consummatory 
behavior is known to be reduced shortly after stress exposure200, we confirmed that on the 
long-term, appetitive behavior is specifically affected33,141. Since the mesolimbic dopamine 
reward system is primarily involved in appetitive behavior and not in the affective component 
of consumption, we hypothesize that reduced appetitive behavior is an adequate 
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representative of depressive-like behavior141,199. Moreover, anhedonia is commonly 
observed in depressive patients201.  
As the present results were obtained in rats 6 months of age, it is unlikely that 
interference with early postnatal development has played a major role202. The age at which 
rats experienced stress in our model (adult rats >11 weeks) is of importance given the 
protracted period of risk for development of affective disorders into young adulthood203.  
As compared with most other stress-induced models34,186, the present paradigm was used 
Figure 4. Differences in DCX-positive cells with different dendritic morphologies after long-term 
social stress and subsequent imipramine treatment. (A) Total number of DCX+ cells in the SGZ per 
hemisphere. The social defeat paradigm (social defeat) significantly reduced total amount of DCX+ 
cells, whereas imipramine treatment (IMI) normalized this stress-induced effect. (B) No effect of social 
defeat or imipramine was found on class-I DCX+ cell numbers. (C) Social defeat significantly reduced 
amounts of class-II DCX+ cells, whereas this reduction was not found in the imipramine treated group 
(IMI)(D). Social defeat significantly reduced the ratio of class-I cells over class-II cells. Imipramine 
treatment had no effect on this ratio. All data show mean ± SEM. n=9 for al experimental groups. ** 
P<0.01; * P<0.05. 
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to study long-lasting effects of social stress on structural plasticity changes, that have been 
implicated in depressive symptoms and maintenance of depression, long after the initial 
exposure to active stress has occurred, and when the rise in stress hormone levels has 
normalized10,12,204.  
 
Neurogenesis – subclasses of DCX+ cells 
We quantified DCX+ cell numbers in the DG to examine whether the persistent anhedonic 
phenotype present long after exposure to social defeat was associated with a reduction in 
neurogenesis. Doublecortin has been previously established as a reliable marker for young 
and migratory neurons in the adult DG193,195,198,205. It is expressed approximately from day 4 
to day 14 after a new cell is born and most likely all DCX+ young neurons originate from cell 
divisions during the past 3 – 4 weeks198. DCX expression is further selective for the neuronal 
lineage, as DCX-positive cells co-express early neuronal antigens like Tuj1, PSA-NCAM or 
pax-6194, but lack specific markers for glia, undifferentiated, stem cells, or apoptotic cells, 
making it a reliable marker of newly generated neurons in the adult DG193,198,206.  
DCX immunoreactivity in dendrites allowed classification of these immature neurons. 
DCX is transiently expressed from the proliferative progenitor cell stage to a postmitotic 
phase with long dendrites194,195. Several subclasses of DCX+ cells can be distinguished 
based on the presence and shape of the apical dendrites195,196. Smaller cells without a 
dendrite that penetrate the GCL are known to reflect progenitor cells (type-2b and type-3 
cells, see195, whereas longer cells with extensions into the molecular layer are considered 
immature postmitotic neurons. 
Here, we used a simplified scheme of this subdivision195 and defined class-I cells as 
young cells with no or short processes reaching no further than the molecular layer, and 
class-II cells as mature post proliferative cells with at least one dendrite reaching into the 
molecular layer. About 70% of DCX+ cells belong to class-II and 30% to class-I, and it has 
been shown that of this latter 30%, about two thirds is in cell cycle195. Interestingly, the ratio 
of class-I and –II cells we found were similar to those in rodents 2 months of age, despite the 
fact that the total number of DCX+ cells equals about 10% of what is observed in these 
younger animals. This implies that despite the lower overall DCX+ cell numbers, different 
stages of the neurogenic process are present in similar proportions both in young adults as 
well as adult animals.  
In a recent paper207, DCX+ cells were sorted using fluorescence activated cell sorting 
(FACS) and particularly the younger DCX+ cells with low levels of DCX per cell, comparable 
with our class-I cells, were shown to be capable of dividing again, in contrast to the older 
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types with higher DCX levels. Although we cannot compare FACS sorted cells with the 
present populations in brain tissue, it is tempting to speculate that as predominantly the 
class-II DCX+ cells were affected in our study, social stress may have affected progression 
through the cell cycle and thereby limited neuronal differentiation and/or newborn cell 
survival. 
 
Neurogenesis – social defeat and reversal by imipramine 
We found that at the end of the social defeat paradigm total DCX+ cell numbers in the DG 
were reduced, which was due to a reduction in class-II cells, whereas the class-I cells 
remained unaffected. It has been proposed that neurogenic stimuli that act on precursor 
cells are different from those regulating dendritic maturation and survival of newborn cells. In 
contrast to chronic unpredictable (physical) stress exposure, after which a rapid recovery of 
neurogenesis occurs (Heine et al., 2004), our present results imply that social defeat 
reduces neurogenesis for a prolonged period of time and that it does so by inhibiting 
specifically the differentiation and survival stage, but leaves progenitor cells unaffected.  
A remaining question however, is whether this long-term reduction in neurogenesis is 
caused by 1) long-term effects of social defeat, 2) by the individual housing or, –most likely– 
3) by a combination of both. In adult rats, individual housing by itself is considered to be a 
social stressor. Adult individual housing induces changes in anxiety- and anhedonia-like 
behavior83 as well as neurochemical alterations208. However, social isolation in male rats 
does not result in an increased, lasting expression of stress hormones83,209,210, which is in 
line with our current findings. Also, in the absence of external factors, adult social isolation 
does not affect hippocampal neurogenesis209,211. However, individual housing does increase 
the stress response to external stressors, both on glucocorticoid levels83,210 and 
neurogenesis209,211, and it delays the positive effect of physical activity on neurogenesis209. 
This would argue that individual housing in our paradigm might be involved in the 
maintenance of the reduction in neurogenesis rather than in its onset.  
This additive effect of social isolation is further supported by the observations that 
depressive-like behavior (e.g. reduced anticipation to sucrose) induced by social defeat is 
maintained during individual housing, but can be counteracted by social housing33.  
As social isolation itself cannot reduce anticipation towards 5% sucrose33, the observed 
reduction in neurogenesis is most likely induced by repeated social defeat stress, and 
maintained on the long term due to a lack of social support. This would match human 
depression in which active stress is often involved in the onset of depression, while passive 
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stress, e.g., in the form of social isolation, has strong precipitating effects on the 
development of the disease84.  
The current reduction in hippocampal neurogenesis was associated with an anhedonic 
phenotype, which is in accordance with the concept of a role for neurogenesis in depression 
or antidepressant action. This concept originated from animal studies in which stress was 
shown to inhibit neurogenesis188,212, and from studies in which various classes of 
antidepressants were found to promote newborn cell proliferation20,46,189, survival and 
neurogenesis187,189,213. Furthermore, the 3- to 4-week therapeutic time lag of antidepressants 
coincides with the maturational time course of newborn neurons214.  
However, ablating neurogenesis does not result in a depressive-like phenotype per se215. 
Also, the enhanced survival of newborn cells that occurs upon administration of 
antidepressants to young mice, is age- and strain dependent, and is abolished when older 
mice are studied185,216,217. Similarly, in hippocampal tissue of depressive patients, the 
stimulatory effect of antidepressants218 also appears to depend on age184. Hence, both 
neurogenesis-dependent and neurogenesis-independent mechanisms are likely to 
contribute to the reversal of depressive-like behaviors by antidepressants47,216.  
In this study, treatment with imipramine during the last 3 weeks of a 3-month individual 
housing period following exposure to severe social defeat stress restored total DCX+ cell 
numbers back to control levels. Interestingly, whereas the social defeat paradigm affected 
specifically class-II DCX+ cells, imipramine’s action is not cell-type specific as it left the ratio 
of type-II over type-I cells unaffected. This is in accordance with previous studies in which 
imipramine increased several stages of the neurogenesis process46,219, including 
proliferation, neuronal differentiation, survival as well as integration of adult-generated cells 
into existing neuronal circuits. 
 
Overall, using a paradigm that models both temporal aspects of a social stress-mediated 
onset and the maintenance phase of depressive symptoms, we have shown that in absence 
of lasting changes in corticosterone levels at the end of the social defeat paradigm, 
neurogenesis is still significantly reduced. This is accompanied by a reduction of 
differentiation and/or survival of the newborn neurons, whereas younger cells are 
unaffected. An interesting outcome of our study is that this form of long-term social stress 
does not affect all domains of the adult neurogenic process but appears selective for the 
differentiation and survival stages. In addition, these neurogenic deficits can still be 
normalized by late imipramine treatment that increased both classes of DCX+ cells. 
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Major depressive disorder (MDD) is a multifaceted disease with a broad spectrum of 
symptoms. Evidently, the underlying causative factors of MDD are diverse in nature. 
Environmental factors exert a major influence on the initiation of MDD; a common factor 
causing the disease is stressful life events. Stress impacts on the individual thereby affecting 
mood- and cognition-related functioning. In particular, this disease-triggering factor can be 
modeled in animals, thereby providing the opportunity to investigate the molecular and 
cellular changes in distinct brain areas. 
In this thesis, research focused on the impact of a natural occurring type of stressor, 
social defeat stress, on the functioning of the hippocampus in terms of learning and memory 
and the potential alleviating role of antidepressant and behavioral therapy. This thesis 
yielded several novel findings concerning the molecular and cellular correlates of MDD that 
originated from animal models of depression, and will be discussed below. 
 
Major conclusions 
First, we identified a mechanism by which ketamine may exert a direct and lasting 
antidepressant effect. We found that ketamine probably exerts its long-term antidepressant 
effects by increasing hippocampal synaptic membrane α-amino-3-hydroxy-5-methyl-4-
isoxazole propionic acid (AMPA) receptor function. This sheds new light on using ketamine 
in the treatment of depression. 
Second, we found that impaired hippocampal function observed both short- and long-
term after social defeat stress originated from different synaptic mechanisms. In particular, 
we noticed alterations in the glutamate receptor system only at the short-term, whereas on 
both time points hippocampal spatial memory performance was clearly affected. 
Third, we showed that long after social defeat stress, hippocampal plasticity was 
severely affected. This translates into concomitant behavioral dysfunction. The long-term 
impairment of the hippocampal functioning can be alleviated by imipramine treatment and, 
much to our surprise, to the same extent with behavioral therapy. 
Fourth, we found that neurogenesis in the hippocampal dentate gyrus was affected in a 
lasting manner after social defeat by a decrease in a distinct neuronal population of more 
mature newborn cells. Here, imipramine was able to rescue the neurogenic deficit. 
Fifth, we were able to identify synaptic mechanisms that are regulated long-term after 
social defeat stress. A proteomics analysis turned out to be a useful approach to identify 
potentially new targets for MDD research. 
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Overall, in this thesis, observations are made concerning the molecular and cellular changes 
in the hippocampus related to depressive-like phenotypes. In the next sections I will discuss 
these findings in the context of ongoing MDD research. 
 
 
Animal models of depression 
 
Model validity 
To appreciate the improvement of using animal models for depression based on long-term 
effects of stress over acute stress, it is important to compare how they meet criteria for a 
valid animal model.  
At the very least, animal models must resemble the human condition in several 
respects220, including (a) similarity in the symptom profile presented (face validity), (b) 
amelioration or attenuation by treatments effective in treating the human condition 
(predictive validity), (c) provocation by events thought to be important in eliciting the human 
disorder (etiological validity), and (d) involvement of similar neurochemical processes 
(construct validity) (Box 1).  
 
An acute stress model to study antidepressant action 
In this thesis several stress-induced animal models for depression have been used. The 
most basic and straightforward is the forced swim test (FST). This model has been proven 
efficient in predicting the clinical efficacy of antidepressants in a cost efficient way and 
therefore has good predictive validity80. However, this model has low etiological validity as 
acute swim stress is used to induce a depression-like phenotype. Also, its face validity is 
limited as only behavioral despair is accessed as readout parameter.  
Using the predictive validity of this model, we showed in chapter 2 that ketamine, an N-
methyl-D-aspartic acid (NMDA) receptor antagonist with acute and lasting clinically 
antidepressant effects, also showed acute and lasting efficacy in the FST and we revealed 
aspects of the contributing synaptic mechanisms. However, considering the limited validity of 
the test, care should be taken when interpreting the clinical relevance of these findings. 
 
Using chronic stress to gain insight into mechanisms of depression 
To gain insight in the molecular and cellular neurobiology of depression, animal models with 
the highest attainable validity should be used. In rodents, the social defeat paradigm is a 
good candidate. Since a natural type of social defeat stress is used, this model has good 
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Box 1. Validation criteria for evaluating animal models for psychiatric disorders 
Category of 
validation criteria Definition 
Face validity The phenomenological similarity between the behavior exhibited by the animal 
model and the specific symptoms of the human condition.  
Predictive validity The ability to predict changes in the human subject based upon changes in the 
model. This requires constant reality checking with clinical measures to make sure 
that the changes in the model correspond to those in the human. In terms of drug 
development, the special condition of predictive validity is usually determined 
through pharmacological validation that refers to clinically effective drugs showing 
activity in the test or model (pharmacological isomorphism). 
Etiologic validity The concept of etiological validity is closely related to the causes of the disorder in 
humans. When etiology can be established, the model becomes very useful. 
Unfortunately, the causes of behavioral disorders are often diverse. Therefore, this 
validity is limited to hypothesis regarding possible etiology. 
Construct validity Construct validity is closely related to the pathology and symptomatology of the 
disorder, and the accuracy with which changes in the model organism reflects that 
in the human. For example, close correspondence of changes in neurochemical or 
endocrinological parameters in depressed subjects and in the model systems 
used study depression endow the model with increasing construct validity. 
etiologic validity, especially since chronic psychosocial stress is particularly effective in 
predicting human depression10. Moreover, social defeat has been shown to induce behavior 
relevant to depressive symptoms both acute221 and long-term after defeat stress33. These 
symptoms include anhedonia (reduced sucrose preference or anticipation towards sucrose), 
behavioral despair, and reduced social interest, and therefore the model meets the criterium 
of face validity. Moreover, these symptoms were counteracted by chronic141,222, but not 
acute34 antidepressant treatment thereby establishing appropriate predictive validity. Finally, 
rodents subjected to the social defeat paradigm show neurobiological changes also 
observed in postmortem human studies, such as increased BDNF expression in the nucleus 
accumbens81 and reduced hippocampal volumes223 indicating that the paradigm has at least 
to some extent construct validity.  
Here we adopted a social defeat paradigm, in which rats were subjected to severe 
social defeat stress once every day for five days. In chapter 3, we showed that this results in 
an overactive hypothalamic-pituitary-adrenal (HPA) axis response 24 hour after the last 
social defeat encounter, expressed by an increase in plasma levels of the stress hormone 
corticosterone. This further supports the construct validity of social defeat stress, as 
dysregulation in HPA axis responses are also observed in MDD patients224. As further 
shown in this chapter; this social defeat stress reduced performance in a hippocampus 
dependent spatial memory task, a phenotype relevant to the cognitive symptoms of 
depression.  
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Long-term effects of chronic stress 
In humans, depressive episodes are still apparent long after the cessation of the stress 
exposure and depression is often considered as a chronic disease. Moreover, depression is 
a highly recurrent disorder; more than 75% of depressed patients have more than one 
depressive episode, often relapsing within two years of recovery from a depressive 
episode225. Indeed, between one-half and two-thirds of the people, who have ever been 
clinically depressed, will be in a relapse episode in any given year over the remainder of 
their lives226. Therefore, interest is in understanding the underlying mechanisms that 
determine particularly longitudinal aspects of the disorder and its maintenance182.  
To model the maintenance phase of depression rather than its induction phase, thereby 
increasing validity of the social defeat model, we adopted a social defeat paradigm in which 
five days of social defeat stress was followed by individual housing for 12 weeks33. In 
chapter 4, we confirmed face validity by showing that that this model induces depressive-like 
behavior by invoking anhedonic behavior, as indicated by reduced anticipation towards a 
palatable 5% sucrose solution, and by depression-associated cognitive impairments. 
Moreover, predictive validity was confirmed by showing that both behavioral and 
antidepressant therapy recovered both symptoms.  
 
 
Novel neurobiological mechanisms of depression 
 
Synaptic plasticity processes 
Throughout this thesis, several novel mechanisms have been characterized concerning 
stress-induced depressive-like phenotypes and antidepressant action. These mostly concern 
synaptic plasticity processes. In chapter 2 of this thesis, we showed that ketamine exerts its 
antidepressant effects by interfering with glutamatergic signaling in hippocampal synapses. 
Ketamine is a non-competitive (NMDA) receptor antagonist that has been shown to have 
immediate antidepressant effects in treatment-resistant patients when administered at a 
subanesthetic dose31,85. Its primary mechanism of action is blocking the NMDA receptor at 
the phencyclidine site, i.e. in the pore of the ion channel. In addition, ketamine induces rapid 
increases in presynaptic release of glutamate, a process hypothesized to be mediated by 
NMDA autoreceptors, and/or mediated by activated GABAergic neurons89. We show that the 
long-term antidepressant effects of ketamine in the FST were paralleled by increased Ser-
845 phosphorylation of GluA1 in hippocampal synapses. Moreover, a molecular blockade of 
regulated AMPAR endocytosis, using a TAT-Glu23Y peptide in the CA1 region of the dorsal 
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hippocampus, mimicked this antidepressant effect. This substantiates the hypothesis that 
the antidepressant effects of ketamine are initiated by an increased AMPAR turnover and 
functionality. These results argue that ketamine exerts its antidepressant effects through 
glutamatergic signaling mechanisms. The role of glutamate signaling in MDD is supported 
by growing evidence showing that antidepressants ultimately converge to regulate AMPA 
and NMDA receptor-mediated synaptic plasticity94, via a cascade of time-dependent 
signaling. 
Using the social defeat paradigm, we found that after severe social stress synaptic 
plasticity mechanisms are affected. In chapter 3, we showed that reduced spatial memory 
after social defeat is associated with reduced hippocampal synaptic expression of the 
glutamatergic receptor subunits GluN1, GluN2B and GluA2. In particular, the regulated 
synaptic expression of NMDA receptor subunits provides a dynamic and potentially powerful 
mechanism for the regulation of synaptic efficacy and remodeling. Indeed, it has been 
shown that alterations in NMDAR number and/or subunit composition contribute to the 
expression mechanisms of LTP (NMDAR-LTP)150 and LTD (NMDAR-LTD)151. This is another 
example in which synaptic glutamate signaling plays a role in generating a depressive 
phenotype. The reduced expression of NMDA receptor subunits is of particular interest since 
it might represent a mechanism of metaplasticity in the glutamatergic system37, and most 
likely underlies the cognitive impairments in a hippocampus-dependent memory task.  
Long after social defeat, synaptic changes are also apparent (chapter 4). Brain slice 
recordings of the hippocampus revealed a typical depressed state of the synapse. This 
reduced LTP in CA1 subfields probably affected hippocampus-dependent cognitive 
performance. We then used a proteomics analysis to identify synaptic alterations at the 
molecular level. The cognitive impairments and reduced LTP were associated with an 
increased hipocampal synaptic expression of the Na,K ATPase subunit AT1B2. Na,K 
ATPases are membrane localized proteins responsible for active transport of Na+ and K+ 
ions across the plasma membrane, thereby generating a gradient responsible for cell 
polarization and repolarization173. Increased expression and increased transporter activity 
could cause a faster clearance of K+ from the synaptic cleft, and of Na+ from the 
intrasynaptic compartment. This would result in a faster re-polarization after firing of an 
action potential, and therefore less glutamate release and calcium influx. Together, this 
might cause less plasticity in hippocampal synapses and underlie impaired LTP. Moreover, 
this Na,K ATPase dependent mechanism is a possible route through which stress can alter 
plasticity mechanisms, thereby inducing depressive symptoms.  
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Different mechanisms short and long-term after stress 
Stress has well-established effects on spatial memory performance in rodents by affecting 
hippocampal LTP40,41,43. Since hippocampal LTP is dependent on subunit specific regulation 
of AMPA receptors, it is not surprising that synaptic expression of GluA2 is affected after 
social defeat stress. In line with this, the stress hormone glucocorticoid enhances AMPA 
receptor mobility in hippocampal synapses135. Our observation that also synaptic localization 
of two NMDA receptor subunits was affected provides another mechanism through which 
plasticity mechanisms are regulated acutely after stress.  
Also, long after social defeat spatial memory performance and LTP in the CA1 subfields 
were reduced hinting towards altered glutamatergic signaling. However, in contrast to 24 
hour after social defeat, none of the glutamate receptor subunits were differentially 
expressed in synaptic membrane fractions. Instead, we observed an increase in synaptic 
expression of AT1B2. The fact that this Na,K ATPase subunit was not differentially 
expressed 24 hours after social defeat (data not shown), further confirms that on the long-
term different synaptic plasticity mechanisms are involved in causing reduced hippocampal 
LTP and memory. This argues that direct changes in levels of glutamate receptor subunits 
are involved in the installment of cognitive impairments immediately after stress exposure, 
while different synaptic mechanisms, e.g., changing the membrane potential, account for the 
maintenance of these symptoms. 
 
Depressive-like phenotypes after normalization of corticosterone levels 
The hypothalamic-pituitary-adrenal (HPA) axis has been found abnormal in depressed 
patients224. For example, a significant percentage of depressed patients have increased 
levels of cortisol in the saliva, plasma and urine, and increased size (as well as activity) of 
the pituitary and adrenal glands227. It is hypothesized that impaired hippocampal signal 
processing, due to damage by increased glucocorticoid levels, interferes with feedback 
inhibition of the HPA axis35. The resulting hyperactive HPA axis would then lead to an 
inappropriate stress response and, thereby, to the installment of depressive symptoms. 
However, here we show that despite hippocampal signaling being affected long after social 
defeat stress, corticosterone levels were normal. This argues that impaired hippocampal 
processing can induce depressive-like phenotypes, independent of HPA axis dysfunction. 
This supports the hypothesis that HPA axis hyperactivity is not a simple consequence or an 
epiphenomenon of depressive phenotypes, but on the contrary, that it is a risk factor 
predisposing to the development of depression228.  
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Social defeat stress affects hippocampal neurogenesis 
In chapter 5, we showed that after three months of individual housing, following a 5-day 
period of repeated social defeat, hippocampal neurogenesis is reduced indicated by a 
decrease in doublecortin postivie (DCX+) cells. This was most profound for older DCX+ cells 
with long apical dendrites, whereas younger cells remained unaffected. Chronic imipramine 
treatment subsequently increased both cell populations. Whether there is a causal relation 
between depressive phenotypes, cognitive impairments and a decrease in neurogenesis is 
still an active field of investigation68. However both neurogenesis-dependent and 
neurogenesis-independent mechanisms are likely to contribute to the reversal of depressive-
like behaviors by antidepressants47,216. This is in agreement with the network hypothesis of 
depression stating that depressive-like behavior reflects problems in information processing 
within particular neural networks in the brain and that antidepressant drugs and other 
treatments that alleviate depression function by gradually improving information processing 
within these networks229. 
 
Behavioral therapy 
Another interesting novel finding is the efficacy of behavioral therapy consisting of housing in 
an enriched environment for one hour daily. This type of therapy resembles activation and 
fysical execise therapy and aspects of behavioral therapy for depressed patients. Behavioral 
therapy was found equally effective in treating anhedonic symptoms, depression-associated 
cognitive impairments, as well as their underlying molecular and cellular correlates when 
compared with chronic imipramine treatment. Enriched environments produce functional and 
anatomical changes in neural networks that are reflected in the gradual improvement of 
natural behavior230. In analogy, behavioral psychotherapy might also have therapeutic 
effects on mood disorders through use-dependent neuronal plasticity. Therefore, behavioral 
and pharmacological therapies, might all lead to improved information processing and mood 
recovery through mechanisms that stimulate similar processes of plasticity. In this scenario, 
a combination of drug treatment and psychotherapy would be expected to be more 
beneficial than either treatment alone, and there is evidence that this might be the case231.  
 
 
Depression and neuroplasticity 
Increasing evidence demonstrates that neuroplasticity, a fundamental mechanism of 
neuronal adaptation, is disrupted in mood disorders and in animal models of depression156. 
Chronic stress, which can cause depression, also disrupts neuroplasticity35,44, whereas 
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several forms of antidepressant treatment induce opposing effects67. As discussed in the 
previous section, throughout this thesis, we made several novel observations supporting the 
neuroplasticity theory of depression. These findings hold throughout three different levels: 
structural plasticity, functional plasticity, and molecular mechanisms accompanying such 
changes. At the structural level we found that neurogenesis was affected after social defeat 
stress and imipramine treatment was able to restore the neurogenic process at this late time 
point, long after stress experience. This indicates that antidepressants might facilitate 
optimization of neuronal connectivity by increasing the choice of neurons available for 
selection through activity-dependent mechanisms. This process is expected to take time to 
develop and mature, which is consistent with the delayed appearance of the clinical effects 
of antidepressants229. 
Chronic stress impairs hippocampal LTP232. Short after social defeat stress, we found 
that hippocampal memory impairments were associated with decreased synaptic expression 
of glutamate receptor subunits. These are possibly caused by synaptic signaling pathways 
affected by social defeat stress. For example, several forms of chronic stress have been 
observed to increase the phosphorylation of MAPK233. The activation of MAPK appears to be 
critical for the effects of behavioral stress on hippocampal LTP234. Also, increased stress 
hormone levels and chronic stress can impair CREB activity235.  
The increased expression of AT1B2 that is associated with a decrease in LTP long after 
social defeat stress is a novel mechanism by which hippocampal plasticity is affected, and 
supports the neuroplasticity hypothesis of depression. However, care should be taken when 
projecting these findings to other brain regions. For example, in the amygdala51 and nucleus 
accumbens34 stress has opposing effects when compared with our data and increases 
neuroplasticity. Thus, our findings are brain region- and circuit-dependent and relate to the 
specific role of the hippocampus in MDD pathophysiology. The observation that both 
behavioral therapy and imipramine treatment (both effective treatments for MDD) have 
similar effects on plasticity and reverse of depressive-like phenotypes at the affective and 
cognitive domain argues that these changes are relevant for the disease phenotype of MDD.  
 
 
Clinical relevance 
 
Depression and cognition 
The observed changes in neuroplasticity in our depression model hint to aberrant 
information processing. Indeed, we found reduced cognitive hippocampal performance 
CHAPTER 6 
122	  
associated with plasticity changes both short- and long-term after social stress exposure. By 
employing the social defeat model, we were capable of modeling aspects of cognitive 
impairments after a severe stress experience. Socially stressed rats showed decreased 
spatial memory, a symptom also observed in MDD patients130. Our finding that increased 
plasticity induced by both pharmacological treatment and behavioral therapy were able to 
relieve symptoms in both the affective and cognitive domain argues that improved 
information processing contribute to their antidepressant effects.  
There is a long history of research investigating the interaction of cognition and emotion 
in MDD. Clinicians and researchers alike have focused on cognitive processes and on the 
content of depressive cognition in trying to gain a more comprehensive understanding of 
MDD. These studies postulate that “associative networks” lead to cognitive biases on 
negative emotions in depressed individuals. Biases in cognitive processes, such as attention 
and memory, may not only be correlates of depressive episodes; they may also play a 
critical role in increasing the individuals’ vulnerability for the first onset and recurrence of 
depression236. Most cognitive theories propose vulnerability-stress hypotheses that posit that 
the onset of this disorder is due to the interaction of a psychological vulnerability (e.g., 
certain cognitions or particular ways of processing information) and a precipitating stressor. 
Importantly, one of the most effective interventions for depression, cognitive-behavioral 
therapy, focuses on modifying biased interpretations and dysfunctional automatic 
thoughts237.  
Depressed people experience difficulties involving concentration and memory (Burt et 
al. 1995). A general accepted attempt to integrate these findings with cognitive biased 
processes is the resource-allocation hypothesis. This postulates that because cognitive 
capacity is reduced, depressed individuals have deficits in remembering and in engaging in 
other effortful cognitive processes238. Additionally, the amount of resources available for 
cognitive operations is limited and depression either occupies or functionally reduces these 
resources, for example, because resources are used by task-irrelevant emotional 
processing. Thus, deficits should become evident in effortful, resource-demanding 
components of memory tasks.  
Given these still unsubstantiated views, the question remains how cognitive deficits are 
related to the hallmark feature of depression, the sustained negative affect. Therefore this 
interaction should be a focus of future depression research. 
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Implications for treatment strategies 
Throughout this thesis, several observations were made with important implications for 
treatment strategies for MDD. Our social defeat paradigm models symptoms in the affective 
and cognitive domains. In this paradigm, depressive-like behavior is induced by social stress 
experience in adult rats and, therefore, models adult onset stress-induced depression with 
cognitive impairments seen in depressed patients239. Here, we found that behavioral therapy 
was just as effective as imipramine treatment in rescuing depressive phenotypes and their 
underlying cellular and molecular correlates. This argues that behavioral therapy should be 
explored further as treatment option for depressed patients with cognitive impairments, that 
do not need, do not respond to or have adverse effects from pharmacological treatment. 
Furthermore, antidepressant effects of imipramine and behavioral therapy went hand in 
hand with an increase in hippocampal plasticity in glutamatergic systems as expressed by 
an increase in LTP after social stress. Also the acute and lasting antidepressant effects of 
ketamine were associated with a possible increase in AMPA receptor function in the 
hippocampus. This underscores that glutamatergic signaling pathways should be explored 
for potential therapeutic targets of MDD with faster therapeutic effects54. 
Finally, we showed that during the maintenance phase, likely different cellular and 
synaptic mechanisms are involved in stress-induced depressive phenotypes when 
compared with synaptic changes involved in the establishment of these symptoms directly 
after stress exposure. Since MDD patients are mostly treated (long) after cessation of the 
stress period, i.e., when depressive symptoms are evidently manifest, data originating from 
paradigms that model the maintenance phase of depression might be more relevant for 
implementation of treatment strategies. Therefore I argue for a shift in pre-clinical depression 
research, in which studies should focus increasingly on the maintenance phase of the 
disease rather that the induction phase of depression.  
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Moleculaire en cellulaire neuroplasticiteit in diermodellen voor depressie 
 
Depressie is een veelvoorkomende psychiatrische aandoening die vaak diep in het leven 
van mensen ingrijpt. Depressie wordt gekenmerkt door een gedeprimeerde stemming en 
een verlies van belangstelling in aangename activiteiten. De oorzaak van depressie is 
grotendeels onbekend, maar in het algemeen wordt aangenomen dat een combinatie van 
genetische- en omgevingsfactoren hieraan ten grondslag ligt. Van de omgevingsfactoren is 
stress de meest voorkomende factor.  
Neurobiologisch gezien zijn er verschillende hersengebieden betrokken bij het tot stand 
komen van depressie symptomen. Eén van de gebieden waarin duidelijke veranderingen 
waarneembaar zijn bij depressieve patiënten is de hippocampus. Deze is betrokken bij 
verschillende cognitieve processen waaronder het semantisch geheugen en ruimtelijke 
oriëntatie. Daarnaast staat de hippocampus in verbinding met verschillende andere 
limbische hersengebieden die eveneens betrokken zijn bij gemoedstoestandregulerende 
processen.  
In het afgelopen decennium is duidelijk geworden dat er een verband bestaat tussen 
depressie en neuroplasticiteit. Deze relatie is duidelijk geworden door het gebruik van 
verschillende preklinische diermodellen voor depressie. Hiermee is aangetoond dat stress – 
één van de belangrijkste oorzaken van depressie – verschillende mechanismen van 
neuronale plasticiteit aantast. Ook is duidelijk geworden dat antidepressiva en niet-
farmacologisch gebaseerde therapieën deze processen juist stimuleren, hetgeen 
neuroplasticiteit meer in het focus van aandacht heeft gebracht.  
In dit proefschrift heb ik gebruik gemaakt van verschillende diermodellen in knaagdieren 
om de relatie van depressie met neuroplasticiteit te bestuderen. Naast de directe effecten 
van stress heb ik ook de lange termijn effecten van stress bestudeerd. Dit verdiend 
bijzondere aandacht omdat bij mensen de depressieve symptomen nog lang na een 
stressvolle levenservaring tot utdrukking komen. 
 
Hoofdsuk 2: Het antidepressieve effect van ketamine door middel van regulatie van 
AMPA receptor activiteit 
Ketamine is een N-methyl-D-aspartic acid (NMDA) receptor antagonist en wordt doorgaans 
gebruikt als verdovingsmiddel. Onlangs is gebleken dat deze stof, wanneer deze in lage 
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(sub-anesthetische) concentraties wordt toegediend, zowel een acute als een langdurige 
antidepressieve werking heeft in patiënten die verder niet reageren op klassieke 
antidepressiva, die hun eerste aangrijpingspunt hebben op het monoaminerge systeem. Van 
de klassieke antidepressiva is bekend dat ze pas effectief worden na chronische toediening 
van tenminste drie weken. De acute (binnen een uur) en langdurige werking van ketamine 
zijn daarmee erg interessant omdat dit impliceert dat de stof via, tot nog toe onbekende, 
monoamine-onafhankelijke mechanismen werkt. Om deze mechanismen te achterhalen heb 
ik gebruik gemaakt van de ‘forced swim test’. Dit is een preklinische test in muizen die 
effectief is in het voorspellen van de mogelijke antidepressieve werking van een stof. Met 
behulp van deze test heb ik ontdekt dat locale injectie van ketamine in de CA1 regio van de 
dorsale hippocampus een acute en langdurige (negen dagen na toediening) antidepressieve 
werking heeft. Door middel van immunoblot analyse op het synaptisch proteoom van de 
dorsale hippocmapus, heb ik vervolgens aangetoond dat negen dagen na toediening van 
ketamine de phosphorylatie van Ser-845 van α-amino-3-hydroxy-5-methylisoxazole-4-
propionic acid (AMPA) receptor subunit GluA1 verhoogd is. Dit duidt op een verhoogde 
‘turn-over’ snelheid – en daardoor op een mogelijke verhoogde receptor functie – van AMPA 
receptoren. Om aan te tonen dat het antidepressieve effect van ketamine wordt veroorzaakt 
door een verhoogde AMPA receptor activiteit in de hippocampus, hebben we deze situatie 
nagebootst door toediening van een TAT-Glu23Y peptide dat de gereguleerde endocytose 
van AMPA receptoren blokkeert. Toediening van dit peptide in de dorsale hippocampus had 
een antidepressieve werking in de ‘forced swim test’. Hiermee hebben we aannemelijk 
gemaakt dat de antidepressieve werking van ketamine in ieder geval deels wordt 
veroorzaakt door een verhoogde AMPA receptor functionaliteit in de hippocampus.  
 
Hoofdstuk 3: ‘Social defeat’ stress induceert veranderingen in de synaptische 
expressie van glutamate receptoren.  
Om een beter inzicht te krijgen in de moleculaire neurobiologie van depressie moet gebruik 
worden gemaakt van diermodellen met een sterke validiteit voor de ziekte in mensen. Het 
‘social defeat’ model in ratten is hiervan een goed voorbeeld. In dit model wordt gebruik 
gemaakt van een hevige sociale stressor, één maal per dag, voor vijf dagen achter elkaar. 
Hierdoor heeft  het model een sterke etiologische validiteit, aangezien psychosociale stress 
in mensen de vatbaarheid voor depressie sterk verhoogd. Met dit model heb ik aangetoond 
dat 24 uur na de laatste sociale stresservaring, het niveau van het stresshormoon 
coritcosteron in het bloedplasma 2.5 keer zo hoog is in vergelijking tot controle ratten. Deze 
sociale stress vermindert ook de prestatie van deze ratten in een hippocampus afhankelijke 
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cognitieve gedragstaak gebaseerd op het ruimtelijk geheugen. Bovendien heb ik 
aangetoond dat dit verminderde ruimtelijke geheugen gepaard gaat met een verlaagde 
synaptische expressie van de NMDA receptor subunits GluN1 en GluN2B en de AMPA 
receptor subunit GluA2 in de dorsale hippocampus. Vervolgonderzoek moet uitwijzen in 
welke mate de veranderde expressie van deze receptor subunits leidt tot 
elektrofysiologische veranderingen in synaptische plasticiteit.  
 
Hoofstuk 4: Gedragstherapie herstelt verminderde cognitieve prestaties na ‘social 
defeat’ stress, die samengaan met een verlaagde LTP en verhoogde synaptische 
expressie van AT1b2 in de hippocampus.  
In mensen komen depressieve symptomen meestal nog lang na een stressvolle 
levenservaring tot uitdrukking. Om een beter inzicht te krijgen in de neurobiologie van 
depressie en om op zoek te gaan naar moleculaire targets voor antidepressiva is het van 
grote meerwaarde om juist de lange termijn effecten van stress te onderzoeken. Om deze 
aanhoudende fase van depressie te modelleren hebben we ratten na ‘social defeat’ stress 
voor drie maanden in sociale isolatie gehouden. Door deze behandeling werden 
(hippocampusafhankelijke) cognitieve prestaties van ratten sterk verminderd. Dit zou 
overeen kunnen komen met de cognitieve disfuncties, zoals een verminderd geheugen, die 
vaak worden waargenomen in depressieve patiënten. De verminderde cognitieve capaciteit 
van deze ratten gaat gepaard met depressieve symptomen, zoals een verminderde 
anticipatie ten opzicht suikerwater. Bovendien konden zowel de verminderde cognitieve 
prestaties als de anhedonische symptomen hersteld worden door zowel gedragstherapie – 
bestaande uit dagelijkse huisvesting in een verrijkte omgeving gedurende een uur – alswel 
door een farmacologische behandeling, bestaande uit chronische toediening van het 
tricyclisch antidepressivum imipramine.  
Verder heb ik aangetoond dat deze verminderde cognitieve capaciteit lang na social 
defeat stress, gepaard gaat met een verlaagde lange-termijn-potentiatie (LTP) in CA3-CA1 
synapsen in de dorsale hippocampus. Deze plasticiteitsverandering is te herstellen middels 
de gedrags- en farmacologische therapie. Om te achterhalen welke moleculaire 
veranderingen in de synaps hieraan ten grondslag zouden kunnen liggen, werd met behulp 
van iTRAQ proteomics de samenstelling van het synaptische ‘proteoom’ in de dorsale 
hippocampus geanalyseerd. Dit is een zeer gevoelige techniek, die het mogelijk maakt om 
synaptische eiwitten te detecteren en kleine veranderingen in eiwitexpressie te 
kwantificeren. Hiermee heb ik gevonden, dat lang na ‘social defeat’ stress, de synaptische 
expressie van de Na,K ATPase subunit AT1b2 met ~40% verhoogd is ten opzichte van 
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controle ratten. Zowel gedragstherapie als chronische toediening van imipramine zijn in 
staat om de verminderde LTP en verhoogde AT1b2 expressie te normaliseren. Of de 
verhoogde expressie van AT1b2 ook de oorzaak is van de verminderde cognitieve 
prestaties zal in vervolgexperimenten onderzocht moeten worden.  
 
Hoofstuk 5: Neurogenese in de hippocampus is verminderd lang na social defeat 
stress 
In verschillende stress geïnduceerde modellen voor depressie in knaagdieren is in 
voorgaande studies een verminderde neurogenese in de hippocampus waargenomen. 
Bovendien zijn verschillende soorten antidepressiva in staat om deze verminderde 
neurogenese te herstellen. Deze bevindingen hebben geleid tot de neurogenese theorie van 
depressie. In dit hoofdstuk heb ik gekeken of neurogenese ook aangetast is in de 
aanhoudende fase van de depressieve symptomen, dus lang na de laatste ‘social defeat’ 
ervaring. Hiervoor heb ik door middel van stereologische technieken het aantal doublecortin 
(DCX) immunopositieve cellen bepaald. DCX is een marker voor nieuwgeboren immature 
neuronen. Op basis van de morfologie van de dendritische bomen van deze cellen heb ik 
specifiek het aantal jonge (klasse-I) en meer volgroeide (klasse-II) DCX positive (DCX+) 
cellen bepaald. Het aantal DCX+ cellen was sterk verminderd lang na ‘social defeat’ stress, 
hetgeen vooral werd veroorzaakt door een afname van klasse-II cellen, terwijl het aantal 
klasse-I cellen onveranderd was. In tegenstelling tot verhoogde niveaus stresshormoon 
corticosteron direct na de ‘social defeat’, was op de lange termijn het niveau genormaliseerd 
tot dat van controle dieren. Verder heb ik laten zien dat chronische behandeling met 
imipramine de vermindering in neurogenese herstelt door een toename van zowel klasse-I 
als klasse-II cellen te bewerkstelligen. Hieruit kunnen we concluderen dat, ondanks dat de 
stresshormoon niveaus genormaliseerd zijn, neurogenese blijvend is aangetast na ‘social 
defeat’ stress door een afname van klasse-II cellen. Het is opmerkelijk dat imipramine de 
verminderde neurogenese in dit late stadium nog kan herstellen.  
 
Conclusie 
In dit proefschrift heb ik laten zien dat in verschillende diermodellen voor depressie, diverse 
plasticiteitsprocessen in de hippocampus zijn aangetast. Interessant daarbij is dat deze 
processen niet direct gekoppeld zijn aan het monoaminerge systeem. Dus met dit 
onderzoek zijn nieuwe mechanismen gekarakteriseerd, die mogelijk kunnen worden gebruikt 
voor farmacologische interventies. Bovendien heb ik aangetoond dat andere moleculaire 
processen betrokken zijn bij de lange termijn effecten van stress, in vergelijking tot de acute 
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effecten die betrokken zijn bij de inductie van depressieve symptomen. De karakterisatie van 
deze lange termijn effecten is interessant voor ontwikkeling van nieuwe antidepressiva, 
aangezien depressieve patiënten over het algemeen pas lang na een stressvolle 
levenservaring worden behandeld. Een andere interessante bevinding is dat 
gedragstherapie een vergelijkbare efficiëntie heeft in het verminderen van 
stressgeïnduceerde depressieve symptomen in vergelijking tot chronische behandeling met 
imipramine. Bovendien was de gedragstherapie net zo efficiënt in het herstellen van 
aangetaste plastische processen in de hippocampus. Deze bevinding heeft mogelijk een 
implicatie voor de behandelingsstrategie van depressie, die in de toekomst wellicht meer op 
activiteitentherapie gericht zou kunnen worden.  
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Dankwoord 
 
Yeah!!! Mijn proefschrift is af. Eens even terug kijken. Was het leuk? Een van de coolste 
dingen die ik ooit heb gedaan. Was het zwaar? Viel best mee. Ooit spijt gehad? Nee nooit. 
Veel geleerd? Van handmatig cellen tellen tot hoe de wereld in elkaar zit. Ga ik het missen? 
Heel erg, ik zal mijn passie voor de wetenschap altijd meedragen. Had ik het alleen kunnen 
doen? Nee nooit, daarom wil ik hier een aantal mensen bedanken. 
 
Ten eerste de mensen die dit proefschrift voor een groot gedeelte mogelijk hebben 
gemaakt, Sabine Spijker, Guus Smit en Witte Hogendijk. Sabine, ik weet zeker dat ik 
helaas nooit meer een ‘baas’ zal krijgen zoals jij, je bent een uniek persoon. Bedankt voor 
alle vrijheid die je me altijd hebt gegeven en vooral voor je oneindige enthousiasme. 
Guus, in de jaren dat ik hier werkte is de afdeling enorm gegroeid. Door je zeer brede 
maar ook specifieke kennis heb je toch altijd controle over alle projecten kunnen houden. 
Dit geeft een stabiele basis waardoor ik nooit heb getwijfeld of mijn project wel tot een 
goed einde zou komen. Bedankt daarvoor. Guus en Sabine, door jullie plezier in het werk 
en vrijheid die jullie geven zorgen jullie voor een ongekend goede werksfeer op het lab. 
Dat ga ik niet snel ergens anders vinden. Witte, je stond iets verder van mijn onderzoek 
af, maar ik heb onze besprekingen altijd als bijzonder prettig ervaren. Hiermee heb je 
ervoor gezorgd dat ik mijn onderzoek altijd vanuit een humaan oogpunt bleef bekijken. Dit 
heeft voor een juiste balans in mijn proefschrift gezorgd.   
 
Tijdens mijn promotieonderzoek heb ik met een aantal collegae goed en met veel plezier 
samengewerkt. Hierdoor hebben zij ieder een wetenschappelijke bijdrage aan mijn 
proefschrift geleverd. Samen met Johanneke van der Harst heb ik het social defeat model 
opgezet op de Vrije Universiteit. Ik denk een enorm valide model waar de VU nog veel 
profijt van gaat hebben. Paul Lucassen, de neurogenese experimenten die ik bij jullie op 
het lab heb uitgevoerd, waren een welkome afwisseling op mijn werk op de VU. Ik heb 
me altijd erg thuis gevoeld op de UvA en bovendien heeft dit tot een mooi artikel en 
hoofdstuk geleid. Danai, what happens in the basement stays in the basement. Door 
samen met Erwin van Geldrop flexibel met bureaucratie om te gaan heb ik mijn 
gedragsexperimenten tot een goed einde kunnen brengen. Paul van Eijck, de 
experimenten op de microarray facility waren goed, en vooral netjes, uitgevoerd. Helaas 
vind je niet altijd significante resultaten, ook al analyseer je 44.000 probes. Roel van der 
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Schors, de proteomics experimenten die we samen hebben uitgevoerd, hebben de basis 
gelegd voor hoofdstuk drie en vier van dit proefschrift. En tussendoor hielden we ook nog 
in de gaten of één van de gebroeders Schleck al aan het demarreren was op de 
Toumalet. Huib Mansvelder, Tim Heistek en Jaap Timmermans, de elektrofysiologische 
metingen die ‘op de vierde’ uitgevoerd worden, zijn onmisbaar voor gedegen 
neurobiologisch onderzoek. Bruce Jencks, gedurende mijn master aan de Radboud 
Universiteit heb je me tijdens je fantastische colleges over de neurobiologie enthousiast 
weten te maken voor dit vakgebied. Dat heeft indirect tot dit proefschrift geleid.   
 
Every day I went to the VU, I went there happily. That’s for the most part because of my 
colleagues. Especially the ones from the first and the last hour. In order of appearance: 
Pri (the Berlin Bombs will always be in my memory, or they won’t, I don’t really know), 
Nutabi, Eva, Rolinka, Frau Klemmer, Jochem (SQ), Marlene, Bart (godverdomme!), 
Danai (shoe!), and Michel. Probably the best part of my PhD was having the chance to 
get to know all of you. You are all amazing people, each in your very, very own way. 
There is no limit in the amount of fun we had both inside and outside the lab, during lunch 
breaks, coffee breaks, just random breaks, Friday beers in ‘de Stelling’, lab outings, 
conferences, and Indian weddings. And ooohhw man, we know how to party! 
Bart, ik ben blij dat je mijn paranimf wilt zijn en met de vriendschap die we de afgelopen 
tijd hebben opgebouwd. Jochem, we vormen een super goed team en ik denk dat onze 
samenwerking zeker zijn vruchten af gaat werpen.  
 
Andere collega’s: Pim, Harold, Danielle, Maarten, Loek, Yvonne (ik verwacht het 
bierkanon op mijn promotiefeest), Mark, Nikhil, Andrea, Ronald, Brigitte, Marion, Anna, 
Remco, Ruud, Ka Wan, Ning, ‘Stelling-gangers van de vierde’, de ONWAR aio’s van de 
UvA, en mijn JtF commissiegenootjes. Jullie gezelligheid en wetenschappelijke bijdrage 
waren voor mij van onschatbare waarde! 
 
 
Daarnaast wil ik mijn vriendenkring bedanken. Een groep mensen met een oneindige 
hoeveelheid humor en levenslust. Daarmee zijn ze een onmisbare steun. Bovendien hebben 
ze indirect een belangrijke bijdrage aan dit proefschrift geleverd. Een doel van dit 
proefschrift was het vinden van een effectieve behandeling van depressie. Stap-voor-stap 
komt de wetenschap dichterbij, maar er is nog een lange weg te gaan. Gelukkig weet ik 
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dankzij jullie al wel hoe je een depressie kan voorkomen. Ik adviseer een intensieve omgang 
met de volgende personen: 
 
Mijn drie maten: Paul, Heck en Sté: grollen in het huis, kijken of er een bandje speelt in 
Dadas, Hein stompjes geven als hij die verdient (eigenlijk altijd wel), rennen over het 
spoor, vier frikadellen. Wie wil er een Bator? Rik, praten over voetbal, wetenschap en 
vrouwen. Wat wil een mens nog meer. De koningen van de Regulierstraat en Krista, er is 
voor mij geen mooier moment in het jaar dan het moment waarop er op een vrijdagavond 
in mei ‘Moonshadow’ uit de speakers komt. Again my colleagues. Scheldeplein 6: Veer, 
Eef, Sexma en Jeroen, Brabantse gezelligheid in Amsterdam. Chaan, ooit zullen onze 
telefoongesprekken tot radioprogramma gepromoveerd worden. We bellen (smiley). 
Maart, we hebben lang naar de Buurvrouw gezocht en veel later ook gevonden. Dat 
hebben ze geweten. Lisa, wij weten elkaar ongevraagd te motiveren en hebben veel 
plezier, ook samen met Lau en Janna. Anneke vd Bijgaart, jij hebt het in genetisch 
opzicht wel zo goed voor elkaar. Daardoor ben je zo chill. Dalila, nergens eet ik zo lekker 
uit ergonomisch en esthetisch volmaakte bakjes. De Venmilie, een bont gezelschap van 
warmte en vooral gezelligheid.  
 
Mijntje, tijdens het schrijven van dit dankwoord ben je steeds een stukje verder richting 
het einde opgeschoven. Schuif maar lekker door, dan heb ik straks ’t lekkerste voor ’t 
laatst.  
 
Tot slot, mijn familie. Ik denk dat het afgelopen jaar duidelijk is gebleken hoe sterk onze 
band is. Mam en Jack, jullie zijn er altijd voor me geweest. Ook al maak ik soms andere 
keuzes dan jullie voor ogen hebben, ik word altijd door jullie gesteund. Een steun die rust 
geeft, maar ook motiveert. Jullie hebben me enthousiast weten te maken voor alles wat er in 
deze wereld speelt.  
Mijn zus, Anneke; onbegrensd, onbezonnen, doelgericht, gepassioneerd, alom geliefd en vrij 
van geest. En dan ook nog super lief.  
 
 
Pieter 
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Curriculum Vitae 
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